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ABSTRACT
N-HETEROCYCLIC CARBENES:
FROM DESIGN TO SYNTHESIS AND THEIR APPLICATION AS NUCLEOPHILIC 
CATALYSTS
Justin Robert Struble
Jeffrey W. Bode
Our group has pioneered novel internal redox process of aldehydes possessing an 
internal !-reducible functionality mediated by N-heterocyclic carbenes (NHCs). Two 
discrete discoveries have been crucial to the success of our program. The first has been 
the identification of  reaction parameters intimately related to the fate of the putative 
reactive intermediates to exquisitely allow  access to a single reaction outcome (e.g. 
NHC-enolate vs homoenolate). The second, and more crucial, has been the 
development of  new  N-mesityl substituted triazolium and imidazolium salts that serve as 
precursors to the N-heterocyclic carbene nucleophilic catalyst. Our achiral and chiral, 
bicyclic N-mesityl triazolium salts have shown unprecedented reactivity and selectivity in 
a variety of conceptually new  transformations. As such we have been the first to disclose 
highly enantioselective intermolecular annulations providing access to stereochemically 
rich heterocycles. Moreover, the synthesis of  a novel N-mesityl aminoindanol-derived 
imidazolium salt allowed for the first time the investigation into the inherent reactivity 
differences that exist between two classes of NHCs (triazolium vs. imidazolium). Current 
efforts toward catalyst development via a combinatorial approach promise the 
opportunity to discover new enantioselective NHC-catalyzed processes.
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Chapter 1:  History of N-Heterocyclic Carbenes (NHCs) as  
 Nucleophilic Catalysts
1.1  Introduction
 Over the past two decades N-heterocyclic carbenes (NHCs) have received 
increasing attention due to their storied role as ligands for transition metal complexes 
and, more recently, their remarkable properties as catalysts in their own right. For 
transition-metal-mediated processes they act as surrogates for phosphine ligands due 
their well-documented !-donating abilities.1–3 Perhaps even more impressive is their 
ever-growing use as nucleophilic organocatalysts that promote a variety of  umpolung or 
“charge reversal” processes.4–7 Beside their facile reactivity and selectivity, NHCs are 
also touted as environmentally safe whereby they tend to exhibit little to no toxicity and 
the reaction conditions in which they are used are often very mild. 
Y
N Z
RR
N S
R
N N
RR
N
N N
RR
H
Base
+
X
Figure 1. General classes of N-heterocyclic carbenes employed as nucleophilic catalysts.
1
 In general there are three types of NHCs used in small molecule catalysis; all of 
which are most commonly derived from their bench-stable parent salts upon 
deprotonation of  the C-2 proton with a suitable base (Figure 1). The three types stem 
from the difference in the heteroatomic ring. Thiazolium salts bear a sulfur atom (Y = C, 
Z = S) in the parent heterocycle; imidazolium salts are imidazole derivatives whereby 
two nitrogen atoms flank the C-2 center and can be fully saturated at the C-4 and C-5 
positions (Y = C, Z = N); and triazolium salts, which are derivatives of 1,2,4-triazoles (Y = 
N, Z = N) containing three nitrogen atoms in the carbene heterocycle. Although N-
heterocyclic carbenes possess the common features of all carbenes as neutral, six-
electron, bivalent species they are particularly stable compared to the classical carbenes 
discovered at the turn of the 19th century by Buchner and Curtius8 and Staudinger and 
Kupfer9 due to the presence of the heteroatoms adjacent to the singlet carbene center. 
1.2  Reactions of Acyl Anion Equivalents: The Benzoin and Stetter   
 Reaction
 1.2.1 Reactions of Acyl Anion Equivalents: The Benzoin Condensation
 Discovered in 1832 by Liebig and Wöhler,10 the benzoin reaction is one of the 
oldest reactions in organic chemistry. Classically, the reaction was catalyzed by the 
cyanide ion that causes the self condensation of an aryl aldehyde to produce an !-
hydroxyketone (Scheme 1). In 1903, Lapworth proposed a mechanism whereby addition 
of hydrogen cyanide across the carbonyl of benzaldehyde followed by deprotonation 
resulted in an anion of  inverted nucleophilic reactivity which he termed an “active 
aldehyde”.11 The catalytically generated “active aldehyde” has since been renamed as 
an “acyl anion equivalent” and represents an umpolung of the aldehyde C-1 position 
from an electrophile to a nucleophile (a1"d1).12 
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Scheme 1. Cyanide catalyzed benzoin condensation.
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Scheme 2. Breslow’s proposed mechanism for the thiazolium-catalyzed benzoin condensation.
 In 1943, Ukai et al. found that the vitamin B1 enzyme cofactor thiamine, a naturally 
occurring thiazolium salt, catalyzed the benzoin self-condensation of benzaldehyde.13 
Shortly thereafter, in his seminal 1958 report, Breslow  proposed that the C-2 conjugate 
3
base of  the thiazolium ring acts as a nucleophilic ylide (a mesomeric structure to the 
carbene) to activate the aldehyde in analogous manner to cyanide.14 The overall 
catalytic process is presented in Scheme 2. Deprotonation of  thiazolium salt I yields the 
free carbene II that undergoes nucleophilic attack on benzaldehyde. A proton transfer 
event produces IV (the Breslow  intermediate), a resonance form of V (the acyl anion 
equivalent) that undergoes nucleophilic attack on a second equivalent of  benzaldehyde. 
A subsequent proton transfer event yields VI, this intermediate collapses to produce the 
!-hydroxyketone benzoin and regenerate the nucleophilic carbene catalyst II. 
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Figure 2. Selected chiral thiazolium salts for the asymmetric benzoin condensation.
 In addition to the formation of  a new  C–C bond, the benzoin reaction creates a new  
stereogenic center. Naturally, this caused an explosion of  interest in the synthesis of 
chiral heteroazolium salts to render the benzoin reaction enantioselective. In 1966, 
Sheehan was the first to validate this concept when he reported an asymmetric benzoin 
4
condensation, albeit with low  yield and enantioselectivity (22% ee), using chiral 
thiazolium salt 1 (Figure 2).15 In 1974, he introduced a modified precatalyst 2 that offered 
improved enantioselectivity (52%) but with a meager yield of only 6%.16 Since these ini-
tial reports, many research groups have focused on the production of  chiral thiazolium 
salts for improving the efficiency and selectivity of the asymmetric benzoin condensation. 
Notable contributions are summarized in Figure 2.17–20
 Before 1997, the chiral thiazolium catalysts possessed a free degree of rotation in 
the chiral element adjacent to the reactive site. Leeper and co-workers19 as well as 
Rawal20 were the first to present the rational design of chiral thiazolium salts with a rigid 
backbone that they hypothesized would restrict the degrees of  free rotation during the 
C–C bond-forming event and thus lead to enhanced selectivity. Although their initial 
designs fell short of achieving high enantioselectivity (See Figure 2 5 and 6), this 
thinking laid the groundwork for subsequent heteroazolium NHC catalyst design. 
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Scheme 3.  Arduengo’s isolation of free imidazolium-derived carbenes.
 With that in mind, the field of  asymmetric benzoin heteroazolium catalysis 
underwent a resurgence when two events unfolded. The first was the isolation and 
characterization of a stable heteroazolium-derived carbene (often termed Wanzlik 
carbenes after his pioneering research in the area)21, 22 by Arduengo in 1991 (Scheme 
3a).23 He later went on to isolate and fully characterize several imidazolium-derived 
5
carbenes with less bulky substituents (Scheme 3b).24 These reports presented solid 
evidence that the previously implicated carbenes in NHC-promoted processes were real. 
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Figure 3. Selected chiral triazolium NHC catalysts for the asymmetric benzoin condensation.
 The second event was Enders’ synthesis of a chiral triazolium-derived NHC in 
1996 that was capable of  catalyzing the asymmetric benzoin condensation thus opening 
up the possibility to include an extra degree of chirality compared to the thiazolium 
counterpart.25 This work was followed by several groups in the next decade designing 
and synthesizing chiral triazolium salts that led to the vast improvement in efficiency and 
selectivity in the benzoin reaction. Recent identification of  bistriazolium NHC 12 currently 
stands as the state of the art for asymmetric benzoin condensation (Figure 3).26–28 
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Figure 4. Intramolecular aldehyde-ketone crossed benzoin.
 In 2003, Suzuki, Hachisu and Bode reported the first crossed-benzoin reaction 
between a ketone and an aldehyde for the preparation of preanthraquinones using a 
thiazolium NHC catalyst.29 They followed up in 2006 with an asymmetric variant 
employing a chiral triazolium salt 13 derived from cis-1,2-aminoindanol.30 In 
contemporaneous work, Enders and co-workers published an asymmetric version of the 
intramolecular crossed-benzoin reaction utilizing a novel chiral triazolium NHC catalyst 
14 to produce 5- and 6-membered acyloins in moderate to high yield and 
enantioselectivity (Figure 4).31, 32
 1.2.2 Reactions of Acyl Anion Equivalents: The Stetter Reaction
 In the early 1970s Stetter developed a logical extension of the benzoin reaction by 
employing a Michael acceptor as the electrophilic partner for the acyl anion addition to 
provide 1,4-dicarbonyl derivatives (Scheme 4).33, 34 As with the benzoin condensation the 
first Stetter addition was catalyzed by the cyanide ion and was then extended to 
thiazolium salts shortly thereafter in 1976.35, 36
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Scheme 4. The Stetter reaction.
 A possible detriment in the intermolecular Stetter reaction is for the donor aldehyde 
to undergo a self-benzoin condensation instead of  the 1,4-addition. In 2004, Scheidt and 
co-workers37 developed a strategy that employs acylsilanes as precursors to acyl anion 
equivalents.38–40 Using a thiazolium catalyst in the presence of an acylsilane and a 
conjugate acceptor smoothly afforded the corresponding Sila-Stetter adducts in good 
yield (Scheme 5).
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Scheme 5. Thiazolium catalyzed Sila-Stetter reaction.
 In the postulated catalytic cycle the carbene catalyst I, formed in situ via 
deprotonation by base, undergoes nucleophilic addition to the acylsilane 15. A 
subsequent 1,2-silyl migration (Brook rearrangement) affords II and III that undergoes 
desilyation in the presence of  DBU and alcoholic solvent (i-PrOH) to afford the Breslow 
intermediate IV. A 1,4-addition to the Michael acceptor 16 and collapse of  the tetrahedral 
intermediate V expels the carbene catalyst I and the Stetter product 17 (Figure 5). In 
subsequent reports, Scheidt and co-workers extended this concept employing a one-pot 
process for the production of furans and pyrroles41 as well as acyl anion addition to N-
8
phophinoylimines42 and toward the direct acylation of  nitroalkenes43 in the presence of a 
thiourea and a fluoride source.
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Figure 5. Mechanistic proposal for the Sila-Stetter reaction.
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 Although the Stetter reaction offered great promise for the synthesis of  optically 
active 1,4-dicarbonyl derivatives, it laid much less explored for the greater part of two 
decades. In 2002, Enders and co-workers reported the first asymmetric intermolecular 
Stetter reaction between n-butanal and chalcone using chiral thiazolium catalyst 22, 
albeit only as a footnote in a review  possibly due to the poor yield and moderate 
selectivity (Scheme 6).44, 45 More recently Enders and Han communicated an 
enantioselective intermolecular Stetter addition between 2-furyl-aldehydes and 
arylidenemalonates. Enantioselectivities of up to 76% (up to 99% after one 
recrystalization) were achieved using N-benzyl chiral triazolium catalyst 26 derived from 
pyroglutamic acid (Scheme 7).
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Scheme 7. Highly asymmetric intermolecular Stetter reaction reported by Enders.
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Scheme 8. First detailed study of the intramolecular Stetter reaction reported by Ciganek.
 The intramolecular Stetter reaction has received considerably more attention than 
the intermolecular variant. Starting in 1995, Ciganek reported an interesting 
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intramolecular version of the Stetter reaction to provide benzo-annulated furanones and 
pyranones using the achiral thiazolium salt 27.46 The transformation of 28 to 
benzannulated pyranone 29 has become the test for catalyst efficiency and selectivity in 
the intramolecular Stetter reaction (Scheme 8). Enders was the first to disclose an 
asymmetric variant of this transformation employing the same chiral triazolium 
precatalyst 7 (See Figure 3) that was used to promote the asymmetric benzoin 
condensation.47
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N N
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X X
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electronic/steric
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counteranion
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cis-1,2-amino
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N N
N
Bn
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35 Ar2 = Ph
36 Ar2 = p-CF3C6H4
37 Ar2 = C6F5
N
NN
O
Ar1
32 Ar1 = Ph
33 Ar1 = p-anisyl
34 Ar1 = C6F5
BF4
Figure 6. Rovis’ approach to chiral catalyst design for the asymmetric intramolecular Stetter 
reaction.
 Beside a few  scattered reports for the asymmetric intramolecular Stetter reaction, 
the research program developed by Rovis and co-workers has emerged at the forefront 
of this transformation. Since 2002, they have disclosed several reports regarding highly 
enantioselective intramolecular Stetter additions, and their body of  work has recently 
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been nicely reviewed.45 The success of their program has been a direct result of their 
systematic studies of two chiral bicyclic triazolium scaffolds: 31 derived from chiral 
pyrrolidinones and 32 derived from chiral 1,2-cis-amino alcohols (Figure 6).45 These 
studies originate from the pioneering work of Knight and Leeper who were the first to 
report these chiral motifs for use in the asymmetric benzoin condensation.26 Rovis’ 
subsequent investigation of  these motifs has led to the identification of superior catalysts 
of two general classes that efficiently catalyze the intramolecular Stetter reaction with 
high levels of enantioselectivity for a variety of  tethered electrophiles. The first class are 
triazolium salts 32–34 derived from aminoindanol; the second are triazolium salts 35–37 
derived from a chiral pyrrolidinone that ultimately is traced back to L-phenylalanine.
H
O
X EWG
R1
X = C, NR2, O, S
EWG = –CO2R, CO(SR),                
               COR, CO(NR2), 
               CN, PO(OEt)2, PO(Ph)2
NHC cat.
base
solvent
X
O
EWG
R1
up to 99% ee
Scheme 9. Rovis’ systematic study of aromatic substrates in the intramolecular Stetter 
reaction.
! The two catalyst scaffolds provided complementary reactivity and selectivity when 
it came to substrates that were unsatisfactory in either reactivity or selectivity. In general 
the aminoindanol motif often led to a higher degree of  selectivity whereas the 
phenylalanine-derived motif was on average more reactive.45 Thus, Rovis and co-
workers were able to probe systematically the various effects of the substrate in the 
asymmetric intramolecular Stetter reaction. They began investigating aromatic 
substrates and probing the effects of different tethers and and tether lengths, substitution 
of the aromatic ring, and type of electron-withdrawing-group (Scheme 9). They found 
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that carbon, nitrogen, sulfur and oxygen were all well tolerated in the tether and that 5 
and 6-membered rings formed smoothy while seven-membered rings were often 
unsuccessful. The aromatic backbone tolerated electron-donating and electron-releasing 
groups as long as the position was not ortho to the aldehyde. Finally, this method was 
also extended to the production of all carbon quaternary stereocenters often in high yield 
(11–96%) and enantioselectivity (82–99%).48
O
H
OR
O
O
O
OR
R
R
20 mol% 32
20 mol% KHMDS
toluene
O
O
OEt
R
O
O
OEt
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>90% yield
85/15 cis/trans
94–96% ee cis
98% ee trans
95–98% ee cis
84–94% ee trans
<5% ee cis
<5% ee trans
Scheme 10. Effects of preexisting stereocenters in the intramolecular Stetter reaction.
 Next they extended the scope of the intramolecular Stetter reaction to aliphatic 
substrates utilizing NHC precatalysts 34 and 35, affording good yields and enantiomeric 
excesses of up to 99% even for cases that produced a quaternary stereocenter. This led 
them to probe the effect of preexisting stereocenters on the cyclization event to produce 
chiral disubstituted-cyclopentanones (Scheme 10).49 Interestingly no diastereoselectivity 
was observed upon cyclization when the preexisting stereocenter was at the 3- or 4-
position; however, high levels of enantioselectivity for both the cis and trans isomer were 
achieved. Conversely, when the preexisting stereocenter was at the 2-position (alpha to 
the aldehyde) then good levels of  diastereoselectivity were observed but no 
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enantioselectivity suggesting that the substrate stereocenter overrides the catalyst 
selectivity preference.
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O
H R
CO2Me
CO2Me
20 mol% 37
100 mol% DIPEA
CCl4, MgSO4, !10 °C
+
O
N
O
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CO2Me
CO2Me
R
51–97% yield
80–91% ee
38 39 40
Scheme 11. Asymmetric intermolecular Stetter addition of glyoxamides to alkylidenemalonates.
 Finally, Rovis and co-workers turned their sights back toward the asymmetric 
intermolecular Stetter reaction and in 2008 disclosed the Stetter reaction between 
glyoxamides 38 and alkylidenemalonates 39 (Scheme 11).50 The N-pentafluorophenyl 
phenylalanine-derived NHC precatalyst 37 provided the proper balance for promoting 
the addition with excellent yields and enantioselectivities. Noteworthy is that the authors 
have demonstrated that the Stetter products could be converted to "-lactones with three 
contiguous stereocenters as a single diastereomer with 90% ee. Very recently, Rovis 
and co-workers have disclosed two subsequent highly diastereo- and enantioselective 
intermolecular Stetter reactions.51, 52 With the aforementioned set of  NHC precatalysts, it 
is likely that a general asymmetric Stetter reaction will someday soon come to fruition.
1.3  NHC-Promoted Transesterifications
 Early contributions to the NHC-promoted esterification were reported in 1994 by 
the Smith research group.53 The transfer of  an alkoxycarbonyl from 2-alkoxycarbonyl-
imidazolium salts to benzyl alcohol was carried out in the presence of  DABCO. However, 
several limitations existed; notably the alkoxycarbonyl unit was transferred directly from 
a preformed stoichiometric amount of the 2-alkoxyimidazolium salts (Scheme 12).
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68–78% yieldR1 = alkyl, benzyl
Scheme 12. NHC-mediated transesterification developed by Smith and Bakhtiar.
 In 2002, the research groups of  Nolan54 and Hedrick55 concurrently reported the 
first NHC-catalyzed transesterification reactions using substoichiometric amounts of an 
N-heterocyclic carbene catalyst (Scheme 13). In the case of  Nolan and co-workers, as 
little as 0.5 mol% catalyst loading of  either IMes (44) or ICy (45) could efficiently promote 
an acyl transfer from vinylacetate to primary alcohols under mild conditions. The work of 
Hedrick and co-workers expanded the scope of  the reaction to secondary alcohols by 
employing the NHC 43 and benzoylacetate as the acetylating agent. An interesting 
application to arise from this process was the production of  several polyesters. In 2004, 
Nolan followed up on his initial report and expanded the scope of the NHC-promoted 
transesterification to a variety of secondary alcohols including aliphatic, cyclic and 
aromatic by using NHC 45 in the presence of methyl- or ethyl acetate and molecular 
sieves to drive the equilibrium reaction.56 A limited number of tertiary alcohols 
participated in the transesterification albeit under prolonged reaction times and high 
catalyst loadings.
O
OR2R1 + R
3OH
NHC cat.
base, rt
O
OR3R1 R
2OH+
N N
44, R4 = Mes
45, R4 = Cy
43, R4 = Me
R
4R
4
Scheme 13. NHC-promoted transesterification reactions developed by Nolan and co-workers 
and Hedrick and co-workers.
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Scheme 14. NHC-catalyzed kinetic resolution of secondary alcohols by Suzuki (Top) and 
Maruoka (Bottom)
 An interesting extension of this method came from the groups of Suzuki57, 58 and 
Maruoka59 whereby a C2-symmetric chiral imidazolium salt 46 was used to promote the 
kinetic resolution of  chiral secondary alcohols. The initial report from Suzuki et al. pro-
duced up to 58% ee using vinyl acetate as the acetylating agent and later 68% with vinyl 
propionate. Maruoka et al. found that by employing the preformed free carbene of 46, 
formed by deprotonation with t-BuOK, and the more sterically demanding vinyl diphenyl 
acetate led to improved enantiomeric excesses of  up to 96% (Scheme 14). However, it 
should be noted that in 2004 Rovis and co-workers disclosed the kinetic resolution of 
racemic ethyl lactate and racemic hydrobenzoin using a catalytically generated activated 
carboxylate from an !-bromoaldehyde and a chiral bicyclic triazolium salt (vida infra).60 
16
1.4  Internal Redox Reactions of !-Functionalized Aldehydes
 1.4.1 Activated Carboxylates
 An activated carboxylate refers to a carbonyl-derived species that is more 
susceptible to nucleophilic attack than a free carboxylic acid. Examples of  classical 
activated carboxylates include, but are not limited to, thioesters, acyl cyanides, acid 
halides, acid anhydrides, and activated esters of  carboxylic acids formed from common 
peptide coupling reagents such as HOBt or HATU. However, NHCs can act as potent 
reagents for transforming an aldehyde possessing an internal, !-reducible functional 
group into an activated carboxylate poised for nucleophilic displacement. This basic 
process is outlined in Scheme 15. The nucleophilic carbene, either preformed or formed 
in situ in the presence of base, undergoes nucleophilic attack on the aldehyde, giving 
rise to a tetrahedral intermediate that upon proton transfer renders the Breslow 
intermediate. Internal displacement of the reducible functional group X yields an NHC-
enol intermediate that tautomerizes to the activated carboxylate.
O
H
R1
X
X = reducible functional group
      e.g. unsaturated bond, halide,
             epoxide or aziridine
Y
NZ
R2+
X
R1
Z
Y
N
O H R
2
X
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Z
Y
N
R2OH
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Intermediate
proton
transfer
R1
Z
Y
N
R2OHR1
Z
Y
N
R2O
Activated 
Carboxylate
Tetrahedral
Intermediate
tautomerism
Enol
Intermediate
Scheme 15. NHC-promoted formation of activated carboxylates from aldehydes possessing an 
internal !-reducible functional group.
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 In 2004, Ken Chow  from our group successfully applied this concept to the 
stereoselective synthesis of #-hydroxyesters from chiral !,#-epoxyaldehydes employing 
thiazolium NHC precatalyst 51 (Scheme 16).61 In the same report our group disclosed 
the redox esterification of chiral N-tosylaziridinyl aldehydes. The postulated catalytic 
cycle is presented as follows (Figure 7). Deprotonation of  thiazolium precatalyst 51 
yields the free carbene I which undergoes nucleophilic attack on the epoxyaldehyde 55 
leading to the tetrahedral intermediate II. A proton transfer event forms the Breslow 
intermediate III. Internal opening of the epoxide followed by a second proton transfer 
event affords NHC-enolate V. Alcohol-mediated tautomerization renders the activated 
carboxylate VI which undergoes nucleophilic attack by the resultant alkoxide to turnover 
the carbene catalyst and expel the #-hydroxyester 56.
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N SBn
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Me Me
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10 mol%
8 mol% DIPEA
CH2Cl2, 30 °C 
3–15 h
O
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up to >10:1 dr
51
+
Scheme 16. NHC-catalyzed redox esterification of !,#-epoxyaldehydes and !,#-N-
tosylaziridinyl aldehydes with thiazolium 51.
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Figure 7. Postulated catalytic cycle proposed by Bode for the NHC-catalyzed redox 
esterification of !,#-epoxyaldehydes.
 Around the same time Rovis and co-workers communicated the redox esterification 
of !-haloaldehydes under mild conditions in good yield utilizing triazolium NHC-
precatalyst 35•Cl (Scheme 17).60 It is noteworthy that the use of chiral triazolium salt 57 
exemplified the desymmetrization of  a meso-diol in 75% yield and 83% ee, suggesting 
that the chiral NHC catalyst was intimately involved in the bond-forming event. In 2005, 
Rovis et al. extended this method to redox esterification of !,!-dichloroaldehydes with 
phenols employing the chiral aminoindanol-derived triazolium salt 34 to produce highly 
enantiomerically enriched !-chloroesters (up to 93%) in good yield.62
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Scheme 17. Redox esterification of !-haloaldehydes reported by Rovis.
 An impressive extension of this reaction reported by Dr. Stephanie Sohn from our 
group is the ring-opening esterification of formylcyclopropanes.63 The internal reducible 
functional group is a C–C bond and both alcohols and thiols are viable nucleophiles. In 
the case where chiral trisubstituted formylcyclopropanes 61 are employed, acyclic #-
substituted carbonyl derivatives 62 are obtained (Scheme 18). 
+ Nu–H
N N
N Cl
5 mol%
20 mol % DBU
THF, 23–40 °C, 15 h
81–99% yield
Nu = OR, SR,
EWG
O
H
R1
EWG
O
Nu
R1
Mes
63
61 62
Scheme 18.  NHC-mediated reductive opening of formylcyclopropanes
 In related processes, Sohn reported the amidation of aldehydes with an !-reducible 
functional group (Scheme 19).64 She found that a stoichiometric amount of  imidazole 
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was essential to overcoming imine formation between the starting aldehyde and the 
amine nucleophile. The reaction was optimized for the use of  formylcyclopropanes and 
further exemplified by use of !-chloroaldehydes and enals as aldehyde substrates. Both 
primary, including O-protected (L)-phenylalanine, and secondary amines were smoothly 
acylated. Current efforts are underway in our group to exploit this reaction as a means 
for the kinetic resolution of racemic amines. In parallel studies, Rovis and co-workers 
have documented a similar redox amidation of aldehydes bearing an !-reducible bond.65 
They employed !,!-dichloraldehydes, !,#-unsaturated aldehydes, !,#-epoxyaldehydes 
and !,#-aziridinylaldehydes as substrates and HOAt as the stoichiometric acyl transfer 
reagent.
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Scheme 19. NHC-promoted amidation of aldehydes with an internal reducible bond reported 
by Sohn and Bode.
 It is well-known that thiazolium salts catalyze the oxidation of aldehydes to esters.66 
In the presence of a suitable NHC catalyst, the initially formed 1,2-adduct can be 
oxidized directly to the activated carboxylate, which upon nucleophilic displacement of 
the bound catalyst by an alcohol affords the ester. Significant contributions have been 
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reported by Shinkai,67 Diederich,68, 69 and Higashiura,70, 71 using a combination of 
thiazolium-derived NHC-catalysts and Fe(III) salts as the stoichiometric oxidant. In 
recent years, the Scheidt group has expanded on this tandem oxidation/NHC-redox 
esterification process. Initial reports focused on the in situ oxidation of allylic, benzylic 
and propargylic alcohols to the corresponding !,#-unsaturated aldehyde using MnO2.72 
The authors noted the sensitivity of  the reaction toward azolium catalysts; specifically a 
triazolium catalyst was necessary to provide faster and more complete reaction 
conversion. Subsequently, they have greatly expanded the scope of this process to 
include aliphatic alcohols as well aliphatic and !,#-unsaturated aldehydes.73, 74 Very 
recently, Studer and co-workers reported the NHC-catalyzed oxidation of aldehydes 
using two equivalents of  TEMPO and a stoichiometric amount of DBU at room 
temperature to afford TEMPO esters that could be readily transesterified.75 Again, a 
triazolium salt was identified as a superior precatalyst compared to either thiazolium or 
imidazolium salts. Notably, this process eliminates the need for a metal-based oxidant, 
employs as little as 0.5 mol % of the precatalyst, and allows the recovery and recycling 
of the TEMPO oxidant.
 1.4.2 Catalytically Generated Homoenolates
 N-Heterocyclic carbenes have also been shown to be effective catalysts for 
promoting an a3"d3 umpolung of  the #-carbon of an !,#-unsaturated aldehydes. These 
reactive intermediates are termed homoenolate equivalents and undergo nucleophilic 
additions to a variety of  electrophiles. Seminal reports on this transformation appeared 
simultaneously in 2004 by our group76 and the group of Glorius.77 In both cases the 
imidazolium NHC precatalyst IMesCl (44•Cl) was employed to convert an enal into a 
conjugate donor that efficiently underwent nucleophilic addition to a carbonyl acceptor. 
We reported the cis-diastereoselective (up to 5:1 cis:trans) formation of "-butyrolactones 
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between enals and aromatic aldehydes while Glorius and co-workers found aryl, 
trifluoromethyl ketones to be sufficient electrophiles leading to "-butyrolactones bearing 
a quaternary center with a cis-preference for the Ar and R1 groups of  approximately 2:1 
(Scheme 20). In a follow-up report in 2008, Glorius and co-workers reported that use of 
a thiazolium NHC led to a diastereomeric preference of  up to 10:1 for the 
trans-diastereomer.78 Recently You and co-workers presented a diastereoselective 
synthesis "-butyrolactones using a novel camphor-derived triazolium NHC catalyst and 
!-ketoesters as the electrophilic partner.79
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Scheme 20. First reports of NHC-catalytically generated homoenolates by Bode and Glorius.
 Dr. Ming He in our group extended the synthetic utility of  this reaction by using N-
sulfonyl aldimines as electrophiles to form "-butyrolactams in moderate to good 
diastereoselectivity and good yield.80 Interestingly, we found that homoenolate additions 
worked well in the presence of a protic solvent; in either t-BuOH ("-butyrolactams) or a 
10:1 THF:t-BuOH solution ("-butyrolactones). In 2008, Dr. Michael Rommel in our 
laboratory discovered that the novel bicyclic triazolium salt 63, first identified in our 
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group, efficiently catalyzed the addition of  enals to cyclic ketimines with catalyst loadings 
of as little as 0.5 mol % (Scheme 21).81 This method was tolerant of  a variety functional 
groups on both the aldehyde and imine partners. In addition to aromatic and 
hetoaromatic enals, aliphatic aldehydes including acrolein successfully participated in 
the homoenolate addition. As for the cyclic ketimines, aliphatic, aromatic and 
heteroaromatic were all equally tolerated. In this report, we not only demonstrated that 
an enantioselective variant was achievable (6:1 dr, 73% ee, and 91% yield) but also that 
the cyclic sulfonyl group could be reductively cleaved to unveil a "-butyrolactam bearing 
a quaternary stereocenter.
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Scheme 21. Homoenolate additions to cyclic ketimines with low catalyst loading.
 In less than 5 years since the initial reports of catalytically generated homoenolate 
equivalents, an explosion of interesting chemical transformations have appeared utilizing 
different electrophilic partners and an extensive review  of  this field appeared in 2008 by 
Nair and co-workers.82 Notable contributions from Nair’s group include the addition of 
homoenolates to chalcones83 and acyclic dienones to form 3,4-trans-disubstituted aryl- 
and styrenyl-cyclopentenes, respectively; to tropone84 to afford bicyclic #-lactones; to 
1,2-diketones,85, 86 isatin and to aryldibenzylidene cyclopentanones87 to produce spiro-
annulated adducts. It is worth noting that all the homoenolate additions reported by Nair 
and co-workers occurred in the presence of imidazolium NHC IMes. 
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Scheme 22. Example of the direct amination of an NHC-generated homoeneolate reported by 
Scheidt.
 Scheidt and co-workers have also reported significant progress in the area of NHC-
enolate additions. They have recently discovered that 1,3-dipoles such as azomethine 
ylides88 and N-phenyl nitrones89 participate in formal [3+3] cycloaddition reactions with 
NHC-enolates to afford pyridazinones and "-amino esters, respectively, with excellent 
diastereoselectivities. Furthermore, their group has realized the electrophilic amination of 
NHC-enolates via a formal [3+2] cycloaddition between the catalytically-generated 
homoenolate and acyl aryldiazenes 67 to afford a pyrazolidinone 68 as a single 
regioisomer.90 The cycloadduct 68 was shown to be converted to a #-aminoamide 69 
upon treatment with Sm(OTf)3 in THF/MeOH followed by Raney Nickel reduction 
(Scheme 22). In a related process, Ying and co-workers recently reported a formyl [3+2] 
annulation between nitrosobenzene and an NHC-enolate derived from imidazolium 
precatalyst 70 and enals.91 The intermediate cycloadduct 71 was immediately subjected 
to acidic methanol to afford #-amino ester 72 via an acid catalyzed esterification followed 
by a Bamberger-type rearrangement (Scheme 23).
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Scheme 23. NHC-catalyzed amination of enals.
 1.4.3 Protonation of the Homoenolate: Nucleophilic Trapping of Activated   
          Carboxylates
 During the course of our studies into the catalytic generation of homoeneolates, we 
made the following discovery. When NHCs generated in situ by deprotonation with base 
were allowed to react with enals 73 to produce intermediate homoenolates, the fate of 
the homoenolate was intimately tied to the strength of  the base as well as the type of 
NHC used (imidazolium vs. triazolium). When an imidazolium salt such as IMesCl was 
used in the presence of  the strong base, C–C bond formation was preferred, giving rise 
to the "-lactone dimer 74. However, when a weaker tertiary amine base was employed 
along side the newly discovered N-mesityl bicyclic triazolium precatalyst 63•BF4, then 
protonation of the homoenolate occurred followed by nucleophilic trapping of the 
requisite activated carboxylate to afford the reduced ester 75 (Scheme 24).92  Under 
optimized conditions, primary and secondary alcohols underwent esterification with a 
variety of enals in good to excellent yield (63–99%). At about the same time in 2005, 
Scheidt and Chan independently communicated a similar solution toward protonation of 
the catalytically generated homoenolates, promoted by in situ formed NHCs derived 
from benzimidazolium salts, by using excess phenol as an added proton source. 
Although this related process nicely achieved the desired protonation event, their 
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conditions required 5 equivalents of  alcohol, added phenol, and elevated reaction 
temperatures. 
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Scheme 24. The effect of base and catalyst type on the fate of catalytically generated 
homoenolates.
 Discovery of  the protonation of NHC-homoenolates has greatly expanded the 
synthetic utility of  NHC-promoted internal redox reactions. In 2006, Zeitler developed an 
analogous extension of this method for the stereoselective preparation of  (E)-configured 
!,#-unsaturated esters from propargylic aldehydes.93 It is noteworthy that the sterically 
demanding imidazolium salt IMesCl was again found to be the most effective precatalyst 
but also that weak tertiary amine bases (DIPEA, DMAP, imidazole) were crucial to the 
success of  the reaction. This underlies our initial observation that a sufficiently acidic 
conjugate acid is likely responsible for the protonation of the catalytically generated 
homoenolate. These related processes are outlined in Figure 8. Nucleophilic addition of 
the N-heterocyclic carbene to either an enal or alkynal leads to the Breslow  intermediate 
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which is in resonance with the homoenolate equivalent. Protonation at the #-position by 
the conjugate acid of the weak tertiary amine base gives rise to an NHC-enol that 
undergoes tautomerism to the activated carboxylate. Nucleophilic attack by an alcohol 
releases the catalyst and affords the acylated nucleophile. 
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Figure 8. Nucleophilic trapping of activated carboxylates generated from protonation of NHC-
homoenolates derived from enals and alkynals.
1.5  Conclusion
 
 Since their initial use as organocatalysts for the benzoin and Stetter reactions, 
NHCs have witnessed an explosion in their scope as nucleophilic catalysts for a variety 
of conceptually new  organic transformations. As new  catalyst manifolds are developed, it 
is likely that new  substrate types and electrophiles that are currently unreactive in 
already reported transformations will be utilized, thus expanding the horizon of  the types 
of chemistry that will be achievable by these interesting small molecule catalysts. 
Similarly, the ever-expanding advent of  new  chiral scaffolds will likely render known 
reactions enantioselective in the upcoming years.
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Chapter 2:  Design and Synthesis of N-Mesityl Triazolium  
 Salts for NHC-Catalyzed Redox Reactions
2.1 State of the Art Syntheses for Triazolium Salts
 2.1.1 Syntheses of Achiral Triazolium Salts
 There are two general methods for the syntheses of 1,4-disubstituted triazolium 
triazolium salts and 1,3,4-trisubstituted triazolium salts.1-3 The first method begins from 
the bisformyl hydrazine 78 (derived from an alkyl- or arylhydrazine that has been 
formylated via a mixed anhydride) which is condensed with acetic anhydride in the 
presence of  perchloric acid. The intermediate oxadiazolinium 79 is then subjected to a 
ring-opening ring-closing (RORC) reaction with an appropriate amine to afford the 1,4-
disubstituted triazolium salt 80 (Scheme 25). The 1,3,4-trisubstituted triazolium salts can 
be synthesized by starting from an acylhydrazine and then performing the subsequent 
aforementioned chemical transformations. The second, and perhaps more often utilized, 
method for the preparation of  1,4-disubstituted triazolium salts and 1,3,4-trisubstituted 
triazolium salts is a one-pot procedure outlined in Scheme 26. Condensation between an 
in situ prepared imidoyl chloride 82 and an N-substituted, N-formylhydrazine 83 followed 
by cyclization and anion exchange affords the desired triazolium salt 84. 
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Scheme 25. A general synthesis of of 1,4-disubstituted triazolium salts.
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Scheme 26. A general synthesis of 1,4-disubstituted and 1,3,4-trisubstituted triazolium salts.
 A notable utilization of  the latter method is Enders preparation of  1,3,4-triphenyl-
4,5-dihydro-1H-1,2,4-triazol-5-ylidene (85), an unusually stable free carbene that can be 
stored for prolonged periods of  time.4 The free carbene can be obtained by treatment of 
its parent triazolium salt with a methanolic solution of sodium methoxide followed by !-
elimination in vacuo of the resultant C-2 ether to afford the free carbene. Enders and co-
workers have shown that this free carbene can undergo a wide variety of electrophilic 
additions: additions to alcohols, thiols, and amines to yield the corresponding insertion 
products (Figure 9, path a); to molecular oxygen, sulfur, and selenium to form the 
triazolinone, -thione, and -selenone (Figure 9, path b); to heterocumulenes such as 
phenylisocyanates and carbon disulfide to produce the corresponding betaines (Figure 
9, path c); and to doubly activated double bonds such as fumaric and maleic esters, 
nitriles, maleic imides and nitro olefins to afford the open-chain allylic adducts (Figure 9 
path d). Furthermore, it can also add to transition metals to form metal-ligand complexes 
(Figure 9, path e) and even be used as a nucleophilic NHC catalyst for the formation of 
acyl anion equivalents that can undergo benzoin condensations (Figure 9, path f).5
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Figure 9. Electrophilic additions of Enders’ free carbene 85.
 While 1,4-disubstituted triazolium salts and 1,3,4-trisubstituted triazolium salts have 
been used as competent NHC precatalysts for a variety of transformations (See Chapter 
1 and the references therein), by far the most widely used achiral triazolium salts 
employed are those based on a bicyclic motif. In 2005, Rovis and co-workers6 disclosed 
an elegant synthesis of bicyclic triazolium salts derived from 2-pyrrolidinone based on 
the modification of Leeper’s work (Scheme 27).7 Starting with O-methylation of  2-
pyrrolidinone with dimethyl sulfate followed by condensation with phenylhydrazine, 
treatment with base, and reacidification with HCl provided the intermediate hydrochloride 
41
salt 88. Final treatment with trimethyl orthoformate in MeOH afforded the bicyclic N-
phenyl triazolium salt 57. 
N
H
O
N
OMe
MeOSO3
N
NH2
NHPh
Cl
N N
N
Ph
Cl
(MeO)2SO2
CH3CN
80 °C, 12 h
(90%)
1) PhNHNH2
    23 °C, 4 h (84%)
2) 40% KOH (77%)
3) HCl, MeOH (95%)
86 87
88
HC(OMe)3
o-dichlorobenzene
HCl, MeOH
120 °C, 24 h
(73%)57
Scheme 27. Rovis’ linear synthesis of bicyclic N-phenyl triazolium salt 57.
 In the same report the authors disclosed a modified one-pot synthesis of  the 
bicyclic triazolium salts (Scheme 28). Meerwein methylation of 2-pyrrolidinone followed 
by condensation with pentafluorophenylhydrazine followed by removal of solvent 
provided the hydrazinium salt 89 in excellent yield. Final ring closure by treatment with 
neat triethyl orthoformate at elevated temperature smoothly provided the N-
pentafluorophenyl bicyclic triazolium salt 90 in good yield.
N
H
O
N
NH2
NHC6F5
BF4
N N
N
C6F5
86 89
HC(OEt)3
110 °C, 1 h
(64%)
90
1) Me3O
+BF4, CH2Cl2 
     23 °C, 12 h
2) H2NHNC6F5
     23 °C, 2 h
     (95% 2 steps)
BF4
Scheme 28. Rovis’ one-pot protocol for the production of bicyclic triazolium salts.
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 2.1.2 Syntheses of Chiral Triazolium Salts
 The two most commonly employed scaffolds utilized for chiral triazolium salts are 
again bicyclic in nature. The first class is based on chiral 2-pyrrolidinones whereby the 
chiral element resides at the 3 position (Figure 10a). The chiral lactams employed as the 
starting material are conveniently prepared from either an amino acid or pyroglutamic 
acid. The second class is derived from cis-1,2-aminoalcohols (Figure 10b). The cis-1,2-
aminoalcohols are often derived from !-amino acids as well.
N
NN
O
Ar
N N
N
Ar
X
X
NH
O
OH
O
NH2
NH
HO2C
O
!-amino acids
pyroglutamic acid
or(a)
NH2
OH
(b)
cis-1,2-aminoalcohols
Figure 10. Common motifs for chiral triazolium salts.
 In 1998, in the search for a catalyst capable of  stereoinduction in the benzoin 
condensation, Knight and Leeper introduced the first chiral bicyclic triazolium salt 91 
(Scheme 29).7 Starting from morpholinone 92, synthesized from phenylalanol, Meerwein 
methylation followed by liberation of the resultant salt with base provided the free 
iminoether 93. Condensation with phenylhydrazine hydrochloride and subsequent ring 
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closure of 94 with trimethyl orthoformate afforded the desired chiral triazolium salt 91. In 
the same report Knight and Leeper disclosed the synthesis of  two triazolium salts 
derived from (L)-pyroglutamic acid employing the same aforementioned three step 
process (Figure 11, 95 and 96). Shortly thereafter, Enders expanded the utility of this 
latter process and communicated the synthesis of  NHC triazolium precatalysts 97–988 
and 99–1029 for enantioselective benzoin condensations utilizing a procedure similar to 
Rovis.
N
H
O
O N
O
MeO
HN
O
N
Ph Ph
Ph
N
O
N
N NH
H
Ph
Ph
Cl
Me3O
+BF4
CH2Cl2
PhNHNH3Cl
MeOH,
HC(OMe)3
MeOH,
92 93
9491
12 h, rt
then NaHCO3
(77%)
50 °C, 2 h
(85%)
80 °C, 12 h
(100%)
Ph
Cl
Scheme 29. First reported synthesis of a chiral bicyclic triazolium NHC precatalyst by Leeper.
N
N N
OR1
95, R1 = Me
96, R1 = Ph
Ph
N
N N
OR1
Ph
Knight and Leeper 
1998
Enders
2006
Cl BF4
97, R1 = TIPS
98, R1 = TBS
N
N N
OR1
Ph
Enders
2008
R2
R2
BF4
99,   R1 = TBS, R2 = Ph
100, R1 = TMS, R2 = Me
101, R1 = TMS, R2 = Ph
N
N N Ph
BF4
Enders
2008
Me
Me
102
Figure 11. Chiral bicyclic triazolium salts derived from (L)-pyroglutamic acid.
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 Rovis and co-workers rejuvenated the cis-aminoalcohol scaffold with their 
syntheses of  several triazolium salts derived from cis-1,2-aminoindanol for use in the 
asymmetric Stetter reaction.6, 10 They employed their one-pot protocol identified for the 
synthesis of bicyclic triazolium salts (see Scheme 28) to afford various N-substituted 
aminoindanol-derived triazolium salts in good yield (Figure 12). NHC catalysts based off 
this scaffold have emerged as some of the most efficient and selective for a variety of 
NHC-promoted internal redox processes (See Chapter 1 and vide infra).
N
N N
O
Ar NH
O O
NH2
OH
104
cis-1,2-aminoindanol
32, Ar = Ph
33, Ar = p-anisyl
34, Ar = C6F5
BF4
103
Figure 12. Aminoindanol-derived chiral triazolium salts reported by Rovis.
2.2  Synthesis of a Novel N-Mesityl Substituted Achiral Triazolium Salt for  
 NHC-Promoted Redox Reactions: RMesCl
 The first NHC-promoted process investigated by our group was the redox 
esterification of enals.11 Dr. Stephanie Sohn, in the course of her studies, found that 
essential to the success of  this reaction was the identification of  conditions that allowed 
the protonation of  the intermediate homoenolate leading to an activated carboxylate 
poised for nucleophilic displacement by an alcohol. A screening of reaction parameters 
led to the discovery of the necessity to employ the weak tertiary amine base. A screening 
of NHC precatalysts showed thiazolium salts to be incompetent for the desired 
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transformation. Imidazolium salt 44•Cl offered improved efficiency, but tended to produce 
the unsaturated carboxylic acid as a byproduct, an outcome that we attributed to the 
slow  turnover of the catalyst-bound activated carboxylate. Although triazolium salt 57, 
previously described by Rovis, was unproductive, the p-methoxyphenyl analogue 106 
was effective, but with a limited range of substrates. Further studies on catalyst 
syntheses identified N-mesityl triazolium precatalyst 63•BF4 as uniquely active, effecting 
redox esterifications of enals overnight with as little as 2 mol% of the salt (Scheme 30).
O
HR1
X mol% NHC cat.
2X mol% DIPEA
3 equiv EtOH
1 M THF, rt, 24 h
R1
O
OEt
N SR1
Me R2
Cl
51,   R1 = Bn, R2 = Me
105, R1 = Mes, R2 = H
NNMes Mes
Cl
44•Cl
66–99% yield with 63•BF4
N
N N Ar
X
57,   Ar = Ph, X = Cl
106, Ar = 4-MeOC6H4, X = Cl
63•BF4, Ar = Mes, X = BF4
Scheme 30. Screening of azolium salts for the NHC-catalyzed redox esterification of enals.
 Although this result was exciting, our progress in this area was stymied by the 
unreliability for the production of  NHC precatalyst 63•BF4. Rovis has described a 
concise, high-yielding synthesis of a number of achiral bicyclic triazolium salts salts (see 
Schemes 27 and 28).6 While we have found these protocols to be very effective for the 
synthesis of triazolium salts bearing simple aromatic groups, we obtained capricious 
outcomes when attempting to apply these procedures to the preparation of the N-mesityl 
substituted variant. We traced much of our difficulties to the low  purity and poor stability 
of 2-mesitylhydrazine,12 the key condensation partner for the production of the 
amidrazone intermediate. We found that 2-mesitylhydrazine decomposed readily in air 
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and use of the crude hydrazine in the condensation led to intractable oils. To circumvent 
this problem, we adopted the protocol originally reported by Knight and Leeper (See 
Scheme 29),7 in which the neutral iminoether was allowed to react with the arylhydrazine 
hydrochloride salt. 
NH2
Me
MeMe
HCl (conc.)
NaNO2, SnCl2•2H2O NH
Me
MeMe
NH3 Cl
!10 °C"rt , 1 day
107 108
up to 56% yield
on 1 mol scale
Scheme 31. Preparative scale preparation of 2-mesitylhydrazinium hydrochloride 108.
 This approach required a reliable and scaleable synthesis of 2-mesitylhydrazinium 
hydrochloride 108. After arduous experimentation, we found that a refined Sandmeyer 
approach from the corresponding aniline 107 was the most efficient route (Scheme 
31).13 Critical to the success of  this reaction on scale was the vigilant monitoring of  the 
internal reaction temperature during the diazonium formation and reduction steps. When 
internal reaction temperatures rose above 5 °C, decreased yields of <20% were 
observed. The careful, drop-wise additions of the sodium nitrite and stannous chloride 
solutions as well as maintaining a cold external bath of  –10 °C were crucial to the 
outcome of  the reaction. Although the isolated yield of this particular hydrazinium is 
moderate (typically in the range of 36–56%), this procedure is robust and reproducible 
on a preparative scale of up to 1 mole.
 The synthesis of  the desired bicyclic N-mesityl triazolium salt commenced from 2-
pyrrolidinone (Scheme 32). Methylation was executed using dimethyl sulfate, and 
liberation of the free base upon treatment with NaHCO3 provided the iminoether 109, 
which was used without further purification. The condensation of 2-mesitylhydrazinium 
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hydrochloride 108 and the iminoether 109 was carried out under the conditions reported 
by Leeper.7 Final ring closure with triethyl orthoformate in the presence of a 
stoichiometric amount of  anhydrous HCl at elevated temperature afforded the desired 
triazolium salt 63, which we have conveniently coined RMesCl. The synthesis is highly 
reliable and can be performed to give up to 10 g of 63 in a single synthetic run.
NH
O
N
OMe
N
H
N
HN
Me
Me
Me
108, MeOH
60 oC, 0.5 h
(73% 2 steps)
60 °C, 12 h
then NaHCO3
(MeO)2SO2
86 109
110
•HCl
HC(OEt)3, PhCl
120 °C, 1 h
(63%)
1 equiv HCl (dioxane)
N
N
N
Me
Me
Me
63
Scheme 32. Synthesis of N-mesityl triazolium salt 63 (RMesCl).
 The most challenging aspect of the synthesis of  the N-mesityl substituted 
triazolium salt 63 was the ring-closing reaction with triethyl orthoformate. After 
considerable experimentation, we found two important factors that led to clean, high-
yielding reactions for the production of N-mesityl substituted triazolium salts. First, it was 
essential to add an equivalent of anhydrous HCl to the reaction mixture. Second, and 
most critically, we found that extended reaction times were detrimental to the isolation of 
the desired triazolium salts. In contrast to prior protocols that employed longer reactions 
times (>12 hours), reaction periods of  1–2 hours were generally preferred. Qualitatively, 
the progress of  the reaction could be followed by the solubilization of the starting 
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amidrazone hydrochloride; when a clear solution had formed the reaction was generally 
complete.
 Since it’s inception, we have documented the profound reactivity of N-mesityl 
triazolium salt 63. The access to this NHC precatalyst has allowed our group to identify 
many conceptually new  NHC-promoted redox processes that only 63 efficiently 
catalyzes.
2.3 Synthesis of an Aminoindanol-Derived N-Mesityl Triazolium Salt for  
 Enantioselective NHC-Promoted Annulations
 2.3.1 Identification of an NHC-Promoted Azadiene Inverse Electron Demand  
         Diels-Alder Reaction
! In a continuing effort to develop new  carbon–carbon bond forming reactions 
between catalytically generated homoenolates from NHCs and enals (Figure 13), we 
reasoned that protonation or trapping of  the formal homoenolate II should lead to 
formation of an enol III or enolate IV intermediate poised for carbon-carbon bond 
formation and subsequent catalyst expulsion. However, an unexpected obstacle was the 
reluctance of protonation at the #-position of the Breslow  intermediate I, or its resonance 
homoenolate II, when generated from an imidazolium catalyst even in protic solvents at 
elevated temperatures. To address this we designed triazolium NHC precatalyst 63, 
which in conjunction with a weak tertiary amine base provided the desired protonation 
event (vide supra).
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R1
OH
N
X
N
R2
R2
H
R1
O
N
X
N
R2
R2
H
H+ or
proton transfer
or
I Breslow intermediate II homoenolate equivatent
IV enolate III  enol
C–C bond formation
and catalyst turnover
enal
Figure 13. Proposed catalytically generated NHC-enolate formation.
 Yet, efforts to trap these postulated NHC-enolates were frustrated by the tendency 
of the nucleophilic carbene to react with an added electrophile in preference to the enal. 
When a more electrophilic enal, ethyl trans-4-oxo-butenoate (111), was chosen as the 
coupling partner with N-sulfonyl aldimines (112) in conjunction with an imidazolium-
derived carbene (44•Cl), preferential formation of "-butyrolactams (113) was observed 
(Scheme 33). However, when our hindered N-mesityl triazolium precatalyst 63 was 
used, a new  product had formed. Elucidation by single crystal X-ray analysis revealed 
the new  product to be a dihydropyridinone (114) formed via a Diels-Alder reaction 
between the N-sulfonylimine and a catalytically generated enolate. After optimization of 
the reaction conditions, we discovered that the reaction proceeds under extremely mild 
conditions. Naturally, we then turned our attention to developing an enantioselective 
version of this newly discovered LUMOdiene-controlled Diels-Alder cycloaddition. To this 
end, we screened several aminoindanol-derived chiral triazolium catalysts that proved to 
be either unreactive or produce the desired dihydropyridinone in only modest yields and 
enantioselectivities. Postulating that once again a more hindered triazolium catalyst may 
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be needed, we turned our sights toward developing and synthesizing a chiral N-mesityl 
triazolium NHC precatalyst. 
Ph
N
H
ArO2S
+ N
O
Ph
ArO2S
114
CO2Et
N
O
EtO2C
SO2Ar
+
113
44•Cl 57 63
111 112
NNMes Mes
Cl N
N N
Ph
Cl N
N N
Mes
Cl
O
HEtO2C
Ph
cat., NR3
solvent, rt
>10:1 113:114 N.R. >20:1 114:113
Scheme 33. Precatalyst screening for the NHC-promoted azadiene Diels-Alder reaction.
 2.3.2 Synthesis of an N-Mesityl Substituted Aminoindanol-Derived Triazolium Salt
 Due to Rovis’ success with the aminoindanol motif as an effective chiral motif  for 
stereoinduction in the asymmetric intramolecular Stetter reaction (see Chapter 1), we 
sought to apply this privileged scaffold toward the production of an N-mesityl variant in 
the hopes that we might render our newly discovered NHC-promoted azadiene Diels-
Alder reaction enantioselective. Armed with the knowledge that the condensation of  2- 
mesityl hydrazinium hydrochloride and an appropriate iminoether occurs readily at 
slightly elevated temperatures (see Scheme 32), we reasoned that the same method 
could be applied to the condensation of  activated morpholinone 115 described by Rovis 
(Scheme 34). Methylation of  morpholinone ent•103 with Meerwein’s salt and subsequent 
treatment with aqueous sodium bicarbonate afforded iminoether 115. Initial attempts to 
condense iminoether 115 with 2-mesityl hydrazinium hydrochloride 108 under neutral 
conditions failed to yield the desired amidrazone hydrochloride 116. Prolonged reaction 
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times improved the conversion but not to useable levels. Often solvolysis of 116 would 
occur affording morpholinone ent•103 as a major product. Empirically, we found the 
necessity to employ a catalytic amount of anhydrous HCl and a prolonged reaction 
period of 2 days to afford the desired amidrazone hydrochloride in good yield. Finally, 
treatment of  116 with excess triethylorthoformate and an equimolar amount of anhydrous 
HCl in chlorobenzene provided smooth conversion to the crude precatalyst 117, which 
was recrystallized from toluene and isolated as a white powder in 64% yield. Again it 
should be stressed that prolonged exposure to heating caused decomposition of the 
triazolium salt and that the added stoichiometric amount of  anhydrous HCl was crucial to 
the success of  the reaction. Impressively, we optimized the procedure to forego any 
chromatography and the production of either enantiomer could be achieved on a >20g 
scale.
108, MeOH, 
cat. HCl 
60 oC, 2 d
(81%)
HC(OEt)3, PhCl
120 °C, 1 h
(64%)
1 equiv HCl (dioxane)
Me3O
+BF4
CH2Cl2
12 h, rt
then NaHCO3
(86%)
NH
O
O
N
O
OMe
115ent•103
O
N
N
N
Cl
Me
Me
Me
117
O
NH
N
HN
Me
Me
Me
• HCl
116
Scheme 34. Concise and scalable synthesis an N-mesityl substituted aminoindanol-derived 
triazolium salt.
 With the new  chiral triazolium precatalyst 117 in hand, we tested its efficacy in the 
NHC-promoted azadiene Diels-Alder reaction against other chiral triazolium precatalysts 
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possessing different substitution of the N-aryl group (Scheme 35). The p-methoxy 
derivative 33 reported by Rovis6 was found to be completely ineffective. Although o-tolyl 
derivative 118 provided the dihydropyridinone 114 with excellent diastereo- and 
enantioselectivity, the yield was only modest. To our delight our new  N-mesityl derivative 
117 not only provided the dihydropyridinone 114 in excellent yield but also as a single 
stereoisomer. 
O
N
N
N
OMe
No Reaction
Cl
O
N
N
N
Me
41% yield
97% ee
> 50:1 dr
Cl
90% yield
> 99% ee
> 50:1 dr
O
N
N
N
Me
Me
Me
Cl
 (1.1 equiv) (1.0 equiv)
10:1 PhMe/THF
 rt, 15 h
10 mol% cat.
10 mol% DIPEA
Ph
N
H
ArO2S
N
O
Ph
ArO2S
114
CO2Et
111 112
O
HEtO2C
33 118 117
Scheme 35. Screening of chiral aminoindanol-derived triazolium salts for the enantioselective 
azadiene Diels-Alder reaction.
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Table 1. NHC-catalyzed, enantioselective azadiene Diels-Alder reaction.a
R2
N
H
ArO2S
+ N
O
R2
ArO2S
(1.1 equiv) (1.0 equiv)
10:1 PhMe/THF, rt
10 mol% 
10 mol% DIPEA
H
O
OEt
O
OEtO
O
N
N
N
Cl
Me
Me
Me
Entry R2 Product yield (%)b ee (%)d
1
2c
3
4
5
6
Ph
MeO
O
Me
O
n-Pr
Ph
N
O
Ph
ArO2S
OEtO
N
O
ArO2S
OEtO
N
O
ArO2S
OEtO
N
O
ArO2S
OEtO
N
O
n-Pr
ArO2S
OEtO
N
O
Ph
ArO2S
OEtO
O
OMe
90
90
81
55
71
88
99 (S, S)
99 (R, R)
99 (S, S)
99 (S, S)
99 (S, S)
99 (S, S)
a Ar = 4-MeOC6H4.  All reactions were performed at 0.05 M for 23–48 h. In all cases only a single 
  diastereomer was detected in unpurified reaction mixtures by 1H NMR or HPLC analysis 
b Isolated yield after chromatography.  
c 10 mol % ent-117 was used as catalyst.  
d Determined by HPLC analysis.
Me
O
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 Our NHC-catalyzed annulation proceeds under exceptionally mild conditions. 
Simply stirring nearly an equimolar ratio of the enal and imine substrates in the presence 
of 10 mol % of precatalyst 117 and 10 mol % DIPEA at ambient temperature for 23–48 h 
followed by removal of the solvent and purification by chromatography provided the cis-
3,4-dihydropyridinones in good to excellent yield and excellent enantioselectivity (97–
99% ee) as a single diastereomer (>50:1) with a preference for the cis isomer. This 
process tolerated a full range of !,#-unsaturated imines including both electron-rich and 
electron-deficient cinnamaldehyde derivatives as well as heterocyclic and aliphatic 
aldehydes (Table 1).
Table 2. Variation of the enal substrate in the NHC-catalyzed Diels-Alder reaction.a
R2
N
H
ArO2S
+ N
O
R2
ArO2S
(1.1 equiv) (1.0 equiv) 10:1 PhMe/THF, rt
10 mol% 
10 mol% DIPEAH
O
R1
O
R1O
O
N
N
N
Cl
Me
Me
Me
Entry R2 Product yield (%)b ee (%)d
1
2c
3
4
Ph
MeO
n-Pr
Ph
N
O
Ph
ArO2S
Ot-BuO
N
O
ArO2S
PhO
N
O
n-Pr
ArO2S
MeO
N
O
Ph
ArO2S
MeO
OMe
70
51
71
52
97 (S, S)
99 (S, S)
98 (S, S)
98 (S, S)
a Ar = 4-MeOC6H4.  All reactions were performed at 0.05 M for 23–48 h. In all cases only a single 
  diastereomer was detected in unpurified reaction mixtures by 1H NMR or HPLC analysis 
b Isolated yield after chromatography.  
c An additional 1.0 equiv of enal was added after 15 h.
d Determined by HPLC analysis.
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 This process was further amenable to changes in the enal substrate (Table 2). The 
synthetically attractive tert-butyl ester readily participated in the annulation providing the 
dihydropyridinone adduct in excellent yield and enatioselectivity (Table 2, entry 1). 
Methyl and phenyl ketones also readily participated Diels-Alder reaction (Table 2, entries 
2–5) affording the desired products with exceptional enantioselectivity (>98% ee).
 Our azadiene Diels-Alder process was the first highly enantioselective NHC-
promoted intermolecular annulation reported. The exceptional diastereoselectivity 
(>50:1) is rationalized by the high preference for the endo transition state that not only 
benefits from secondary orbital overlap but is accentuated by the trans periplanar 
relationship of the nitrogen lone pair of the N-sulfonylimine and the C–O ! bond of  the 
NHC-enolate, providing additional stabilization by means of a transition-state anomeric 
effect.14, 15 Furthermore, we have postulated that protonation of the Breslow  intermediate 
can only occur in a fully conjugated, extended arrangement that necessarily leads to the 
(Z)-enolate or (Z)-enol arrangement.11 The cis-diastereoselectivity would arise from this 
(Z)-enolate geometry of the dienophile provided by the sterically demanding N-mesityl 
group of the bound NHC catalyst. The absolute stereochemistry is believed to be a result 
of the induced facial bias by the bulky aminoindanol backbone. The model shown in 
Figure 14 rationalizes the observed relative and absolute stereochemistry of the 
products.
Ar
H
R1ON
N N
N R2S
O O
p-MeOC6H4
O
Figure 14. Stereochemical model for the observed stereoselectivity in the NHC-promote 
LUMOdiene-controlled inverse electron demand Diels-Alder reaction.
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2.4  Discovery of New Redox Processes Preferentially Promoted by N- 
 Mesityl Substituted Triazolium Salts
 2.4.1 Extension of the NHC-Promoted Hetero Diels-Alder Reaction
 Access to N-mesityl aminoindanol-derived triazolium salt 117 has allowed our 
group to discover a plethora of novel NHC-promoted redox processes. We first were 
able to extend the utility of  the NHC-catalyzed hetero Diels-Alder process to include an 
oxodiene Diels-Alder variant. Critical to the success of this process was the identification 
of new  substrates capable of  forming NHC-enolates as unactivated enals tend to 
undergo dimerization reactions.
O
HR1
OH O
R1
N N
N
O
R1
N N
N
H H
acyl anion enolate activated carboxylate
R1
R3N–H
N
N
N
N
N
N
Cl
Cl
Figure 15. Recognition of the intermediate NHC-enolate en route to the activated carboxylate.
 In 2005, Rovis et al. reported the enantioselective protonation of catalytically 
generated chiral enolates as an approach to the synthesis of !-chloroesters.16 The chiral 
NHC-enolates were formed via a reaction between a chiral triazolium-derived NHC 
catalyst and !,!-dichloroaldehydes. In a previous report, !-chloroaldehydes were utilized 
to access activated carboxylates for NHC-promoted redox esterifications.17 A proposed 
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intermediate in the catalytic pathway to the activated carboxylate is an NHC-enol or 
NHC-enolate (Figure 15). We surmised that racemic !-chloroaldehydes could serve as 
suitable substrates for the generation of  chiral enolates foregoing the dimerization pitfalls 
previously encountered when enals were employed. 
 
66–94% yield
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95–99% ee
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Scheme 36. Enantioselective 1-oxodiene hetero Diels-Alder reaction with low catalyst loading.
 Using our recently synthesized chiral triazolium salt Dr. He from our group realized 
the highly enantioselective NHC-promoted 1-oxodiene Diels-Alder process between !-
chloroaldehydes 119 and chalcones 120 to afford nonracemic 3,4,6-trisubstituted 
dihydropyran-2-ones (Scheme 36a).18 Particularly noteworthy is that this highly 
enantioselective process proceeded in the presence of only 0.5 mol % of precatalyst 
117. Yet, the greatest detriment to this process was the need for the !-chloroaldehydes 
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as they had to be freshly prepared prior to use due to their sensitivity. To circumvent this 
issue, Dr. He subsequently reported the use of  !-chloroaldehyde bisulfite salts 122 as 
bench stable precursors to !-chloroaldehydes for the enantioselective oxodiene Diels-
Alder reaction (Scheme 36b).19 Again the requirement of  only 1 mol % of 117 to promote 
the oxodiene Diels-Alder reaction in excellent yield and superb diastereo- and 
enantioselectivity is a testament to the unprecedented efficiency and selectivity of  our N-
mesityl aminoindanol-derived precatalyst.
 2.4.2 NHC-Promoted Benzoin-Oxy-Cope Reactions
 In 2006, the Nair research group reported a highly diastereoselective annulation 
between catalytically generated homoenolate equivalents and chalcones promoted by 
imidazolium salt 44•Cl to produce trans-1,3,4-trisubstituted triarylcyclopentenes as a 
single diastereomer (Scheme 37). The postulated mechanism is exemplified in Figure 
16. The mechanism begins with a homoenolate-Michael addition by the Breslow 
intermediate onto the chalcone leading to an NHC-enol that subsequently undergoes 
keto-aldol addition. Finally, #-lactonization via nucleophilic displacement of  the catalyst 
followed by decarboxylation turns over the catalytic cycle and affords the cyclopentene 
adduct.
O
H
R1
O
R3
R2
R3
R1 R2
N N MesMes
44•Cl
6 mol%
Cl
12 mol% DBU
THF, rt, 8 h
+
R1 = Aryl, Me R2 = Aryl, Me
R3 = Aryl
55–88% yield
Scheme 37. Diastereoselective synthesis of trans-1,3,4-cyclopentenes reported by Nair.
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Figure 16. Mechanistic hypothesis for Nair’s NHC-promoted cyclopentene reaction.
 During the course of our investigations into the NHC-promoted Diels-Alder annula-
tions we observed an interesting by-product, a 1,3,4-cyclopentene similar to the products 
reported by Nair. Recognizing that a catalytically generated homoenolate might be 
involved in the formation of cyclopentenes via addition to chalcones, we surmised that 
our chiral N-mesityl triazolium salt might allow  us to render this process enantioselective. 
Pei-Chen Chiang from our group found that under optimized conditions precatalyst 117 
was highly effective for the enantioselective construction of 1,3,4-cyclopentenes from 
enals and electron-deficient chalcones (Scheme 38).20 Contrary to Nair’s findings, a 
preference for the cis-diastereomer was observed in all cases examined. Further 
investigation into the reaction mechanism implicated a benzoin–oxy-Cope process 
instead of an initial homoenolate addition (Figure 17). We postulate that a keto-crossed-
benzoin addition of the Breslow  intermediate to the chalcone sets a boat transition state 
for an oxy-Cope rearrangement leading to an NHC-enolate intermediate similar to the 
one reported by Nair. Congruent with Nair’s proposal, intramolecular aldol addition 
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followed by #-lactonization and subsequent decarboxylation affords the cis-1,3,4-
cyclopentene adduct.
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Scheme 38. Enantioselective cyclopentene annulation reported by Chiang and Bode.
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Figure 17. Mechanistic proposal for the triazolium-derived NHC-mediated annulation between 
enals and chalcones.
 Armed with this mechanistic insight and the unprecedentedly reactive and selective 
precatalyst 117 Dr. Ming He was able to realize the enantioselective, NHC-catalyzed 
bicyclo-#-lactam formation via direct annulations of  enals and unsaturated N-sulfonyl 
ketimines (Scheme 39).21 Mechanistically speaking, we believe that this highly 
stereoselective annulation is analogous to the aforementioned benzoin–oxy-Cope 
formation of  cis-1,3,4-cyclopentenes. A NHC-mediated aza-benzoin–oxy-Cope process 
and subsequent tautomerization leads to the chiral NHC-enolate. An intramolecular 
Mannich reaction followed by #-lactam formation affords the bicyclic-#-lactam adducts 
(Figure 18).
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Scheme 39. Highly enantioselective, bicyclo-#-lactam formation via direct annulations of enals 
and unsaturated N-sulfonyl ketimines catalyzed by 117.
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Figure 18. Mechanistic proposal for the triazolium-derived NHC-mediated annulation between 
enals and N-sulfonyl ketimines.
2.5 Development of a Modular Platform for the Synthesis of Chiral 
        N-Mesityl Triazolium Salts
 
 2.5.1 Identification of a Platform with a Suitable Functional Handle
 We reported the first N-mesityl substituted triazolium salt (63) in 2005 for the redox 
esterification of enals,11 which we have conveniently named RMesCl. Our protocol for 
the synthesis of N-mesityl substituted bicyclic triazolium salts is not limited to the 
production of RMesCl (63) or the aminoindanol-derived precatlyst 117. Our group has 
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also found these protocols to be directly applicable to other classes of N-mesityl 
substituted triazolium NHC precatalysts (Figure 19). Pei-Chen Chiang from our group 
has demonstrated that this procedure was amenable to N-mesityl substituted triazolium 
salts based on bicyclic scaffolds of  increasing ring size (124–125),22 the chiral bicyclic 
scaffold derived from !-amino acids popularized by Rovis (126–128),6, 22 and the achiral 
morpholinone precatalyst 129. We have further utilized our synthetic process to prepare 
the chiral the morpholinone-derived bicyclic precatalysts (130–131) first reported by 
Scheidt and co-workers.23, 24 
N N
N
i-Pr
Mes
Cl
N N
N
Bn
Mes
Cl
N N
N
Ph
Mes
Cl
N N
N
Mes
Cl
N N
N
Mes
Cl
N N
N
Mes
Cl
O
N
N
N
O
Mes
Cl
N
N
N
O
Mes
Cl
Ph
Ph
Ph
Ph
Ph
124 125
128127126
129 130 131
Figure 19. Examples of N-mesityl substituted triazolium salts prepared by our reported 
method. 
 Our anticipation that the synthesis of novel N-mesityl substituted triazolium NHCs 
by our method will facilitate the discovery of new  NHC-promoted processes and offer the 
possibility to render such processes enantioselective have led us to investigate a 
combinatorial approach toward the rapid access of chiral triazolium salts. We decided 
that there were three prerequisites for this approach. First, both enantiomers of the 
catalyst must be easily accessible. Second was the need to identify a functional group 
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that can be easily manipulated into a variety of  functional groups under mild conditions. 
Third, and possibly most critically, was that the functional group manipulation should 
occur after the triazolium ring system has been built. By doing so we would possibly 
avoid the most difficult synthetic step in the sequence, the final ring closure to the 
triazolium salt. 
 2.5.2 Synthesis of the Platform Based on an Azide Functional Handle
 To execute this strategy we identified chiral azide 132 derived from (L)-
pyroglutamic acid25 as a viable precursor on which to build this platform (Figure 20). 
More specifically, we have already shown that chiral 2-pyrrolidinones serve as 
substrates for the synthesis of  chiral bicyclic N-mesityl triazolium salts (vide supra). 
Furthermore, azides are precursors to a variety of  transformations such as the [3+2] 
Hüisgen cycloaddition to form 1,2,3-triazoles and reduction to the amine which can act 
as a functional handle itself.
NH
O
O
OH
(L)-Pyroglutamic acid
NH
O
N3
N
N3
NN
Mes
Cl
132133
Figure 20. Retrosynthetic approach for the modular synthesis of chiral N-mesityl triazolium 
salts.
 The synthesis of  triazolium salt 133 was readily achieved in three steps from azide 
132. Meerwein methylation followed by condensation of the free iminoether with 2-
mesitylhydrazinium hydrochloride (108) provided the crude amidrazone 134. 
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Subsequent ring closure under our conditions optimized for the syntheses of N-mesityl 
triazolium salts provided the desired salt 133 in 32% overall yield (Scheme 40).
NH
O
N3
132
1. Me3O
+BF4, CH2Cl2
    rt, 12 h
    then NaHCO3 NH
N3
134
120 °C, 1 h
(32% over 3 steps)
N
N3
NN
Mes
Cl
133
N NH
Mes
•HCl
2. 108, MeOH
    50 oC, 1 h
HC(OEt)3, PhCl
HCl (4 M  dioxane)
Scheme 40. Synthesis of triazolium salt 133 possessing an azide functional handle.
 
 2.5.3 Derivatization of Triazolium Salt 133
 With our triazolium platform in hand, we explored some functional group 
transformations of the azide. We initially explored a Cu(I) promoted [3+2] Hüisgen 
cycloaddition to access 1,2,3-triazole-functionalized triazolium salts since this would 
open the possibility to attenuate rapidly the steric bulk of the chiral arm. Employing 
conditions similar to those reported by Sharpless,26 cycloaddition between the azide of 
the triazolium salt 133 and phenyl acetylene (135) readily occurred to afford the desired 
triazole-functionalized triazolium salt 136 (Scheme 41). The modest isolated yield re-
flects the difficulty in isolation of the triazole salt.
N
N3
NN
Mes
Cl
133
H
Ph
2.5 mol% CuSO4•H2O
25 mol% sodium ascorbate
1:1 t-BuOH/H2O
rt, 30 h
N
N
NN
Mes
Cl
NN
Ph
136
+
135
Scheme 41. [3+2] Hüisgen cycloaddition between azide 133 and phenylacetylene.
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 We next chose to reduce the azide to the primary amine as this had the potential to 
open up avenues for further derivatization. We were delighted to find that reduction with 
zinc metal under mild aqueous acidic conditions smoothly afforded the reduced 
triazolium salt in good yield after one hour (Scheme 42). Currently it is unclear as to 
whether the reduced product exists as the free amine triazolium salt 137a or the free 
carbene 137b. The latter is supported by 1H NMR due to the absence of the C-2 proton 
in the region of 9.0–12 ppm and the presence of a singlet upfield with an integration of 
three protons. However, this result might reflect a deprotonation that occurs in solution. 
N
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Zn0, NH4Cl
3:1 EtOH/H2O
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(64%)
N
NH2
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or
N
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NN
Mes
Cl
137b
Scheme 42. Reduction of azide triazolium salt 133.
 With the amine-functionalized triazolium salt in hand, we surmised that this could 
provide access to a thiourea derivative. We chose two commercially available 
isothiocyanates with which to treat the amine. We were pleased to find that when 
triazolium salt 137 was treated with either isocyanate 138 or 139 in DMF at 40 °C over-
night, considerable conversion to the thiourea adducts 140 and 141 was observed by 1H 
NMR and LRES MS ESI+ (Scheme 43). However, difficulty in purification precluded isola-
tion of the pure thiourea derivatives. Interestingly, the reaction between triazolium 137 
and the p-nitrophenyl isothiocyanate afforded a bis-adduct from the addition of  both the 
amine and the carbene. This result lends credence to our previous observation that 137 
may exist as a free carbene in solution. Although these studies are currently in their 
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infancy, we anticipate the syntheses of thiourea-functionalized triazolium salts in the 
near future.
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Scheme 43. Initial investigation into thiourea-functionalized chiral triazolium salts.
2.6 Conclusion
 We have described the synthesis of the first N-mesityl substituted triazolium salt 63 
(RMesCl) in 2005 for the redox esterification of enals. Since this initial report we have 
extended our method to the production of a chiral N-mesityl aminoindanol-derived 
triazolium salt 117 that has shown its unprecedented reactivity and selectivity in a variety 
of NHC-mediated redox processes including the first reported NHC-catalyzed Diels-
Alder and benzoin–oxy-Cope reactions. The utility of our method has been exemplified 
by the syntheses of several novel N-mesityl bicyclic triazolium salts in our group. 
Furthermore, we have identified a modular platform for the combinatorial approach to-
ward the production of a variety of chiral triazolium salts. Initial investigations show  great 
potential to access a wide range of new  chiral N-mesityl triazolium salts. We anticipate 
that our unique N-mesityl triazolium salts will allow  the identification of  new  NHC-
promoted processes and offer a possible solution toward rendering such processes 
enantioselective.
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Chapter 3:  A Modular Synthesis of Chiral 
 Aminoindanol-Derived Imidazolium Salts
3.1  Introduction
 Over the past two decades N-heterocyclic carbenes (NHCs) have received 
increasing attention due to their storied role as ligands for transition metal complexes1-7 
and, more recently, their remarkable properties as catalysts in their own right.8-12 As an 
increasing number of  processes catalyzed by either NHCs or their transition metal 
complexes are reported, interest in developing highly enantioselective variants through 
the design and synthesis of chiral NHCs continues to grow.13-15 To this end, important 
advances have been made by Grubbs,16 Hoveyda,17 Glorius,13, 18 Montgomery,19 and 
many others in the preparation and application of novel, chiral imidazolium-derived 
NHCs for catalytic applications (Figure 21).
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Figure 21.  Selected examples of chiral imidazolium salts as NHC-precursors.
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 In our own studies, we have pioneered the development of novel NHC-catalyzed 
redox processes of !-functionalized aldehydes, resulting in conceptually new 
approaches to ester20-22 and amide23 formation and the development of  a new 
generation of highly selective annulation reactions from simple starting materials.24-31 We 
have documented that these novel NHC-catalyzed reactions appear to fall into two 
discrete categories: those catalyzed by imidazolium-derived NHCs and those promoted 
by triazolium-derived NHCs.32 For example, our group24 and that of Glorius,33 have 
independently documented the imidazolium-derived NHC catalyzed generation of 
homoenolate equivalents from enals. These species undergo nucleophilic additions to 
aldehydes, activated ketones, imines, and enones to give stereochemically rich 
annulation products under exceptionally mild and simple reaction conditions (Figure 22).
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Figure 22. NHC-promoted annulations of catalytically generated homoenolates with various 
electrophiles.
 The use of a simple organic molecule as a catalyst raises the promise of 
developing enantioselective variants of  these annulations through the design and 
synthesis of chiral NHC catalysts. Indeed, chiral triazolium-derived NHCs have been 
employed as highly selective catalysts for benzoin and intramolecular Stetter 
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reactions.34, 35 Our group has also reported a number of novel annulation processes that 
employ chiral N-mesityl substituted aminoindanol-derived triazolium precatalyst 117 for 
highly enantioselective annulations for inverse electron demand hetero-Diels-Alder 
reactions and benzoin–oxy-Cope reactions (Figure 23).26-29, 31 In almost all cases, the 
NHC catalyst 117 affords the expected products in good yields and outstanding 
enantioselectivities.
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Figure 23. N-Mesityl substituted aminoindanol-derived triazolium NHC precatalyst.
 In contrast, with the exception of  a few  instances,30, 36 the use of  117 or other 
triazolium-derived NHCs uniformly fails to provide products arising from NHC-catalyzed 
generation of homoenolates. The lack of  reactivity of the triazolium salts, coupled with 
the relative difficulty in preparing chiral imidazolium salts that promote homoenolate-
based annulations of  enals has stymied the development of enantioselective variants of 
these promising annulation reactions.
 In seeking to address this, we have developed a practical synthesis of  chiral 
imidazolium-derived NHC precatalysts built onto the chiral aminoindanol backbone that 
has proved so successful for enantioselective NHC-catalyzed reactions. In this chapter, 
we document these studies in detail, including the application of this synthetic route to 
diverse chiral N-substituted imidazolium salts and their preparation on a multi-gram 
scale.
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3.2  Synthetic Routes Toward Imidazolium Salts
 3.2.1 Most Commonly Employed Synthetic Preparations of Imidazolium Salts
 The most easily accessible imidazolium salts are derived from imidazole. For N,N’-
symmetrically substituted imidazolium salts with an unsaturated backbone (Scheme 
44a), a single-pot procedure is employed whereby an appropriate amine is condensed 
with glyoxal (R1 = H) or a 1,2-diketone in the presence of formaldehyde and a mineral 
acid. The N,N’-unsymmetrically substituted imidazolium salts (Scheme 44b) are readily 
prepared in analogous manner by first condensation of  an amine and ammonium 
chloride with glyoxal (R1 = H) or a 1,2-diketone in the presence of  formaldehyde followed 
by alkylation of the intermediate imidazole. An orthoformate route allows the conversion 
of 1,2-diamines, obtainable from a Pd-catalyzed Buchwald coupling, directly to the 
imidazolium salt (Scheme 44c).2, 37 This is the preferred route for the preparation of 
imidazolium salts with a saturated, often chiral, backbone. Furthermore, both N,N’-
symmetrical and N,N’-unsymmetrical derivatives are accessible via this method.
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Scheme 44. Most common preparations of imidazolium salts.
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 3.2.1 Recent Progress in the Synthesis of Imidazolium Salts
 Subsequent to our work, Glorius and co-workers have recently disclosed a modular 
one-pot synthesis of both symmetrical and unsymmetrical imidazolium salts (Scheme 
45).38 This procedure is an improvement of Fürstner’s recent report (vide infra). In the 
key step, formamidines and !-halo ketones are coupled to afford imidazolinium 
intermediates that are readily dehydrated to yield to corresponding imidazolium salt. 
O
R4R3
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MeCN, 110 °C
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X = Cl, Br
OH
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NNR1 R2
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N
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Scheme 45. Glorius’ modular synthesis of imidazolium salts.
 A postliminary report from Gilbertson and Prasad has addressed the synthesis of  
imidazolium salts with an unsaturated backbone. Their synthesis featured a one-pot 
process from N-(2-iodoethyl)arylamine salts and primary amines (Scheme 46). The 
authors note the ready, gram-scale accessibility of  the N-(2-iodoethyl)arylamine salts 
from commercially available 2-iodoethanol. Nucleophilic coupling of the salt and amine 
leads to the 1,2-diamine which can be closed under standard conditions, triethyl ortho-
formate and formic acid, to provide the desired imidazolium salt. This procedure 
complements previous strategies that require the 1,2-diamine production via a bisimine 
reduction, exhaustive bisamide reduction or Pd-catalyzed couplings. In this manner 
nearly thirty imidazolium salts (symmetrical, unsymmetrical, and chiral) were prepared.
N
IAr
H H
+ R1 NH2
Cl HC(OEt)3, HCO2H
120 °C
NNR1 Ar
Cl
Scheme 46. Gilberston’s synthesis of saturated imidazolium salts.
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3.3  Synthesis of a N-Mesityl Substituted Aminoindanol-Derived 
 Imidazolium Salt
 3.3.1 Retrosynthetic Analysis
 The intense interest in the development and understanding of  N-heterocyclic 
carbenes and their complexes have led to a number of notable advances in their 
preparation.37, 39, 40 Unfortunately, in our hands we were generally unable to extend these 
routes to the preparation of our desired, chiral bicyclic imidazolium salts. During the 
course of  these efforts, Fürstner41 reported a new  synthetic entry into unsymmetrically 
N,N’-disubstituted imidazolium salts based on a heterocyclic interconversion strategy 
(Scheme 47). This elegant procedure hinges on a three-step, one-pot protocol to 
prepare diverse imidazolium salts from N-formyl amino ketones or aldehydes. We 
reasoned that chiral aminoindanol-derived imidazolium salts such as 145 could be 
similarly accessed from intermediates 146 and 147, a retrosynthetic analysis that 
considerably simplifies access to this highly desired class of  NHC-precursors. We further 
postulated that the diastereomeric formyl ketones 146 and 147 could be derived from 
diastereomeric epoxides 148 and 149 by intramolecular cyclization and oxidation. In 
turn, 148 and 149 would be obtained from readily available chiral aminoindanol 104 by 
N-formylation, alkylation, and epoxidation (Scheme 48).
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Scheme 47. Fürstner’s synthetic route to unsymmetrically substituted imidazolium salts.
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Scheme 48. Retrosynthetic approach toward the synthesis of a N-mesityl aminoindanol-
dervied imidazolium salt.
 
 3.3.2 Alkylation Strategy
 We began our studies with a literature procedure for the N-formylation of (1R, 2S)-
(+)-1-amino-2-indanol, 104.42 We initially surmised that the N-fomylated amide 150 
would be reluctant to undergo alkylation, making possible selective O-alkylation in the 
subsequent step. This O-alkylation, however, proved to be difficult, and yields greater 
than 40% were never consistently achieved even after several attempts to optimize the 
reaction parameters. In many cases, competing N-alkylation of the formamide reduced 
the isolated yields of  the desired product. In contrast, excellent overall yields of the 
desired N-formyl, O-crotylated product 151 were achieved simply by switching the order 
of the steps and performing the O-alkylation directly on unprotected aminoindanol 
(Scheme 49).
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Scheme 49. Chemoselective alkylation and formylation of 1,2-aminoindanol.
 3.3.3 Epoxidation and Cyclization
 With 151 in hand we were pleased to find that epoxidation occurred readily under a 
variety of straightforward conditions. Treatment of the alkene with excess mCPBA (~3 
equivalents) in CH2Cl2 overnight provided 148 and 149 in nearly quantitative yield, as a 
1:1 mixture of  diastereomers. The only drawback to this method was purification of  the 
epoxide, which required the removal of  excess peracid and the acid byproduct, and led 
to the formation of colored impurities that proved difficult to remove upon scale-up. We 
therefore turned to epoxidation via the in situ generation of dimethyldioxirane (DMDO).43 
This epoxidation was clean and scalable, but afforded slightly lower conversions than 
mCPBA. Nevertheless, this approach proved to be the method of choice for preparative 
scale synthesis of diastereomeric mixture of the epoxides 148 and 149 (Scheme 50)
 Early attempts to induce a 6-exo-tet ring closure onto the epoxide under basic 
conditions (NaH or KHMDS) were stymied by low  yields and decomposition. A single 
precedent for this ring closure employed 10 equivalents of NaH in DMF.44 Indeed, ring 
closure ensued under these conditions, but yields were only moderate (~50%) and 
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purification and characterization of  152 and 153 proved difficult due to the resultant 
mixture of diastereomers and amide rotamers.
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NH Me
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O
NH Me
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O
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rt, 16 h
(91%)
or
Acetone, Oxone,
NaHCO3, rt, 2 h
(81%)
O
N
H
O HO
Me
O
N
H
O HO
Me
151 148, 149
+
152 153
10 equiv NaH
DMF, 0 °C, 90 min
(52%)
Scheme 50. Epoxidation and intramolecular epoxide opening.
 We sought to improve the overall yield of  the cyclization through the stereo-
selective synthesis of  a single epoxide diastereomer via a Shi epoxidation (Scheme 
51).45 Since the D-fructose derived Shi catalyst was more readily prepared than its 
enantiomer, we explored this hypothesis by using the two enantiomers of  aminoindanol 
-derived formyl olefins, 151 and ent-151, and a single enantiomer of  the Shi catalyst 
154. When formyl olefin 151, derived from (1R, 2S)-(+)-cis-1-amino-2-indanol, 104, was 
employed, the epoxidation was quite efficient (~90% yield) but the diastereoselectivity 
was only moderate (5:1). However, a single diastereomer of the epoxide 148 was 
obtained after one recrystallization from hexanes/EtOAc. In evaluating the modest yield 
and product mixture of the cyclization, we were cognizant of the fact that the two 
diastereomeric epoxides 148 and 149 could potentially undergo ring formation at 
different rates, possibly leading to complications or by-products.
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 When the other formyl olefin, ent-151, derived from the opposite enantiomer of 
aminoindanol was used as the starting material, the epoxidation also proceeded cleanly 
to afford ent-149 as a 5:1 mixture of  diastereomers, and again a single diastereomer 
could be obtained after one recrystallization from hexanes/EtOAc. This diastereomer 
also cyclized cleanly in the presence of  sodium hydride to afford 156 in 76% yield. 
Although yields of  the morpholine products were consistently higher when pure 
diastereomers were employed in the ring-closing step, there does not appear to be a 
significant rate difference in the cyclization of the two diastereomeric epoxides. Despite 
the different stereochemistry, both diastereomers proved amenable to the subsequent 
steps and gave the identical imidazolium salts as the final product. These observations, 
coupled with other findings on the conversion of ketones 146 and 147 to the final product 
,led to our decision to stay with the lower yielding, but operationally simpler, achiral 
epoxidation and ring closure shown in Scheme 50 for further studies.
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Scheme 51. Stereoselective synthesis of morpholines 155 and 156 by Shi epoxidation.
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 3.3.4 Oxidation
 An early route to the chiral imidazolium salts began with allylation, rather than 
crotylation of aminoindanol 104. While epoxidation and cyclization proceeded cleanly, 
we encountered serious difficulties in obtaining the N-formyl aldehyde via oxidation of 
cyclization product 157. Oxidation of the primary alcohol using standard protocols 
(TEMPO, TPAP, IBX, SO3·pyridine, DMP) yielded little or none of  the desired aldehyde 
but rather numerous byproducts and returned starting material, with the major side 
product identified as over-oxidized morpholinone 158 (Scheme 52).
O
N
H
O
O
N
H
O
O
HO
[O]
other
products
+104
157 158
Scheme 52. Unexpected oxidative cleavage of N-formyl amino alcohol 157.
 To circumvent this unexpected difficulty, we elected to introduce the crotyl group 
during alkylation, which would subsequently lead to a secondary alcohol poised for 
oxidation to the ketone. We were pleased to find that Dess-Martin periodinane (DMP) 
gave smooth conversion to the ketone in high yield. Further studies, particularly for 
larger scale preparation of  ketones 146 and 147, also identified Swern oxidation 
conditions that also afforded the ketone in good yield on a 10-gram scale. Under the 
Swern conditions, we found the N-formyl ketones to be sensitive toward epimerization, 
affording 146 as the major diastereomer (Scheme 53).
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Scheme 53. Oxidation of secondary alcohols 152 and 153.
 
 3.3.5 Oxazolinium Formation and Conversion to N-Substituted Imidazolium Salts
 Ketone intermediates 146 and 147 are the key precursors to Fürstner’s 
heterocyclic interconversion strategy for the synthesis of imidazolium salts from an 
oxazolinium intermediate. Although Fürstner had demonstrated a remarkably diverse 
range of compounds prepared with this strategy, he reported no examples of  the use of 
sterically hindered anilines with ketone-derived amino carbonyls.41 Initial attempts to 
form the oxazolinium salt 159 by treatment of  the N-formyl ketones with Ac2O and 
aqueous or anhydrous acids HCl and HBF4 proved unsuccessful. Reactions performed 
at low  temperature returned only starting material; upon heating, deprotection of the N-
formyl group was observed. When HClO4 was employed, a trace amount of product was 
observed by mass spectrometric analysis of  the crude reaction mixture. From this initial 
hint, we quickly discerned that the oxazolinium adduct was heat sensitive. Thus, 
treatment of the formyl ketone with HClO4 in Ac2O was carried out at 0 oC to prevent 
deformylation. Furthermore, the oxazolinium salt could not be handled or stored for an 
extended period of time. Once triturated from the reaction mixture, residual solvent was 
removed in vacuo at room temperature since even a gentle warming of the solution upon 
rotary evaporation bath caused decomposition. We further found that analytically cleaner 
reactions occurred when diastereomers 146 and 147 were taken on separately through 
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the modified Fürstner protocol, although the identical final product and similar yields 
were obtained in each case. These important modifications led to a robust and reliable 
procedure for the preparation of 145, which served as the key starting material for a 
modular synthesis of diverse N-substituted NHCs (Scheme 54).
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O
N
N Me
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Mes
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CH2Cl2/PhMe
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160145
Scheme 54. Heterocyclic interconversion and elimination for the synthesis of imidazolium salts.
 Acetal 159 was allowed to react with a variety of  amines giving rise to the aminal 
intermediate 160 (e.g., with 2,4,6-trimethylanilne) as a set of  diastereomers. Although in 
several cases the aminal could be isolated, purification was difficult and most of the 
aminal intermediates were used directly for the elimination step without purification. 
Furthermore, the diastereomers could not be separated, but this was without 
consequence as the offending stereogenic center was destroyed upon acid elimination 
to give the imidazolium salt. We also improved upon Fürstner’s heterogeneous protocol, 
which used toluene as the solvent, for a homogeneous one with CH2Cl2/toluene that 
often allowed a cleaner rearrangement to the aminal intermediate.
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 The acid catalyzed acylation/elimination strategy originally outlined by Fürstner 
typically led to decomposition and only trace amounts of the desired imidazolium salt in 
our hands. We found that by dramatically reducing the equivalents of Ac2O a cleaner 
reaction occurred, a finding mirrored by Fürstner in a recent application of this method.46 
Still, in several cases, purification of the imidazolium salt was hindered by an intractable 
oil formed in the reaction. During the optimization of  the reaction for large-scale 
production of  145, we discovered that changing from a heterogeneous protocol (toluene) 
to a homogeneous one (1,2-dichloroethane) provided cleaner elimination, allowing for 
easier purification of  the imidazolium salt. Furthermore, under these conditions the 
reaction could be readily monitored by 1H NMR of an aliquot from the reaction. 
 These conditions proved (vide infra) reliable for a broad range of  amines, allowing 
access to a diverse set of  N-substituted imidazolium salts that can be used as 
precursors to N-heterocyclic carbene ligands and catalysts.
 3.3.6 Preparative Scale Production of N-Mesityl Imidazolium Salt  145
 Given our success of utilizing the N-mesityl substituted, aminoindanol-derived 
triazolium salt 117 for highly enantioselective annulation reactions, we were particularly 
interested in undertaking a systematic survey of  the differences between the imidazolium 
and triazolium salts of otherwise identical structure. In anticipation of these studies, we 
applied our optimized route to the synthesis of  the aminoindanol derived NHC-
precursors to a preparative scale synthesis of 145. Beginning with (1R, 2S)-(+)-cis-1-
amino-2-indanol, each step up to the oxazolinium intermediate can be performed on >8 
gram scale. The final three-step sequence was performed on a 5 g scale to produce 
~4.5 g of  145 in 51% yield from the formyl ketone intermediates 146 and 147 (Scheme 
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55). The structure of  this compound was confirmed by single crystal X-ray diffraction 
(Figure 24).
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Scheme 55. Preparative scale synthesis of N-mesityl substituted imidazolium salt 145. 
Figure 24. ORTEP plot of N-mesityl substituted imidazolium salt 145. Anion omitted for clarity.
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Table 3. N-Substituted chiral aminoindanol-derived imidazolium salts prepared from common 
acetal intermediate 159.
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O CH3
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R
O
N
N CH3
R
ClO4
RNH2, PhMe
or 
RNH2,PhMe/CH2Cl2
Ac2O, cat. HClO4
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rt, 3–16 h 70–80 °C, 0.25–20 h
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145, 78% yield 161, 51% yield 162, 70% yield 163, 61% yield
164, 35% yield 165, 48% yield 166, 35% yield 167, 75% yield
168, 63% yield 169, 53% yield 170, 50% yield
171, 20% yield 172, 22% yield 173, 69% yield
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3.4  Synthesis of Other N-Substituted Chiral Imidazolium Salts
 An important consideration in any catalyst or ligand design strategy is the ability to 
rapidly access structural derivatives that may enhance reactivity or selectivity in a 
catalytic reaction. A major attraction of the Fürstner method, and our implementation of it 
to prepare chiral amino alcohol-derived imidazolium salts, is the ability to introduce a 
wide range of N-substituents at the final stage of the synthesis simply by choice of  the 
appropriate amine.
 In preliminary studies, we have confirmed that this modular approach to chiral 
imidazolium salts is indeed viable and provides access to diverse N-substituents (Table 
3). Indeed both hindered and unhindered anilines work well in the reaction, making 
possible the preparation of 145, 161–167, and 170–173. Unprotected functional groups 
including phenols and amides do not significantly suppress the heterocyclic 
interconversion. Alkylamines are also excellent reaction partners, allowing, for example, 
the synthesis of N-Me substituted imidazolium 169. Even hydrazines are viable, 
providing access to N-morpholino imidazolium 168.
3.5 Conclusion
 In summary, we have developed a modular, scaleable route to the preparation of 
chiral aminoindanol-derived imidazolium salts, which will find use as precursors to N-
heterocyclic carbene catalysts and ligands. Our eight-step route takes advantage of a 
chemoselective alkylation, intramolecular epoxide-opening, and a modification of the 
Fürstner imidazolium synthesis to achieve a robust, scaleable method for the 
preparation of N-aryl, N-alkyl, and N-amino imidazolium salts. We have recently 
established that precatalysts such as 145 can serve as catalysts for enantioselective 
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NHC-catalyzed homoenolate additions of  enals to aldehydes, imines, and enones 
(Chapter 4). We anticipate that the facile access to diverse and complex imidazolium 
salts will facilitate our own ongoing studies aimed at improving the reactivity and 
selectivity of these novel annulation reactions. Furthermore, our studies provide one of 
the first practical routes to chiral, bicyclic imidazolium salts that may find use as novel 
ligands for transition metal-mediated reactions and NHC-catalyzed transformations.
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Chapter 4:  Observed Differences in the Reactivity 
 of Triazolium and Imidazolium NHC-   
 Precatalysts of Nearly Identical Structure
4.1  Introduction
 N-Heterocyclic carbenes derived from azolium salts are remarkable and versatile 
catalysts for a wide range of organic transformations.1-5 The classical benzoin and 
Stetter reactions of simple aldehydes are catalyzed by thiazolium and triazolium-derived 
carbenes.6-8 More recently, an extensive array of new  processes operating via reactive 
intermediates catalytically generated by internal redox reactions of !-functionalized 
aldehydes have been discovered.3, 9, 10 Successful developments from our laboratory 
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Figure 25. Selected stereoselective annulations promoted by NHC-precatlyst 117 recently 
reported by our group.
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include enantioselective triazolium-catalyzed annulations affording cis-disubstituted 
dihydropyranones11, 12 and dihydropyridinones,13 cyclopentenes,14 and bicyclic #-
lactams,15 all with exceptional levels of  diastereo- and enantioselectivity employing our 
N-mesityl aminoindanol derived triazolium catalyst (Figure 25). We and Glorius have 
also documented diastereoselective annulations of  enals and aldehydes to afford "-
butyrolactones using imidazolium catalysts;16-18 and our group has also disclosed the 
diastereoselective annulations of enals and N-sulfonyl aldimines to afford "-lactams.19
 The starting materials for many of these annulation processes are similar or 
identical, but the reaction outcomes differ dramatically by the choice of imidazolium vs 
triazolium NHC precatalysts. These disparate results have led to considerable confusion 
over the difference between the imidazolium and triazolilum precatalysts. Direct 
comparisons between the reactivity and mechanistic pathways of these two classes 
have been precluded by the use of structurally different catalyst classes in each case. 
We sought to explore systematically whether an inherent reactivity difference existed 
between a NHC catalyst derived from imidazolium or triazolium salts of  nearly identical 
structure.
N
O
NN
Me
Me
Me
Cl ClO4
O
NN
Me
Me
Me
Me
ent-117 145
Figure 26. N-Mesityl  aminoindanol-derived triazolium salt ent-117 and imidazolium salt 145 of 
nearly identical stucture.
 To address these important issues we designed and synthesized the chiral 
imidazolium salt 145 (see Chapter 3), which corresponds to the N-mesityl aminoindanol-
derived triazolium salt ent-117 that has served as the most reactive and selective 
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precatalyst in numerous annulation processes. The successful synthesis of 145 allowed 
us for the first time to directly compare these two catalyst classes, which differ only by a 
single atom distal from the reactive center. The distinct reactivity profiles of  these two 
catalyst classes provided valuable insight into the mechanistic differences and the 
challenges associated with developing enantioselective variants.
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Scheme 56. Reactive intermediates catalytically generated by NHC-promoted redox reactions 
of !,#-unsaturated aldehydes.
 The basis of  the novel annulation reactions of !,#-unsaturated aldehydes and 
electrophiles is the catalytic generation of unique reactive intermediates by internal 
redox reactions promoted by the association of  an N-heterocyclic carbene and the enal 
(Scheme 56). Depending on the structure of the catalyst and the facility of proton-
transfer events, the initially formed Breslow  intermediate i can ultimately serve as acyl 
anion equivalent ii, homoenolate equivalent iii, or enolate iv. In the latter two cases, the 
aldehyde is simultaneously oxidized to the carboxylic acid oxidation state. We have 
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observed that the fate of  the Breslow  intermediate under identical reaction parameters is 
intimately controlled not by the steric demands of  the catalyst but rather by the choice of 
imidazolium vs triazolium-derived NHCs.
 At the outset of our studies, we sought to address two recurring issues in our 
development of novel, NHC-catalyzed reactions. First, numerous annulation processes 
were promoted exclusively by one catalyst type (imidazolium or triazolium) but not the 
other. Even in the few  instances where a given transformation is promoted by either 
catalyst class, such as cyclopentene-forming annulations, we and Nair have 
demonstrated that different mechanisms may be operating.14, 20 Second, although highly 
enantioselective triazolium-catalyzed processes have been achieved for diverse reaction 
types, no examples of highly selective imidazolium-catalyzed processes have been 
documented.
4.2  NHC-Promoted Redox Reactions Preferentially Promoted by 
 Triazolium Salt ent-117•ClO4
 With chiral imidazolium precatalyst 145 in hand, we undertook a systematic 
comparison of imidazolium vs triazolium precatalysts in reactions known to be catalyzed 
by N-heterocyclic carbenes. Our previous studies employed triazolium salt ent-117 as 
the precatalyst, but our corresponding imidazolium salt was most easily prepared and 
handled as the perchlorate salt. To avoid any concern over counterion effects, we 
prepared and employed the perchlorate variant triazolium ent-117•ClO4 for comparison 
by simple anion exchange with LiClO4. All the reactions surveyed were run under 
identical conditions according to known published procedures with no attempts to 
optimize conversion or selectivity.
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Scheme 57. Reactions preferentially catalyzed by triazolium precatalyst ent-117•ClO4.
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 As we anticipated from our results using achiral imidazolium salts, precatalyst 145 
was ineffective for NHC-catalyzed inverse electron-demand Diels$Alder processes; only 
unreacted starting material was observed. This was true regardless of how  the key 
catalyst-bound enolate was generated, either via redox reactions of electron-deficient 
enals13 (Scheme 57a) or !-chloroaldehydes (Scheme 57b).11 Imidazolium salt 145 also 
proved unreactive in our recently disclosed annulation of enals and electron-deficient 
enones14 (Scheme 57c) or N-sulfonyl ketimines15 (Scheme 57d), processes that we 
believe proceed via a benzoin$oxy-Cope reaction; yet as previously reported precatlyst 
ent-117•ClO4 allowed for the formation of the cyclopentene and #-lactam products in 
excellect enantio- and diastereoselectivity.
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Scheme 58. Reactions preferentially catalyzed by triazolium precatalyst ent-117•ClO4.
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 Interestingly, triazolium precatalyst ent-117•ClO4, but not its imidazolium 
counterpart, was highly effective for intramolecular Stetter21, 28 (Scheme 58a) and 
intermolecular benzoin reactions22 (Scheme 58b). Although the benzoin and Stetter 
reactions are well-known to be catalyzed by other triazolium-derived NHCs, this was the 
first time the N-mesityl substituted variant had been employed. These results strongly 
suggest that the lack of  benzoin products observed when N-mesityl substituted 
imidazolium-derived NHCs are employed stem from the properties of  the imidazolium 
ring rather than steric restrictions of  the N-mesityl moeity. Of  particular note is that our N-
mesityl triazolium salt rivals other state-of-the-art catalysts generally employed for the 
asymmetric Stetter reaction in both efficiency and selectivity.8
4.3  NHC-Promoted Redox Reactions Preferentially Promoted by 
 Imidazolium Salt 145
 In contrast, NHC-catalyzed annulation process that we and others have postulated 
to occur via catalytically generated homoenolate equivalents operate preferentially with 
imidazolium-derived precatalysts. The three reactions shown in Scheme X have all been 
reported to proceed in good yields in the presence of catalytic amounts of of the 
commercially available achiral imidazolium salt IMesCl. Although these processes work 
well with this catalyst, only a single report by Glorius of an enantioselective variant had 
appeared prior to our work, who obtained a maximum of 25% ee for a related 
annulation.18 Despite the high reactivity of  triazolium-derived carbenes for the processes 
shown in Schemes 57 and 58, ent-117•ClO4 and related triazolium salts were almost 
ineffective for the reactions shown in Scheme 59. The difference in reactivity between 
the annulations shown in Scheme 59a and Scheme 59b is particularly striking.
 The cyclopentanone-forming annulation shown in Scheme 59c was recently 
reported by Nair and co-workers,28 who suggest that it proceeds via the intermediacy of 
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a catalytically generated homoenolate. In support of  this hypothesis, triazolium ent-
117•ClO4, which is typically a poor catalyst for homoenolate-based annulations, is 
almost unreactive. In contrast, imidazolium 145 effects the expected transformation in 
85% ee, the highest level of enantioselectivity yet reported for any transformation 
catalyzed by a chiral imidazolium-derived NHC at the time of our report.
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4.4  Conclusion
 The results of the catalyst comparison confirmed, for the first time, that profound 
reactivity differences exist between the two classes of NHC-precatalysts. Of nine 
discrete reaction types screened, six processes were promoted almost exclusively by 
the triazolium precatalyst ent-117•ClO4 (Schemes 57 and 58). Another three processes, 
all of which invoke catalytically generated homoenolates as the putative reactive 
intermediates, were preferentially promoted by the imidazolium salt 145 (Scheme 59). 
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Chapter 5:  Formal Synthesis of Salinosporamide A via  
 NHC-Catalyzed Intramolecular Lactonization
5.1 Introduction
 Over the past decade, significant advances have been achieved in reactions 
catalyzed by N-heterocyclic carbenes (NHCs).1-8 Conceptually new  reaction pathways 
have been identified, making possible the production of  stereochemically rich 
heterocycles from simple, readily available starting materials under exceptionally mild 
reaction conditions. An intriguing feature of  these reactions is the often exquisite control 
over competing reaction pathways. For example, !,#-unsaturated enals can react as 
either homoenolate or ester enolate equivalents (Figure 27). In intermolecular annulation 
reactions, we have been successful in achieving complete control over these reaction 
pathways through careful choice of catalysts and reaction conditions.9, 10 
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Figure 27. Catalytically generated intermediates from the reaction of NHCs and enals.
 To further explore the ability of  catalyst design to dictate the reaction outcome, we 
examined the more challenging case of  selective enolate versus homoenolate reactivity 
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in a densely functionalized substrate that would lead to synthetically valuable bicyclic 
products. These studies originate from our recent discovery that !,#-unsaturated 
aldehydes undergo reactions with N-heterocyclic carbenes, leading to the catalytic 
generation of homoenolates or enolates via internal redox processes.11 We have applied 
the generation of  homoenolates to the formation of "-butyrolactones11 and "-lactams.12 
We have disclosed that enals and !-chloroaldehydes serve as precursors to ester 
enolate equivalents for highly enantioselective inverse-electron demand Diels-Alder 
reactions.13, 14 Building on these studies, Scheidt has reported intramolecular variants of 
both the homoenolate and enolate pathways and has alluded to competition between 
these two reaction manifolds in cyclization reactions.15-17
 We recognized that an intramolecular cyclization of 194 via the homoenolate 
pathway would provide a concise entry into the salinosporamide class of natural 
products (Figure 28). Salinosporamide A18-25 is a secondary metabolite of the marine 
actinomycete bacteria of salinospora strain CNB-392. It is a potent inhibitor of  the 20S 
proteasome and has attracted much attention because of  its impressive in vitro cytotoxic 
activity against many tumor cell lines. To execute this synthesis, however, we needed to 
identify catalysts and reaction conditions that would react selectively via the desired 
homoenolate pathway.
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NHC-cyclization
Figure 28. Proposed entry into the synthesis of salinosporamide A.
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5.2  Development of a Novel NHC-Catalyzed Intramolecular Cyclization- 
 Lactonization
 5.2.1 Initial Attempts Toward a General NHC-promoted Intramolecular   
         Cyclization-Lactonization
 At the outset of our studies, we sought to develop a general strategy toward the 
formation of cis-fused "-lactam-"-lactone adducts via an NHC-promoted intramolecular 
homoenolate addition of  an enal to a tethered ketone followed by lactonization of the 
resulting alkoxide on the subsequently formed activated carboxylate (Figure 29). Toward 
this end, enal 196 was synthesized by the coupling of aminoketone 19726 with carboxylic 
acid 198 (Scheme 60). However, when 196 was allowed to react with either 
commercially available imidazolium precatalyst IMesCl (44•Cl) or our achiral N-mesityl 
triazolium precatalyst RMesCl (63) in THF at 40 °C in the presence of DBU, the desired 
product 199 was not observed, rather the N-substituted succinimide 200 was obtained 
exclusively (Scheme 60). We suspect that succinimide 200 results from an NHC-
catalyzed redox generation of  an activated carboxylate and subsequent N-acylation of 
the tethered amide.
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Figure 29. Retrosynthetic strategy toward the formation of "-lactam-"-lactone adducts.
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Scheme 60. Initial attempts at a general NHC-catalyzed intramolecular cyclization.
 5.2.2 Further Investigations into the NHC-promoted Intramolecular Cyclization
 At this point we recognized the need to employ a protecting group on the amide. 
The benzyl protecting group was chosen based on ease of the preparation of  the amine 
coupling partner as well as the potential for its facile removal by catalytic hydrogenation. 
Subsequently, N-benzyl protected phenyl ketone 201 was synthesized from 2-
bromoacetophenone and subsequently coupled with acid 198 using EDCI. Deprotection 
of the acetal using aqueous hydrochloric acid afforded the aldehyde 202 (Scheme 61). 
We subjected the aldehyde to NHC-precatalyst RMesCl with DBU in THF at 40 °C and 
were pleased to find the desired product, albeit in low  yield and as a complex mixture. 
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Careful analysis of the reaction mixture revealed that in addition to the desired "-lactam-
"-lactone product 203, 6-membered lactam 204 was also formed. A plausible catalytic 
cycle is presented in Figure 30. 
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1. EDCI, NEt3, DMAP
    CH2Cl2, rt, 24 h
2. 2N HCl(aq)
N
O
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Ph
Bn O
H
(46% over 2 steps)
+
201 198 202
Scheme 61. Synthesis of N-benzyl protected substrate 202. 
 Deprotonation of  the precatalyst provides the active NHC catalyst I that undergoes 
nucleophilc attack on the enal 202 to provide the initial tetrahedral intermediate II. A 
proton transfer event leads to the Breslow  intermediate III, the fate of which is intimately 
related to the strength of base and reaction conditions employed. A resonance structure 
of the Breslow  intermediate is the homoenolate equivalent IV; this can participate in an 
intramolecular nucleophilic addition to the tethered ketone followed by lactonization via 
the resultant activated carboxylate VI to turn the catalyst over and produce the desired 
lactam 203 (pathway A). Protonation of the homoenolate IV, however, generates an 
NHC-enolate VII that can undergo an intramolecular keto-aldol addition affording 
alkoxide intermediate VIII. Lactonization would then result in expulsion of  the catalyst 
and formation #-lactone 205, which readily undergoes decarboxylation16, 27, 28 to afford #-
lactam 204 (pathway B). From the reaction mixture, we also isolated 206, which we 
believe arises from a base-catalyzed olefin isomerization, followed by an intramolecular 
aldol addition (aldol pathway C). We corroborated pathway C by subjecting aldehyde 
202 to DBU in THF at 40 °C; complete conversion to the !-pyridone 206 was observed 
(Scheme 62).
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Scheme 62. Base-catalyzed intramolecular aldol pathway C.
 Optimization was carried out in an attempt to bias the formation of the desired "-
lactam-"-lactone, which arises from pathway A. The most pertinent results are summa-
rized in Table 4. When imidazolium catalyst IMesCl (44•Cl) was used in conjunction with 
the strong tertiary amine base DBU, the intramolecular aldol pathway C predominated 
(entry 1). However, when a weaker tertiary amine base was employed, pathway C was 
completely suppressed but the formation of  products arising from the enolate pathway B 
increased (entry 3). We attribute this to the facile protonation of  the homoenolate by the 
conjugate acid of  weak tertiary amine bases such as triethylamine. Use of our triazolium 
catalyst RMesCl (63) yielded products of all three pathways with pathway B dominating 
when DBU was used (entry 2), and pathway A and B dominating when the weaker 
amine base triethylamine was used (entry 4). We further discovered that of the chiral 
triazolium NHC-precatalysts tested, pathway C could be suppressed when catalyst 130, 
reported by Scheidt and co-workers,15, 16 was used along with either a strong base under 
dilution (entry 5), a bulky tertiary amine base in a chlorinated solvent (entry 6), or a 
strong base in t-BuOH (entry 7). However, we could never bias the product distribution to 
favor the desired "-lactam-"-lactone product in greater than 50% yield. Perhaps even 
more problematic was the inability to isolate the desired bicyclic product. Multiple 
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attempts to purify the reaction mixtures by recrystalization, column chromatography or 
preparative HPLC were all met with failure.
Table 4. NHC-Catalyzed cyclization-lactonization of substrate 202.
N
O
O
Ph
Bn O
H
N
Bn
O
Ph
N
O
O PhO
Bn
N
O
Bn
N
O
Bn
Ph
OO
Ph
N
O
Bn
O
O
Ph
homoenolate A enolate B aldol C
203 205 207204 206
Pathways:
202
OH
H
N
N
N
O
Mes
Cl
Ph
Ph
130
N
N
N
Mes
Cl
NN
Mes
Cl
Mes
IMesCl RMesCl
44•Cl 63
Entry Catalyst (mol%) Solvent (conc.) Temp. (°C) A B C a
1
2
3
4
5
6
7
8
9
10
IMesCl (20)
IMesCl (20)
RMesCl (20)
RMesCl (20)
130 (15)
130 (15)
130 (15)
130 (15)
130 (15)
130 (15)
Base (mol%) : :
DBU (15)
DBU (15)
DBU (10)
DBU (10)
DBU (10)
DBU (10)
NEt3 (15)
NEt3 (15)
DIPEA (100)
NEt3 (10)
40
40
40
40
40
40
40
60
60
80
THF (0.1M)
THF (0.1M)
THF (0.1M)
THF (0.1M)
10:1 THF:t-BuOH (0.02M)
CH2Cl2 (0.1M)
t-BuOH (0.1M)
t-BuOH (0.1M)
t-BuOH (0.1M)
t-BuOH (0.1M)
9 0 91: :
:
:
:
:
:
:
:
:
: :
:
:
:
:
:
:
:
:25 25 50
55 45 0
42 42 16
50 50 0
50 50 0
50 42 8
58 42 0
62 38 0
58 42 0
All reactions listed proceeded with 100% conversion; isolated yields were not determined.
a Product pathway ratios were determined from 1H NMR analysis of unpurified reaction mixtures.
 From our results we hypothesized that there may exist a rotational barrier for the 
two rotamers of tertiary amide. As such, one rotamer might undergo intramolecular cycli-
zation by the homoenolate faster than the other. The rate of this rotation might be in 
competition with the rate of  protonation of the homoenolate that leads to the NHC-
enolate which cyclizes to form the products of pathway B. To test this hypothesis, we 
subjected 202 to our optimized conditions at 60 °C and indeed a more favorable product 
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distribution was achieved (entries 8 and 9). However, further increase of  the reaction 
temperature did not improve the ratio of desired product (entry 10).
Ph
O
Br
Ph
O
N
Br
O
Ph
Bn
Ph
O H2
N
Br
O
Ph
cat. Pd/C, H2(g)
N
O
OEt
OEt
O
Ph
O
Ph
198, EDCI
 DIPEA, DMAP
PhH, 100 °C, 40 h
(75%)
BnNH2
CH2Cl2, rt, 24 h
(63%)
MeOH, rt
(85%)
N
O
O
Ph
O
Ph
H
O
209 210
2N HCl(aq)
(quant.)
211208
H
Scheme 63. Synthesis of symmetrical enal 208.
 Similarly, we reasoned that a symmetrical tertiary amide would obviate the need for 
elevated temperatures to bias the homoenolate pathway A. Aldehyde 208 was 
synthesized to probe our initial hypothesis further (Scheme 63). The symmetrical 
bisketone 210 was synthesized in two steps from 2-bromoacetophenone and 
subsequently coupled with acid 198 using EDCI. Deprotection of the diethyl acetal (211) 
with aqueous hydrochloric acid furnished the symmetrical !,#-unsaturated aldehyde 208. 
 Initially triazolium catalysts were identified as superior to imidazolium catalysts for 
obtaining the desired "-lactam-"-lactone product 212 (Table 5, entries 1–3). Further 
optimization identified 10:1 THF:t-BuOH as the most suitable solvent system and 
RMesCl the best precatalyst for biasing pathway A (entries 4–13). It should be noted 
that strong bases DBU and t-BuOK (entries 4, 5 and 7) as well as the weaker but bulkier 
tertiary amine base DIPEA (entry 6) helped to suppress pathway C. Lowering the 
temperature initially suppressed pathway C (entries 4 and 5) but further cooling 
suppressed pathway B while enhancing pathway C (entry 8), suggesting that protonation 
of the homoenolate was faster than intramolecular cyclization. Dilution favored pathway 
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A (entries 9–13), whereas raising the amount of  base tended to favor pathway C for the 
strong base DBU (entry 11) but pathway B for the weaker base DIPEA (entry 12). The 
optimum conditions identified employed DBU at lower loading than the catalyst, 
moderate heating (40 °C), and dilute conditions (0.01 M), resulting in a 3:1 ratio of 
annulation products A:B (entry 13). Although we demonstrated that the symmetrical 
substrate did provide an improved ratio of the desired product, again difficulty in 
purification precluded ready access to the desired bicycle 212.
Table 5. NHC-Catalyzed cyclization-lactonization of substrate 208.
N
O
O
Ph
O
H
Pathways:
N
O
Ph
N
O
O PhO
N
O
N
O
Ph
OO
Ph
N
O
O
O
Ph
homoenolate A enolate B aldol C
212 213 215214 216
O Ph O Ph
O Ph
O Ph O Ph
O
Ph
208
OH
H
Entry Catalyst (mol%) Solvent (conc.) Temp. (°C) A B C a
1
2
3
4
5
6
7
8
9
10
RMesCl (15)
130 (15)
IMesCl (15)
RMesCl (15)
RMesCl (15)
RMesCl (15)
RMesCl (15)
RMesCl (15)
RMesCl (15)
RMesCl (15)
Base (mol%) : :
DBU (10)
DBU (10)
DBU (10)
t-BuOK (10)
DBU (10)
DIPEA (10)
DBU (10)
DBU (10)
DIPEA (10)
DBU (10)
60
60
60
60
40
40
40
20
40
40
t-BuOH (0.10M)
t-BuOH (0.10M)
t-BuOH (0.10M)
10:1 THF:t-BuOH (0.10M)
10:1 THF:t-BuOH (0.10M)
10:1 THF:t-BuOH (0.10M)
10:1 THF:t-BuOH (0.10M)
10:1 THF:t-BuOH (0.10M)
10:1 THF:t-BuOH (0.05M)
10:1 THF:t-BuOH (0.05M)
50 17 33: :
:
:
:
:
:
:
:
:
: :
:
:
:
:
:
:
:
:10 14 76
66 17 17
40 60 0
43 57 0
45 55 0
34 33 33
13 0 87
66 17 17
50 50 <1
11
12
13
10:1 THF:t-BuOH (0.05M)
10:1 THF:t-BuOH (0.05M)
10:1 THF:t-BuOH (0.01M)
40
40
40
DBU (50)
DBU (10)
DIPEA (50)
RMesCl (15)
RMesCl (15)
RMesCl (15)
: :9 <1 91
: :50 50 0
: :75 25 <1
All reactions listed proceeded with 100% conversion; isolated yields were not determined.
a Product pathway ratios were determined from 1H NMR analysis of unpurified reaction mixtures.
 Of  the two competing undesired pathways (B and C), pathway C was the easier to 
address. By blocking the !-position of  the ketone, we could effectively eliminate pathway 
C since no enolizable hydrogens would exist. Also, there would be no concern for the 
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use of either a strong base or an excess (compared to the precatalyst) of  base. For this 
purpose, the geminal dimethyl substrate 217 was designed and synthesized (Scheme 
64). Starting from Cbz-AIB, the acid was converted to the Weinreb amide 218 using 
DCC. N-Alkylation was carried out in DMF with NaH and benzyl bromide providing 219 
in quantitative yield. Formation of  methyl ketone 220 was achieved using MeMgBr in 
Et2O, and the benzyl carbamate was subsequently removed by catalytic hydrogenation 
in acidic media to afford 221. Amide formation with acid 198 proved most efficient via the 
isobutyl mixed anhydride at elevated temperature; standard coupling reagents such as 
HBTU, HATU, and EDCI were ineffective. Finally, deprotection of the diethyl acetal 222 
afforded the desired aldehyde 217 in moderate yield due to its sensitivity to silica gel 
purification.
O
NHCbz
Me Me
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Me Me
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N
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Me Me
NBn(Cbz)
N
O
Me Me
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Me
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OEt
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O
Me
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O
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MeMe
O
Me
O
H
O
Me Me
NH2Bn
Me
HN(OMe)Me•HCl
DCC, DMAP, DIPEA NaH, BnBr
MeMgBr, Et2O
Cbz-AIB 218
219
222
221 220
cat. Pd/C, H2(g)
conc. HCl(aq)
2N HCl(aq)
Cl
O
O
Me
Me
198, NMM, THF
!10 °C"50 °C, 20 h
(78%)
CH2Cl2, rt, 5 d
(67%)
DMF, rt, 24 h
(quant.)
0 °C"rt, 20 h
(71%)
EtOH, rt, 6 h
(88%)
THF, 0 °C"rt, 3 h
(64%)
217
Cl Me
MeO
Me
MeO
Scheme 64. Synthesis of gem-dimethyl substrate 217.
 When aldehyde 217 was allowed to react in the presence of 15 mol % of RMesCl, 
10 mol % of  DBU at 0.05 M in 10:1 THF:t-BuOH for 20 h, we only observed the desired 
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"-lactam-"-lactone 223. Furthermore, we identified that IMesCl was an even more 
effective catalyst for the desired transformation, providing the desired lactam in 79% 
isolated yield (Table 6, entry 1). We briefly screened several chiral precatalysts. Our 
triazolium N-mesityl aminoindanol-derived precatalyst ent-117 provided the desired 
product in 75% yield but only 5% ee (entry 2). Our structurally related imidazolium N-
mesityl aminoindanol-derived precatalyst 145 provided 223 in a reduced 50% yield and 
9% ee (entry 3). Two chiral N-mesityl triazolium precatalysts, 130 and 131, developed by 
Scheidt,15, 29 proved just as effective with a slight increase in enantiomeric excess 
(entries 4 and 5). By employing precatalyst 131 and reducing the temperature to –20 °C, 
we obtained the "-lactam-"-lactone 223 with an enantiomeric excess of 40%.
Table 6. NHC-Catalyzed cyclization-lactonization of substrate 217.
N
O
Bn
MeMe
O
Me
O
H
217
15 mol% cat.
10 mol% DBU
10:1 THF:t-BuOH (0.05 M)
40 °C
N
O
O
O
MeMe
Me
Bn
223
N
N
N
O
N
N
N
O
Mes
Cl
N
N
N
O
Mes
Cl
Ph
Ph
Ph
Ph
Mes
Cl
ent-117
130 131
NN
O
Mes
ClO4
145
Me
Ph
Entry Catalyst %eea
1
2
3
4
5
IMesCl
Yield
79%
75%
73
50
78
NA
5
9
9
23 (40)b
a Determined by Chiral SFC analysis. b Performed at !20 °C.
ent-117
130
145
131
118
5.3  Formal Synthesis of Salinosporamide A
 5.3.1 Retrosynthetic Analysis
 Encouraged by our results we sought to apply our method to streamlining the 
previously reported synthesis of salinosporamide A. During the course of our 
investigation, Lam and co-workers reported a formal synthesis of salinosporamide A via 
a nickel-catalyzed reductive aldol cyclization-lactonization strategy to construct 224.25 In 
parallel studies, we had identified intermediate 224 as a target for our NHC-promoted 
intramolecular cyclization-lactonization strategy for a formal synthesis of 
salinosporamide A (Figure 31). 
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salinosporamide A
4 steps
ref. 19 NH
HO
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Me
CO
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N
O
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O
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PMB
O
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2Me
2Me
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N
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O
O
H
O
PMB O
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Figure 31. Proposed formal synthesis of salinosporamide A from aldehyde 225  employing our 
intramolecular NHC-cyclization.
 Our retrosynthetic plan is outlined in Figure 32. Lactam 224 would be obtained 
from the NHC catalyzed cyclization-lactonization of  aldehyde 225, which in turn would be 
synthesized in an analogous manner to our previous aldehyde substrates via amide 
bond formation between acid 198 and amine 227 followed by a deprotection-oxidation 
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sequence. The synthesis of 227 from L-threonine has previously been reported by Corey 
in his synthesis of salinosporamide A.19
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Figure 32. Retrosynthetic analysis for intermediate "-lactam 224.
 5.3.2 Synthesis of Key Substrate 225 
 Attempted amide formation between acid 198 and amine 227 did not appreciably 
proceed in the presence of coupling reagents HBTU, HATU, PyBop or EDCI. Instead, 
either a trace amount of the desired amide, decomposition of the amine, deprotection of 
the silyl group, or no reaction was observed under a variety of conditions. We attempted 
the amide bond formation via the mixed anhydride of acid 198. Neither the isobutyl, 
isopropenyl, nor 2,4,6-trichlorophenyl mixed anhydride provided any of the desired 
amide. Formation of  the amide via the 2,3,4,5,6-pentafluorophenyl ester derivative of 
198 also proved unsuccessful. Attempts to acylate amine 227 via an acid chloride 
formed by means of  the Vilsmeier reagent and acid 198 yielded trace amounts of the 
desired product in certain cases, but often returned starting material and deprotected 
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alcohol accompanied by decomposition of  the acid chloride. After numerous attempts to 
couple amine 227 and acid 198 had failed, we revised our synthesis of aldehyde 225.
 We instead accessed aldehyde 225 from amine 227 by first using a three-step 
sequence of  N-acylation with sorbyl chloride, silyl ether cleavage under aqueous acidic 
conditions, and Dess-Martin29 oxidation to afford ketone 229 in 60% overall yield. Next 
we performed a regioselective Sharpless dihydroxylation30 at the ",$-position of 229 
using a procedure similar to one reported by Zhang and O’Doherty31 to access diol 230 
as a single diastereomer in moderate yield. Finally cleavage of  the diol was smoothly 
accomplished with sodium periodate in quantitative yield (Scheme 65).
Me
NHPMB
OTMS
MeO2C OBn
227
1. sorbyl chloride
    DIPEA, CH2Cl2
    0 °C!rt, 28 h
2. 6N HCl(aq)
    rt, 1 h
(60% over 3 steps)
Me
N
MeO2C
O
O
Me
OBn
PMB
229
3. Dess-Martin, 
    CH2Cl2, rt, 16 h
Me
N
MeO2C
O
O
Me
OBn
PMB OH
OH
230
AD-mix ", 
(DHQ)2PHAL, OsO4
MeSO2NH2, NaHCO3
(40%)
3:2 H2O:t-BuOH, rt, 24 h
Me
N
MeO2C
O
O
H
OBn
PMB O
225
NaIO4
sat. NaHCO3(aq)
(quant.)
CH2Cl2, rt, 20 h
Scheme 65. Synthesis of key enal substrate 225 for NHC-catalyzed intramolecular cyclization.
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 5.3.3 Formal Synthesis of Salinosporamide A
 Having successfully synthesized key intermediate 225, we subjected the enal to 
our previously optimized conditions for cyclization of  substrate 217. When 225 was 
allowed to react with 15 mol % IMesCl and 10 mol % DBU in 10:1 THF:t-BuOH at 40 °C 
a complete conversion to the "-lactam-"-lactone products 231 and 232 was observed 
(Table 7, entry 1). Although the isolated yield was good (75%), the diastereomeric ratio 
was only 3:1 in favor of the undesired diastereomer. We therefore sought to bias the 
stereochemical outcome through the use of  chiral catalyst. We employed our N-mesityl 
aminoindanol derived chiral triazolium catalyst 117 (entry 2); the diastereomeric ratio 
decreased to 1.1:1 still in favor of  the undesired diastereomer but with increased yield 
(84%). Interestingly, the use of the enantiomeric precatalyst ent-117 provided nearly an 
identical outcome (entry 3). Triazolium salts, 130 and 131, which had previously led to 
higher enantiomeric ratios with substrate 225, gave slightly higher diastereomeric ratios: 
1.7:1 and 1.5:1, respectively, but again in favor of the undesired diastereomer (entry 4–
5). Therefore, choice of  the appropriate catalyst, 117, did indeed influence the strong 
substrate control over the diastereoslective homoenolate addition to the ketone whereby 
a 1:1.1 ratio of desired:undersired lactam is our best result (see entry 2). Our NHC-
catalyzed intramolecular cyclization-lactonization of enal 225 provided lactams 231 and 
232 in excellent yield and represents a formal synthesis of salinospoaramide A.
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Table 7. NHC-Catalyzed cyclization-lactonization of substrate 225.a Formal synthesis of 
salinosporamide A.
N
O
O
O
CO2Me
PMB
OBn
Me
N
O
O
O
CO2Me
PMB
OBn
Me
Me
N
MeO2C
O
O
H
OBn
PMB O
15 mol%
10 mol% DBU
225
+
231
Desired
232
Undesired
Entry Catalyst drc (desired/undesired)
1
2
3
4
5
IMesCl
Yieldb (%)
75
88
77
84
93
1:3
1:1.1
1:1.2
1:1.7
1:1.5
117
ent-117
130
131
a Reactions were performed at 0.05 M in 10:1 THF:t-BuOH at 40 °C for 3 h.
b Combined isolated yield of both diastereomers.
c Determined from 1H NMR of unpurified reaction mixtures.
5.4  Conclusion
 We have presented an NHC-catalyzed intramolecular cyclization-lactonization of 
enals to ketones tethered by an amide bond, producing densely functionalized "-lactam-
"-lactone adducts. In the course of these studies we have documented reaction 
parameters that can preferentially favor the formation of one catalytically generated 
reactive intermediate over another (NHC-enolate vs. homoenolate). Furthermore, to 
demonstrate the utility of  this method, we accomplished a formal synthesis of 
salinosporamide A, a potent 20S proteasome inhibitor, via intermediates reported by 
Corey and by Lam. The attraction of our synthesis is the use of a NHC-promoted 
intramolecular cyclization-lactonization strategy to construct the carbocyclic core of 
salinosporamide A whereby a carbon-nitrogen, carbon-oxygen, and carbon-carbon bond 
are all formed in a single catalytic step.
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Chapter 6: Experimental Procedures
6.1  General Methods
 All reactions utilizing air- or moisture-sensitive reagents were performed in dried 
glassware under an atmosphere of dry Nitrogen. Dichloromethane, 1,2-dichloroethane, 
xylenes and chlorobenzene were distilled over CaH2. t-BuOH was distilled from Na0. 
Toluene, THF, MeOH, DMF, DMSO and EtOAc were dried by passage over activated 
alumina under Ar atmosphere. Benzaldehyde and trans-cinnamaldehyde were purified 
by distillation prior to use. 2,4,6-trimethylaniline was fractionally distilled under reduced 
pressure from Zn0 (granular). 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) was distilled 
from KOH. Triethylamine (NEt3) and N,N’-diisopropylethylamine (DIPEA) were distilled 
from CaH2. Acetic anhydride was shaken over P2O5, filtered, shaken over K2CO3, 
filtered, and fractionally distilled. Perchloric acid was purchased from Fisher Scientific as 
60 or 70 wt % solutions in water. Other reagents were used without further purification. 
Thin layer chromatography (TLC) was performed on Merck precoated plates (silica gel 
60 F254, Art 5715, 0.25 mm) and were visualized by fluorescence quenching under UV 
light or by staining with phosphomolybdic acid, potassium permanganate, or cerium 
sulfate solutions. Silica-gel preparative thin-layer chromatography (PTLC) was 
performed using plates prepared from Merck Kieselgel 60 PF254 (Art 7747). Column 
chromatography was performed on E. Merck Silica Gel 60 (230–400 Mesh) using a 
forced flow  of 0.1–0.5 bar. 1H NMR and 13C NMR were measured on a Varian Unity 400 
spectrometer or on a Bruker Avance II 500 MHz, 125 MHz respectively. The peaks 
labeled with an asterisks (*) indicate peaks of  either the minor diastereomer (trans-), 
amide rotamers, or atropisomers where appropriate. Chemical shifts are expressed in 
parts per million (PPM) downfield from residual solvent peaks and coupling constants 
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are reported as Hertz (Hz).  Splitting patterns are indicated as follows: br, broad; s, 
singlet; d, doublet; t, triplet; q, quartet; m, multiplet. Infrared (IR) spectra were recorded 
on a JASCO FT/IR-430 spectrophotometer and are reported as wavenumbers (cm–1). 
Optical rotations were acquired using a JASCO DIP-370 polarimeter operating at the 
sodium D line with a 100 mm path length cell and are reported as follows: [%]T (concen-
tration (g/mL x 100), solvent).
6.2  HPLC Conditions
 Column, Diacel Chiralpak AS-H, (4.6 x 250mm) Eluent: hexanes/i-PrOH. Flow  Rate 
1.0 mL/min. Detection: 254 nm. Column, Diacel Chiralpak AD-H, (4.6 x 250mm) Eluent: 
hexanes/i-PrOH. Flow Rate 1.0 mL/min. Detection: 254 nm.  
6.3 SFC Conditions
 Column, Diacel Chiralpak AS-H, (4.6 x 250mm) Eluent: i-PrOH in CO2, MeOH in 
CO2. Flow  Rate 2.0 mL/min. Detection: 254 nm. Column, Diacel Chiralpak AD-H, (4.6 x 
250mm) Eluent: i-PrOH in CO2. Flow  Rate 2.0 mL/min. Detection: 254 nm. Column, 
(R,R)-Whelk-01 (4.6 x 250mm) Eluent: i-PrOH in CO2. Flow  Rate 2.0 mL/min. Detection: 
254 nm. 
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6.4  Experimental Procedures
NH2
Me
MeMe
conc. HCl (aq)
NaNO2, SnCl2•2H2O NH
Me
MeMe
NH3 Cl
!10 °C"rt , 1 day
107 108
2-Mesitylhydrazinium chloride (108)
 A 3-neck 1-L round-bottomed flask was charged with a magnetic stir bar and placed in a 
$10 °C MeOH bath. The flask was charged with conc. aq HCl (26.5 mL) and H2O. The 
center neck of the reaction vessel was equipped with a 60-mL pressure-equalizing 
addition funnel and charged with 2,4,6-trimethylaniline (15.0 mL, 107 mmol, 1.00 equiv), 
which was added drop-wise over a period of approximately 5 min resulting in a thick 
white slurry and stirring was continued for an additional 15 min. The reaction vessel was 
equipped with a thermometer to monitor the internal temperature of  the reaction. The 
addition funnel was charged with a freshly prepared solution of NaNO2  (7.38 g, 107 
mmol, 1.00 equiv) in H2O (12 mL) and added drop-wise so as to maintain an internal 
temperature of  < 5 °C. The addition funnel was washed with H2O (5 mL) and stirring was 
continued for an additional 30 min. The addition funnel was charged with a solution of 
SnCl2•2H2O (60.4 g, 268 mmol, 2.50 equiv) in 1:1 concd HCl/H2O and added drop-wise 
over 4 h maintaining an internal reaction temperature of  < 5 °C. The addition funnel and 
thermometer were removed and the thick heterogeneous orange mixture was stirred at 0 
°C for 1 h before being allowed to warm to ambient temperature. Vigorous stirring was 
maintained for an additional 16 h. The mixture was cooled to 0 °C. The orange 
precipitate was collected by suction filtration and the reaction vessel washed with brine 
(5 x 50 mL) that was poured over the collected solid with each wash. The orange solid 
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was transferred to a 1-L round-bottomed flask and Et2O (300 mL) and a magnetic stir bar 
were added. The heterogeneous mixture was placed in an ice/brine bath and the flask 
was equipped with a pressure-equalizing addition funnel charged with aq 10 M NaOH 
(200 mL) that was added over approximately 30 min. An additional 100 mL of H2O was 
added and stirring was maintained for an additional 1 h before the biphasic mixture was 
allowed to warm to ambient temperature and transferred to a separatory funnel. The 
organic layer was separated and the aqueous phase extracted with Et2O (2 x 200 mL). 
The organic fractions were combined and washed with brine (250 mL), dried over 
Na2SO4, and filtered into a dry 1-L round-bottomed flask charged with a magnetic stir 
bar. The drying agent was washed with Et2O (3 x 30 mL). The orange solution was 
placed under an atmosphere of N2(g) and immersed in an ice/brine bath. A solution of 
HCl (4 M in 1,4-dioxane, 27.0 mL, 108 mmol) was added via syringe over 15 min 
inducing a white precipitate. Stirring was maintained for 30 min and then allowed to 
warm to ambient temperature. The pale orange precipitate was collected by suction 
filtration and washed with Et2O (50 mL). The crude solid was transferred to a 200-mL 
round-bottomed flask and the residual volatiles removed under reduced pressure. The 
crude solid  was suspended in a solution of 200 proof EtOH/Et2O (5:1, 60 mL) and 
placed in a sonicating bath for 30 min. The pale orange solid was collected by suction 
filtration, and washed with a solution of 200 proof  EtOH/Et2O (1:1, 3 x 30 mL). The 
filtrate was concentrated under reduced pressure to produce an orange crystalline solid 
which was suspended in a solution of 200 proof EtOH/Et2O (1:1, 15 mL) and placed in a 
sonicating bath for 5 min; the pale orange solid was collected by suction filtration and 
washed with a solution of 200 proof EtOH/Et2O (1:1, 3 x 5 mL). The collected solids were 
combined and the residual volatiles removed under reduced pressure to afford the title 
compound (7.28 g, 36.4 %) as a pale orange powder. 1H NMR (500 MHz, d6-DMSO) #: 
9.40 (variable bs, 3H), 6.88 (s, 2H), 6.61 (bs, 1H), 2.32 (s, 6H), 2.20 (s, 3H); 13C NMR 
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(125 MHz, d6-DMSO) #: 137.9, 136.2, 134.9, 129.1, 20.45, 17.8; IR (KBr) ! 3294, 3002, 
2964, 2911, 2680, 1564, 1513, 1481, 852, 825, 753 cm$1; HRMS (ESI) calcd for 
C9H15N2+ [M]+ 151.1230, found 134.0921 [M – NH3]+.
NH
O
N
H
N
HN
Me
Me
Me
2. 108, MeOH
    50 oC, 0.5 h
1. (MeO)2SO2
    60 °C, 12 h
        then NaHCO3
86 110
•HCl
(Z)-2-(2-mesitylhydrazono)pyrrolidine hydrochloride (110)
An oven-dried 100-mL round-bottomed flask was charged with 2-pyrrolidinone and 
dimethyl sulfate. The neat mixture was stirred at 60 °C for 16 h under an atmosphere of 
N2(g). The mixture was allowed to cool to ambient temperature, diluted with CH2Cl2 (20 
mL) and slowly quenched over 3 hours by the addition of sat aq NaHCO3 (30 mL). Once 
effervescence had ceased, the biphasic mixture was transferred to a separatory funnel 
and diluted with CH2Cl2 (80 mL) and sat aq NaHCO3 (70 mL). The organic phase was 
separated and the aqueous phase extracted with CH2Cl2 (50 mL). The combined organic 
fractions were dried over Na2SO4, filtered and carefully concentrated under reduced 
pressure (~450 mbar) at ambient temperature to afford the crude iminoether. To a flame-
dried 200-mL round-bottomed flask was weighed the crude iminoether (5.70 g, 57.5 
mmol, 1.1 equiv) by passage through a plug of  Na2SO4; MeOH (80 mL) and 2-
mesitylhydrazinium hydrochloride 108 were added. The reaction vessel was equipped 
with a water-jacketed condenser and the orange solution stirred at 50 °C under an 
atmosphere of N2(g) for 0.5 h. The solution was allowed to cool to ambient temperature 
and the solvent removed under reduced pressure to afford a crude orange solid. The 
crude solid was suspended in EtOAc (130 mL) and stirred vigorously under reflux until a 
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free-flowing light orange precipitate was observed. The precipitate was collected by 
suction filtration and washed with EtOAc to afford the title compound as a pale-orange 
solid (9.60 g, 73%). 1H NMR (500 MHz, d6-DMSO) # 11.16 (bs, 1H), 10.08 (s, 1H), 7.17 
(s, 1H),  6.84 (s, 2H), 3.63–3.59 (t, 2H, J  = 7.2 Hz), 2.83 (t, 2H, J = 7.9 Hz), 2.19 (s, 9H), 
2.14 (t, 2H, J = 7.4 Hz); 13C NMR (125 MHz, d6-DMSO) # 167.7, 138.6, 133.6, 130.9, 
129.3, 46.8, 28.4, 20.8,  20.3, 17.9; IR (KBr) ! 3436, 3217, 2959, 2908, 1687, 1480, 
1306, 1229, 853 cm$1; HRMS (ESI) calcd for C13H20N3+ [M]+ 218.1652, found 218.1646 
[M]+.
N
H
N
HN
Me
Me
Me
110
•HCl
HC(OEt)3, PhCl
120 °C, 1 h
HCl (4 M in dioxane)
N
N
N
Me
Me
Me
63
Cl
2-Mesityl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium chloride (63)
An oven-dried 350-mL sealed tube was charged with a magnetic stir bar, 110 (9.3 g, 37 
mmol, 1.0 equiv), triethylorthoformate (50 mL, 370 mmol, 10 equiv), chlorobenzene (38 
mL) and anhydrous HCl (4 M in 1,4-dioxane, 9.2 mL, 37 mmol, 1.0 equiv). The reaction 
vessel was purged with N2(g), sealed, and placed in an oil bath. The suspension was 
stirred at 120 °C until all of  starting material 110 had dissolved (ca. 1 h). The tan-colored 
solution was allowed to cool to ambient temperature, transferred to a 250-mL round-
bottomed, and concentrated under reduced pressure to afford a crude brown foam. 
Recrystalization from toluene afforded the title compound (6.5 g, 67%) as a white 
powder. 1H NMR (500 MHz, CDCl3) # 11.19 (s, 1H), 6.95 (s, 2H), 4.87 (t, 2H, J = 7.4 Hz), 
3.21 (t, 2H, J = 7.8 Hz), 2.89–2.85 (m, 2H), 2.32 (s, 3H), 2.08 (s, 6H); 13C NMR (125 
MHz, CDCl3) # 162.4, 143.0, 142.0, 135.1, 132.0, 129.8, 48.6, 27.0, 22.2, 21.3, 17.8; IR 
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(thin film) ! 2975, 1590, 1447, 1387, 1200, 974 cm$1; HRMS (ESI) calcd for C14H18N3+ 
[M]+ 228.1495, found 228.1489 [M]+.
MeOH
60 °C, 2 d
108, cat. HCl
NH
O
O
N
O
OMe
Me3O   BF4
CH2Cl2
then NaHCO3
O
NH
N
HN
Me
Me
Me
• HCl
115 116ent-103
(Z)-2-Mesityl-1-((4aS,9aR)-4,4a,9,9a-tetrahydroindeno[2,1b][1,4]oxazin-3(2H)-ylid- 
ene)hydrazinium chloride (116)
A flame-dried 500-mL round-bottomed flask was charged with a magnetic stir bar, 
(4aS,9aR)-4,4a,9,9a-tetrahydroindeno[2,1-b][1,4]oxazin-3(2H)-one (ent-103)1 (7.00 g, 
37.0 mmol, 1.00 equiv), CH2Cl2 (185 mL) and trimethyloxonium tetrafluoroborate (6.57 g, 
44.4 mmol, 1.20 equiv). The tan solution was stirred at ambient temperature under an 
atmosphere of N2(g) or 16 h. The solution was cooled to 0 °C and quenched by the slow, 
portion-wise addition of sat aq NaHCO3 (150 mL) over a period of 1.5 h; stirring was 
maintained for an additional 1 h. The biphasic solution was transferred to a separatory 
funnel, the organic phase separated, and the aqueous phase extracted with CH2Cl2 (3 x 
100 mL). The combined organic fractions were dried over Na2SO4, filtered, and 
concentrated to afford the crude iminoether 115 (6.48 g, 86%) as a brown solid which 
was used without further purification. A flame-dried 500-mL round-bottomed flask was 
charged with a magnetic stir bar, 2-mesitylhydrazinium chloride (108) (6.44 g, 34.4 
mmol, 1.00 equiv) and MeOH (138 mL) resulting in a light red/orange solution. To this 
solution was added (115) (7.00 g, 34.4 mmol, 1.00 equiv) and the stirred at ambient 
temperature until a deep red homogeneous solution was obtained (ca. 5 min). A catalytic 
amount of  anhydrous HCl (4 M in 1,4-dioxane, 0.86 mL, 0.10 mmol) was added, the 
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reaction flask equipped with a water–jacketed condenser and the solution stirred at 60 
°C under an atmosphere of N2(g) for 48 h. The reaction was allowed to cool to ambient 
temperature and the concentrated under reduced pressure to afford a crude orange 
solid. The crude material was suspended in EtOAc (125 mL) and stirred vigorously in a 
at 90 °C under an atmosphere of  N2(g) for 30 min causing a light yellow  precipitate to 
form. The suspension was allowed to cool to ambient temperature with vigorous stirring 
and immersed in an ice/water bath at 0 °C with vigorous stirring. The precipitate was 
collected by suction filtration and washed with EtOAc (3 x 20 mL) affording the title 
compound (10.0 g 81.3%) as a light yellow  powder. 1H NMR (500 MHz, d6-DMSO) # 
11.29 (s, 1H), 11.06 (d, 1H, J= 3.1 Hz), 7.71–7.69 (m, 1H), 7.31–7.28 (m, 3H), 7.11 (s, 
1H), 6.87 (s, 2H), 5.00 (t, 1H, J = 3.6 Hz), 4.72 (t, H, J = 4.4 Hz), 4.61 (d, 1H, J = 16.7 
Hz), 4.52 (d, 1H, J = 16.7 Hz), 3.29 (dd, 1H, J = 16.9 Hz, 4.7 Hz), 2.97 (d, 1H, J = 16.9 
Hz), 2.22 (s, 6H), 2.20 (s, 3H); 13C NMR (125 MHz, d6-DMSO) # 159.3, 140.2, 139.7, 
138.3, 134.9, 133.8, 131.2, 129.4, 129.1, 128.2, 126.7, 124.9, 124.8, 77.0, 62.0, 60.1, 
56.1, 37.1, 20.4 17.9; IR (KBr) ! 3294, 3119, 2997, 2966, 2951, 2918, 2731, 2692, 
1676, 1514, 1483, 1335, 739 cm$1; HRMS (ESI) calcd for C20H24N3O+ [M]+  322.1914, 
found 322.1912 [M]+.
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(5aR,10bS)-5a,10b-Dihydro-2-(2,4,6-trimethylphenyl)-4H,6H-indeno[2,1-b]-1,2,4-tria
zolo[4,3-d]-1,4-oxazinium chloride (117) 
An oven-dried 350-mL sealed tube was charged with a magnetic stir bar, 116 (9.00 g, 
25.1 mmol, 1.00 equiv), triethylorthoformate (33.4 mL, 201 mmol, 8.0 equiv), 
chlorobenzene (25.5 mL) and anhydrous HCl (4 M in 1,4-dioxane, 6.28 mL, 25.1 mmol, 
1.00 equiv). The reaction vessel was purged with N2(g), sealed, and placed in an oil 
bath. The suspension was stirred at 120 °C until all of  starting material 116 had 
dissolved (ca. 1 h). The tan-colored solution was allowed to cool to ambient temperature, 
transferred to a 250-mL round-bottomed flask, and concentrated under reduced pressure 
to afford a crude brown foam. Recrystallization from toluene afforded the title compound 
(5.86 g, 63.5%) as a white powder. 1H NMR (500 MHz, d6-DMSO) #: 11.28 (bs, 1H), 7.64 
(s, 1H), 7.45–7.33 (m, 5H), 7.21 (s, 2H), 6.11 (s, 1H), 5.26 (d, 1H, J = 16.0 Hz), 5.08 (d, 
1H, J  = 16.0 Hz), 4.99 (t, 1H, J  = 4.4 Hz), 3.50 (dd, 1H, J = 16.9, 4.8 Hz), 3.16 (d, 1H, J 
= 17.0 Hz), 2.37 (s, 3H), 2.12 (s, 6H); 13C NMR (125 MHz, d6-DMSO) #: 150.2, 144.5, 
141.5, 140.7, 136.1, 134.8, 131.2, 129.4, 127.3, 125.5, 123.9, 76.9, 61.2, 59.8, 37.0, 
20.7, 17.0; IR (KBr) ! 2923, 2853, 1581, 1460, 1223, 1099 cm-1; HRMS (ESI) calcd for 
C21H22N3O+ [M]+ 332.1757, found 332.1760 [M]+; [%]2D
0 = $129.4 (c 1.00, EtOH); Anal. 
Calcd for C21H22ClN3O: C, 68.56; H, 6.03; N, 11.42. Found: C, 68.28; H, 6.20; N, 11.26.
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132 134 133
(S)-5-(Azidomethyl)-2-mesityl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium 
chloride (133)
A flame-dried 1-L round-bottomed flask was charged with a magnetic stir bar, 1322 (6.0 
g, 43 mmol, 1.0 equiv), CH2Cl2 (300 mL) and trimethyloxonium tetrafluoroborate (7.0 g, 
47 mmol, 1.1 equiv). The tan solution was stirred at ambient temperature under an 
atmosphere of N2(g) for 17 h. The solution was cooled to 0 °C and quenched by the 
slow, portion-wise addition of sat aq NaHCO3 (300 mL) over a period of 1.5 h; stirring 
was maintained for an additional 1 h. The biphasic solution was transferred to a 
separatory funnel, the organic phase separated, dried over Na2SO4, filtered, and 
concentrated to afford the crude iminoether  (5.6 g, 85%) as a brown oil which was used 
without further purification. A flame-dried 500-mL round-bottomed flask was charged with 
the crude iminoether (5.5 g, 35 mmol, 1.0 equiv), a magnetic stir bar, 2-
mesitylhydrazinium chloride (108) (6.6 g, 35 mmol, 1.0 equiv) and MeOH (140 mL) 
resulting in a deep red-orange solution that was stirred at 50 °C under an atmosphere of 
N2(g) for 1 h. The reaction was allowed to cool to ambient temperature and the 
concentrated under reduced pressure to afford 134 as a crude orange solid. The crude 
material was suspended in EtOAc and placed in a sonicating bath. The light orange 
precipitate (recovered 2-mesitylhydrazinium hydrochloride 108) was removed by suction 
filtration. The filtrate was concentrated under reduced pressure to afford crude 134 (8.7 
g, 79%) as an orange foam. To the round-bottomed flask charged with crude 134 was 
added triethylorthoformate (38 mL, 280 mmol, 10 equiv), chlorobenzene (28 mL) and 
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anhydrous HCl (4 M in 1,4-dioxane, 7.0 mL, 28 mmol, 1.0 equiv). The reaction vessel 
was equipped with a water-jacketed condensor and stirred at 100 °C for 50 min under an 
atmosphere of  N2(g). The brown solution was allowed to cool to ambient temperature 
and concentrated under reduced pressure. The crude brown solid was purified by flash 
column chromatography (gradient, CH2Cl2/acetone, 10:1"5:1"2:1"1:1) to give the title 
compound (4.45 g, 50%) as a tan powder. 1H NMR (500 MHz, d6-DMSO) # 10.77 (bd, 
1H,), 7.16 (s, 2H), 5.03 (bs, 1H), 4.18–4.12 (bm, 1H), 3.95–3.94 (bm, 1H), 3.34–3.18 (m, 
3H), 2.96–2.89 (m, 1H), 2.37 (s, 3H), 2.08 (s, 6H); 13C NMR (125 MHz, d6-DMSO) # 
162.7, 141.8, 141.2, 134.8,131.9, 129.3, 59.5, 52.0, 30.0, 21.3, 20.7, 16.9; IR (KBr) ! 
2919, 2108, 1586, 1442, 1388, 1331, 1290, 1037, 854 cm$1; HRMS (ESI) calcd for 
C15H19N6+ [M]+  283.1666, found 283.1671 [M]+.
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2.5 mol% CuSO4•H2O
25 mol% sodium ascorbate
1:1 t-BuOH/H2O
rt, 30 h
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(S)-2-Mesityl-5-((4-phenyl-1H-1,2,3-triazol-1-yl)methyl)-6,7-dihydro-5H-pyrrolo[2,1- 
c][1,2,4]triazol-2-ium chloride (136)
An oven-dried 10-mL round-bottomed flask was charged 133 (0.25 g, 0.78 mmol, 1.0 
equiv) and 1:1 t-BuOH/H2O (3.1 mL). The reaction vessel was purged with N2(g) and 
freshly prepared solutions of  (+)-L-sodium ascorbate (1.0 M in Millipore H2O, 0.19 mL, 
0.19 mmol, 0.25 equiv) and CuSO4 •5H2O (0.30 M in Millipore H2O, 0.0065 mL, 0.0019 
mmol, 0.025 equiv) were added via syringe through a septum. Phenylacetylene 135 
(0.094 mL, 0.86 mmol, 1.1 equiv) was added and the solution stirred at ambient 
temperature for 30 h. Removal of solvent under reduced pressure provided the crude 
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residue which was dissolved in H2O (10 mL), transferred to a separatory funnel and 
extracted with CHCl3 (3 x 15 mL). The combined organics were dried over Na2SO4, 
filtered, and concentrated under reduced pressure. The crude solid was suspended in 
EtOAc and placed in a sonicating bath for approximately 10 min. The resultant 
precipitate was collected by suction filtration and washed with EtOAc to afford the title 
compound (0.18 g, 55%) as a tan powder. 1H NMR (500 MHz, CDCl3) # 11.47 (s, 1H), 
8.58 (s, 1H), 7.79 (d, 2H, J = 7.0 Hz), 7.40–7.30 (m, 5H), 6.92 (s, 2H), 5.95 (bd, 1H, J = 
14.5 Hz), 5.04 (d, 1H, J  = 14.0 Hz), 3.20–3.06 (m, 2H), 2.89–2.82 (m, 2H), 2.30 (s, 3H), 
1.96 (s, 6H); 13C NMR (125 MHz, CDCl3) # 162.2, 147.8, 142.9, 142.2, 135.0, 131.9, 
129.9, 129.7, 129.0, 158.5, 125.8, 122.9, 60.0, 51.7, 30.8, 21.6, 21.8, 17.6; IR (thin film) 
! 3053, 2976, 1587, 1440,  1386, 1203, 1040, 855 cm$1; HRMS (ESI) calcd HRMS 
(ESI) calcd for C23H25N6+ [M]+ 385.2135, found 385.2125 [M]+.
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133 137a 137b
(S)-5-(Aminomethyl)-2-mesityl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium 
chloride (137a)
To a solution of  133 (3.18 g, 9.97 mmol, 1.00 equiv) in 200 proof EtOH/H2O (3:1, 10 mL) 
was added NH4Cl (0.847 g, 13.0 mmol, 1.30 equiv) and Zn0 powder (1.39 g, 25.9 mmol, 
2.3 equiv); vigorous stirring was maintained for 1 h at ambient temperature. DMSO (10 
mL) was added and the insoluble solids were removed by suction filtration and washed 
with DMSO (5 mL). A magnetic stir bar was added to the filtrate and Et2O (100 mL) was 
added with vigorous stirring resulting in the formation of an oil. In order to induce 
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precipitation, 200 proof EtOH (20 mL) was added with vigorous stirring. The 
heterogeneous mixture was placed in a sonicating bath until all traces of the initially 
formed oil had dissolved. The resultant precipitate was collected by suction filtration and 
washed with EtOAc affording the title compound (1.85 g, 63.6%) as a white powder. 1H 
NMR (500 MHz, d6-DMSO) # 7.05 (s, 2H), 4.60 (q, 1H, J = 8.5 Hz), 3.36–3.14 (m, 2H), 
3.06 (dd, 1H, J = 16.5, 9.0 Hz), 2.752–2.713 (m, 2H), 2.40–2.34 (shoulder m, 1H), 2.32 
(s, 3H), 2.08 (s, 3H), 1.99 (s, 3H); 13C NMR (125 MHz, d6-DMSO) # 172.9, 160.0, 139.4, 
135.4, 134.9, 128.7, 128.6, 57.0, 44.8, 31.7, 30.7, 21.2, 20.7, 17.2, 17.0; IR (KBr) ! 
3434, 3330, 3252, 3049, 2992, 1588, 1402, 1234, 1134, 1023, cm$1; HRMS (ESI) calcd 
for C15H21N4+ [M]+  257.1761, found 257.1746 [M]+.
NH2
OH
crotyl bromide
NaH, DMF
NH2
O
Me
0 °C!70 °C, 2 h
104 152
(1R,2S)-2-((E)-But-2-enyloxy)-2,3-dihydro-1H-inden-1-amine (152) 
A flame-dried 500-mL round-bottomed flask equipped with a magnetic stir bar was 
charged with NaH (60 % oil dispersion, 960 mg, 24 mmol, 1.2 equiv). The NaH was 
washed with anhydrous pentane (1 x 50 mL) and the pentane removed via syringe. The 
flask was charged with THF (200 mL) and cooled to 0 °C. (1R, 2S)-(+)-1-amino-2-
indanol 104 (3.0 g, 20 mmol, 1.0 equiv) was added in two portions 10 min apart. The 
suspension was stirred until H2(g) evolution had ceased. The flask was equipped with a 
water-jacketed condenser and heated to 70 °C under N2(g). A solution (66 v/v% in THF) 
of trans-crotyl bromide (85% purity, 2.7 mL, 22 mmol, 1.1 equiv) was added drop-wise 
over 90 min. The resulting blueish-purple solution was stirred for an additional 40 min at 
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which time it had turned light tan in color. The mixture was cooled to 0 °C and quenched 
by the drop-wise addition of sat aq NH4Cl. The resulting suspension was poured into a 
separatory funnel and brine (250 mL) was added. The organic phase was separated and 
the aqueous phase extracted with EtOAc (2 x 150 mL). The organic phases were com-
bined and dried over Na2SO4, filtered, and concentrated under reduced pressure. The 
resulting oil was dissolved in Et2O (200 mL) and treated with HCl (4 M in 1,4-dioxane, 
5.0 mL) at 0 °C. The white precipitate was collected by vacuum filtration and washed 
with excess Et2O to afford the HCl salt of  compound 152 which was freebased with 1 N 
NaOH and extracted with Et2O. Concentration of  the ethereal phase yielded the title 
compound as a colorless oil (2.6 g, 64%). 1H NMR (500 MHz, CDCl3) # 7.38–7.36 (m, 
1H), 7.22–7.19 (m, 3H), 5.76–5.71 (m, 1H), 5.64–5.59 (m, 1H), 4.27 (d, 1H, J = 5.4 Hz), 
4.13 (dd, 1H, J = 10.8, 5.4 Hz), 4.08–4.0 (m, 2H), 3.02–2.98 (m, 1H), 1.72 (dd, 3H, J = 
6.4, 1.4 Hz), 1.59 (br s, 2H); 13C NMR (125 MHz, CDCl3) # 144.9, 140.0, 129.6, 127.8, 
127.0, 125.2, 124.5, 81.3, 70.6, 65.2, 58.4, 36.0, 17.9; IR (thin film) ! 3378, 3022, 2914, 
2857, 1587, 1458, 1342, 1105, 966 cm$1, HRMS (ESI) calcd for C13H18NO2 [M]+ 
203.1310, found 204.1403 [M+H]+.
NH
O
MeO
HHCO2Et
AcOH, THF
NH2
O
Me
62 °C, 16 h
152 151
N-((1R,2S)-2-((E)-But-2-enyloxy)-2,3-dihydro-1H-inden-1-yl)formamide (151)
A 0.50 M solution of   (1R,2S)-2-((E)-but-2-enyloxy)-2,3-dihydro-1H-inden-1-amine 152 
(5.2 g, 26 mmol, 1.00 equiv) in THF (50 mL) was treated with ethyl formate (16 mL, 200 
mmol, 7.90 equiv) and catalytic glacial acetic acid (0.070 mL, 1.3 mmol, 0.05 equiv). The 
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flask was equipped with a water-jacketed condenser and the solution stirred in an oil 
bath operating with an external temperature of 62 °C under N2(g) for 15 h. The solution 
was concentrated under reduced pressure and the resulting crude solid recrystallized 
from a 70:30 mixture of hexanes/EtOAc and collected by suction filtration in two crops to 
afford 151 as a white solid (5.2 g , 87%). 1H NMR (500 MHz, CDCl3) # 8.38 (s, 1H), 
7.33–7.20 (m, 4H), 6.38 (bs, 1H), 5.73–5.58 (m, 1H), 5.57–5.51 (m, 2H), 4.32–4.30 (m, 
1H), 4.05–4.01 (m, 1H), 3.96–3.92 (m, 1H), 3.08–3.0 (m, 2H), 1.70 (d, 2H, J = 6.3 Hz); 
13C NMR (125 MHz, CDCl3) # 161.3, 141.3, 139.8, 130.3, 128.4, 127.3, 127.3, 125.2, 
124.8, 79.4, 70.6, 54.5, 36.7,18.0; IR (thin film) ! 3071, 3025, 2919, 2856, 1652, 1448, 
1400 cm$1; m.p. 69–72 °C; HRMS (ESI) calcd for C14H17NO2 [M]+ 231.1259, found 
232.1434 [M+H]+, 254.1153 [M+Na]+.
mCPBA
CH2Cl2
rt, 16 h
NH
O
MeO
H
NH
O
O
MeO
H
151 148, 149
N-((1R,2S)-2-((3-methyloxiran-2-yl)methoxy)-2,3-dihydro-1H-inden-1-yl)formamide 
(148, 149) 
To a 0.088 M solution of N-((1R,2S)-2-((E)-but-2-enyloxy)-2,3-dihydro-1H-inden-1-yl) 
formamide  151 (5.2 g, 22 mmol, 1.0 equiv) in CH2Cl2 (250 mL) was added mCPBA (70–
75 % purity, 28 g, 80 mmol, 4.0 equiv). The solution was stirred at ambient temperature 
until the starting material was consumed as visualized by TLC (ca. 12 h). The solution 
was diluted with CH2Cl2 (500 mL), washed with H2O (1 x 1.0 L), 1 N NaOH(aq) (1 x 1.0 
L), and again with H2O (1 x 1.0 L). The organic phase was dried over Na2SO4, filtered, 
and concentrated under reduced pressure to a yellow  oil which was purified by flash 
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column chromatography (gradient, hexanes/EtOAc, 1:1"1:1.5) to yield compounds 148 
and 149 as a white solid as a 1:1 mixture of diastereomers (5.1 g, 91%). 1H NMR (400 
MHz, CDCl3) # 8.34 (s, 1H), 7.30–7.19 (m, 4H), 6.56 (d, 1H), 5.61–5.56 (m, 1H), 4.34–
4.27 (m, 1H), 3.81–3.78 (m, 1H), 3.58 (dd, 2H, J = 11.6, 5.2 Hz), 3.11–3.02 (m, 2H), 
2.93–2.83 (m, 2H), 1.31–1.27 (m, 3H); 13C NMR (100 MHz, CDCl3) # 161.5, 141.0, 
139.7, 128.3, 127.3, 125.2, 124.6, 81.4, 69.9, 58.1, 54.7, 52.2, 37.1, 17.4; IR (thin film) 
! 3307, 3030, 2990, 2924, 2859, 1684, 1497, 1384, 1119, 1084 cm$1; m.p. 77–79 °C; 
HRMS (ESI) calcd for C14H17NO3 [M]+ 247.1208, found 248.1370 [M+H]+, 270.1107 
[M+Na]+.
NH
O
NH
O
Me
O
Me
O
H
O
H
Oxone,
acetone, 
NaHCO3
EtOAc/H2O
rt, 2h
151 148, 149
N-((1R,2S)-2-((3-Methyloxiran-2-yl)methoxy)-2,3-dihydro-1H-inden-1-yl)formamide 
(148, 149)
To a vigorously stirred mixture of NaHCO3 (14.5 g, 171 mmol, 5.00 equiv), water (260 
mL), EtOAc (170 mL), N-((1R,2S)-2-((E)-but-2-enyloxy)-2,3-dihydro-1H-inden-1-yl)form- 
amide 151 (8.00 g, 34.5 mmol, 1.00 equiv), and acetone (25.5 mL, 345 mmol, 10.0 
equiv) in a 1-L round-bottomed flask was added dropwise a 0.235 M solution of 
Oxone® (42.5 g, 69.0 mmol, 2.00 equiv) in H2O (250 mL) over 1 h. The biphasic 
mixture was stirred an additional 1 h at ambient temperature. The organic phase was 
separated and the aqueous phase extracted with EtOAc (500 mL). The combined 
organic phases were washed with brine (500 mL), dried over Na2SO4, filtered, and 
concentrated under reduced pressure. The residue was purified by flash column 
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chromatography (gradient, hexanes/EtOAc, 50:50"40:60"30:70"20:80) to yield 148 
and 149 as a white solid and as a 1:1 mixture of diastereomers (6.45 g, 81%). 
60 mol % 154, Oxone
nBu4N
+HSO4
! , Na2(EDTA)
2:1 CH3CN:DMM
pH 10.5, 0 °C, 5 h
O
O O
O Me
Me
O
OMe
Me
O
NH Me
O
H
O
O
NH Me
O
H
O
151 148
ent-151 ent-149
60 mol % 154, Oxone
nBu4N
+HSO4
–, Na2(EDTA)
2:1 CH3CN:DMM
pH 10.5, 0 °C, 5 h
154
NH
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Representative Procedure for Shi Epoxidation: 
N-((1R,2S)-2-(((2R,3R)-3-Methyloxiran-2-yl)methoxy)-2,3-dihydro-1H-inden-1-yl)for-
mamide (148). 
A 500-mL round-bottomed f lask was charged with magnet ic st i r bar, 
N-((1R,2S)-2-((E)-but-2-enyloxy)-2,3-dihydro-1H-inden-1-yl)formamide 151 (2.31 g, 10.0 
mmol, 1.0 eqiuv), the Shi catalyst derived from D-fructose 154 (0.775 g, 3.00 mmol, 
0.300 equiv), tetrabutylammonium hydrogen sulfate (0.153 g, 0.450 mmol, 0.450 equiv), 
pH 10.5 buffer (100 mL) comprised of  0.050 M aqueous solution of  Na2B4O7 in a 0.40 
mM aqueous solution of  Na2(EDTA), and a mixture of CH3CN/dimethoxymethane (1:2, 
150 mL) and cooled to 0 °C. A solution of Oxone® (10.1 g, 16.5 mmol, 1.65 equiv) in 
0.40 mM Na2(EDTA) (70 mL) was added via syringe pump over 2.5 h; simultaneously a 
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1.0 M solution of K2CO3 (70 mL) was added in small portions. After half of the addition 
was complete another portion of Shi catalyst (0.775 g, 3.00 mmol, 0.300 equiv) was 
added. Once the addition was complete, the biphasic mixture was allowed to stir at 0 °C 
for an additional 2.5 h. Water was added (500 mL) and the mixture was extracted with 
CH2Cl2 (4 x 150 mL). The combined organic phases were washed with H2O (1 x 150 
mL), dried over MgSO4, filtered, and concentrated under reduced pressure to a colorless 
oil. Purification by flash column chromatography (gradient, hexanes/acetone, 
3:1"2:1"1:1) afforded 148 and 149 as a white solid and as a 5:1 mixture of 
diastereomers (2.24 g, 91%). Recrystallization (hexanes/EtOAc, 1:1) afforded 
diastereomerically pure 148. Epoxide ent-149 was prepared in an analogous manner 
from formamide ent-151 (80%). 
148: 1H NMR (500 MHz, d4-methanol) # 8.25 (s, 1H), 7.25–7.19 (m, 4H), 5.47 (d, 1H, J = 
5.4 Hz), 4.32 (dd, 1H, J = 9.9, 4.4 Hz), 3.81 (dd, 1H, J = 11.6, 2.8 Hz), 3.47 (dd, 1H, J = 
11.6, 5.8 Hz), 3.07 (d, 2H, J  = 4.4 Hz), 2.92–2.88 (m, 2H), 1.27 (d, 3H, J = 5.2 Hz); 13C 
NMR (125 MHz, d4-methanol) # 163.8, 142.1, 141.4, 129.2, 128.0, 126.0, 125.2, 82.4, 
71.2, 59.3, 55.7, 53.3,  37.5, 37.5, 17.4; IR (thin film) ! 322.66, 3059, 2997, 2919, 2868, 
1653, 1544, 1382, 1082, 864, 727 cm$1; HRMS (ESI) calcd for C14H17NO3 [M]+ 
247.1208, found 248.1282 (M+H), 270.1097 (M+Na). 
ent-149: 1H NMR (500 MHz, d4-methanol) #   8.25 (s, 1H), 7.25–7.20 (m, 4H), 5.48 (d, 
1H, J  = 5.4 Hz), 4.33 (dd, 1H, J = 9.8, 4.4 Hz), 3.80 (dd, 1H, J = 11.5, 3.1 Hz), 3.45 (dd, 
1H, J = 11.5, 6.0 Hz), 3.06 (d, 2H, J = 4.3 Hz), 2.94–2.87 (m, 2H), 1.28 (d, 3H, J = 5.2 
Hz); 13C NMR (125 MHz, d4-methanol) # 163.8, 142.1, 141.4, 129.2, 128.0, 126.0, 125.2, 
82.2, 71.1, 59.2, 55.7, 53.3, 37.4, 17.4; IR (thin film) ! 3260, 3048, 2919, 2868, 1650, 
1544, 1382, 1082, 858, 727 cm-1; HRMS (ESI) calcd for C14H17NO3 [M]+ 247.1208, found 
248.1247 [M+H]+, 270.1104 [M+Na]+.
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(4aR,9aS)-3-(1-hydroxyethyl)-2,3,9,9a-tetrahydroindeno[2,1-b][1,4]oxazine-4(4aH)-c
arbaldehyde (152, 153) 
A flame-dried 1-L round-bottomed flask equipped with a magnetic stir bar was charged 
with NaH (60% oil dispersion, 15.2 g, 380 mmol, 10.0 equiv). The NaH was washed with 
anhydrous pentane (120 mL), and the pentane removed via syringe. The flask was 
charged with DMF (500 mL) and cooled to 0 °C. A 1.0 M solution of 148 and 149 (9.90 g, 
40.0 mmol, 1.00 equiv) in DMF (40 mL) was added drop-wise over 80 min and stirred for 
an additional 30 min during which time it had turned blue in color. The mixture was 
slowly quenched with ice-cold sat aq NH4Cl. The majority of  DMF was removed under 
reduced pressure and the resultant oil diluted with EtOAc (400 mL) and H2O (300 mL). 
The organic phase was separated and the aqueous phase extracted with EtOAc (2 x 
300 mL). The combined organic phases were washed with brine (2 x 500 mL), dried over 
Na2SO4, filtered, and concentrated under reduced pressure to a red oil which was 
purified by flash column chromatography (gradient, CH2Cl2/acetone, 6:1"4:1"2:1) to 
yield compounds 152 and 153 as an inseparable complex mixture of  diastereomers and 
amide rotamers as an orange solid (5.0 g, 52%). IR (thin film) ! 3408, 3071, 3046, 
3024, 2975, 2911, 1651, 1410, 1273, 1106, 1077 cm$1; HRMS (ESI) calcd for C14H17NO3 
[M]+ 247.1208, found 248.1208 [M+H]+.
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ent-149 ent-153
(3S,4aR,9aS)-3-((R)-1-Hydroxyethyl)-2,3,9,9a-tetrahydroindeno[2,1-b][1,4]oxazine-4
(4aH)-carbaldehyde (152) 
A flame-dried 50-mL round-bottomed flask equipped with a magnetic stir bar was 
charged with NaH (60% oil dispersion, 1.23 g, 30.8 mmol, 10.0 equiv). The NaH was 
washed with anhydrous pentane (7.0 mL). The flask was charged with DMF (38.0 mL) 
and cooled to 0 °C. A 0.16 M solution of N-((1R,2S)-2-((3-methyloxiran-2-yl)methoxy)-
2,3-dihydro- 1H-inden-1-yl)formamide 148 (762 mg, 3.08 mmol, 1.00 equiv) in DMF (28 
mL) was added drop-wise over 75 min. The mixture was stirred for an additional 25 min 
during which time it had turned blue in color. The mixture was slowly poured over ice-
cold sat aq NH4Cl (250 mL). Brine was added (1.0 L) and the solution was extracted with 
EtOAc (5 x 100 mL). The combined organic phases were washed with brine (2 x 1 L), 
dried over MgSO4, filtered, and concentrated under reduced pressure to a yellow  oil 
which was purified by flash column chromatography (gradient, CH2Cl2/acetone, 
8:1"4:1"2:1"1:1) to yield 152 as a white solid as a ~3:1 mixture of rotamers (564 mg, 
74%). Alcohol ent-153 was prepared as ~1.5:1 mixture of rotamers in an analogous 
manner from epoxide ent-149 (76%). 
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152: 1H NMR (500 MHz, CDCl3) # 8.84* (s, 1H), 8.21 (s, 1H), 7.34–7.20 (m, 4H), 7.34–
7.10* (m, 4H), 5.87* (d, 1H, J = 3.9 Hz), 4.92 (d, 1H, J = 4.5 Hz), 4.53–4.47 (m, 2H), 
4.53–4.47* (m, 2H), 4.46* (dd, 1H, J = 4.6, 1.5 Hz); 4.21 (d, 1H, J = 5.7 Hz), 3.89 (dd, 
1H, J = 12.0, 3.3 Hz), 3.85* (d, 1H, J = 2.5 Hz), 3.74 (dd, 1H, J = 12.0, 9.0 Hz), 3.63* 
(dd, 1H, J = 11.5, 10.9 Hz), 3.57–3.54 (m, 1H), 3.25–3.22* (m, 1H), 3.07–3.04 (m, 12H), 
2.95* (d, 1H, J  = 2.6 Hz), 2.51* (d, 1H, 3.9 Hz), 1.78* (s, 1H), 1.31* (d, 3H, J = 6.5 Hz), 
1.23 (d, 3H, J = 6.8 Hz); 13C NMR (500 MHz, CDCl3) # 163.4, 162.0, 141.1, 141.0, 
138.8, 137.2, 129.2, 128.0, 127.5, 127.1, 126.1, 125.6, 124.2, 123.4, 78.0, 77.7, 65.5, 
65.2, 64.4, 64.3, 61.9, 58.9, 57.4, 56.4, 38.5, 37.1, 21.2, 19.5; IR (thin film) ! 3422, 
2975, 2908, 1639, 1273, 1105, 1074, 1032, 738 cm$1; HRMS (ESI) calcd for C14H17NO3 
[M]+ 247.1208, found 248.1325 (M+H). 
ent-153: 1H NMR (500 MHz, CDCl3) # 8.40* (s, 1H), 8.33 (s, 1H), 7.31–7.15* (m, 4H), 
7.31–7.15 (m, 4H), 5.56 (d, 1H, J = 4.5 Hz), 4.82* (d, 1H, 4.3 Hz), 4.37* (t, 1H, J = 4.3 
Hz), 4.33–4.29* (m, 1H), 4.33–4.29 (m, 1H), 4.25 (d, 1H, J = 12.0 Hz), 4.02* (dd, 1H, J = 
9.2, 2.8 Hz), 3.53 (dd, 1H, J = 12.0, 2.9 Hz), 3.48–3.40* (m, 2H), 3.48–3.40 (m, 2H), 
3.15–3.09* (m, 2H), 3.15–3.09 (m, 2H),  3.06–2.99 (m, 1H), 2.13 (d, 1H, J = 4.9 Hz), 
1.82* (d, 1H, J = 5.5 Hz), 1.19* (d, 3H, J = 6.0 Hz), 1.17 (d, 3H, J = 6.2 Hz); 13C NMR 
(500 MHz, CDCl3) # 163.8, 163.6, 140.1, 140.1, 139.9, 128.7, 128.1, 127.2, 127.0, 
125.7, 125.3, 124.4, 123.6, 78.0, 77.8, 65.6, 64.9, 64.6, 64.4, 60.4, 59.3, 55.7, 53.7, 
38.4, 38.2, 20.9, 20.4; IR (thin film) ! 3417, 2980, 2913, 1659, 1412, 1269, 1110, 1077, 
1032, 912, 727 cm$1; HRMS (ESI) calcd for C14H17NO3 [M]+ 247.1208, found 248.1316 
[M+H]+.
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(4aR,9aS)-3-Acetyl-2,3,9,9a-tetrahydroindeno[2,1-b][1,4]oxazine-4(4aH)-carb-
aldehyde (146, 147)
A 0.50 M solution of 152 and 153 (3.73 g, 15.1 mmol, 1.00 equiv) in CH2Cl2 (30.0 mL) 
was added to a suspension of  Dess-Martin periodinane (8.40 g, 22.5 mmol, 1.50 equiv) 
in CH2Cl2 (115 mL). The solution was stirred at ambient temperature until all the starting 
material was consumed as visualized by TLC (ca. 3 h). The solution was diluted with 
CH2Cl2, washed with 1N NaOH (1 x 150 mL), H2O (2 x 225 mL), and brine (150 mL). 
The solution was filtered through Celite, dried over Na2SO4, and concentrated under 
reduced pressure to afford a crude solid which was purified by flash column 
chromatography (hexanes/acetone, 3:2) to give the ketones as a set of  diastereomer 
146 and its amide rotamer and diastereomer 147 as tan solid (3.25 g, 88%). The 
diastereomers could be separated by flash column chromatography. 
146: 1H NMR (400 MHz, CDCl3) # 8.37 (s, 1H), 7.30–7.20 (m, 4H), 5.05 (d, 1H, J = 4.6 
Hz), 4.58 (q, 1H,  J = 4.5 Hz), 4.30 (dd, 1H, J = 7.4, 4.3 Hz), 3.90 (dd, 1H, J = 4.3, 12.0 
Hz), 3.78 (dd, 1H, J = 12.0, 7.4 Hz), 3.12 (d, 2H, J = 4.0 Hz), 1.61 (s, 3H); 13C NMR (100 
MHz, CDCl3) # 203.0, 163.5, 140.7, 138.6, 129.3, 127.6, 126.1, 124.1, 77.8, 64.4, 59.0, 
58.0, 36.9, 28.4; IR (thin film) ! 3074, 3018, 2908, 2864, 1721, 1675, 1400, 1218 cm$1; 
m.p. 174–176 °C; HRMS (ESI) calcd for C14H15NO3 [M]+ 245.1052, found 246.1096 
[M+H]+, 268.0970 [M+Na]+.
147: 1H NMR (500 MHz, CDCl3) # 8.57 (s, 1H), 8.39* (s, 1H), 7.34–7.18 (m, 4H), 7.32–
7.18* (m, 4H), 5.58* (d, 1H, J = 4.1 Hz), 4.96 (d, 1H, J  = 4.2 Hz), 4.71 (d, 1H, J = 3.3 
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Hz), 4.44* (d, 1H, J = 3.4 Hz), 4.42–4.40 (m, 2H), 4.32* (t, 1H, J = 4.5 Hz), 3.83–3.78* 
(m, 2H), 3.61 (dd, 1H, J = 12.2, 4.0 Hz), 3.13–3.12* (m, 1H), 3.10–3.09 (m, 1H), 3.02 (d, 
1H, J = 16.9 Hz), 2.98* (d, 1H, J =16.9 Hz), 2.08 (s, 3H), 2.00* (s, 3H); IR (thin film) ! 
2906, 1724, 1673, 1460, 1402, 1357, 1105, 1044 cm$1; 13C NMR (500 MHz, CDCl3) # 
204.8, 203.1, 164.7, 163.7, 140.1, 140.0, 138.3, 138.1, 128.5, 128.1, 126.9, 126.8, 
126.6, 126.5, 125.5, 125.0, 124.9, 78.2, 78.1, 65.3, 64.2, 65.3, 64.2, 60.2, 56.6, 56.2, 
38.3, 38.1, 27.3, 27.3; HRMS (ESI) calcd for C14H15NO3 [M]+ 245.1052, found 246.1113 
(M+H), 268.0951 (M+Na).
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(4aR,9aS)-3-Acetyl-2,3,9,9a-tetrahydroindeno[2,1-b][1,4]oxazine-4(4aH)-carbalde- 
hyde (146, 147)
To a 0.256 M solution of oxalyl chloride (6.70 mL, 76.8 mmol, 2.50 equiv) in CH2Cl2 (300 
mL) cooled to –60 °C, was slowly added a 1.50 M solution of DMSO (13.6 mL, 192 
mmol, 5.00 equiv) in CH2Cl2 (128 mL). Next, a 1.00 M solution of (4aR,9aS)-3- 
(1-hydroxyethyl)-2,3,9,9a-tetrahydroindeno[2,1-b][1,4]oxazine-4(4aH)-carbaldehyde 
(9.50 g, 38.4  mmol, 1.00 equiv) in CH2Cl2 (38.4 mL) was added portion-wise over 30 
min. The solution was allowed to warm to –20 °C and stirred 1 h. The solution was 
cooled to –60 °C, NEt3 (53.2 mL, 384, mmol, 10.0 equiv) was added drop-wise over 30 
min, and stirring was continued for 30 min before allowing the solution to warm to 
ambient temperature. A white precipitate was collected and the filtrate washed with H2O 
(2 x 500 mL). The combined aqueous phases were extracted with CH2Cl2 (2 x 500 mL); 
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the combined organic phases were dried over Na2SO4, filtered, and concentrated under 
reduced pressure. The residue was purified by flash column chromatography (gradient, 
CH2Cl2/acetone, 20:1"10:1"5:1"2:1) to yield a mixture of 146 and 147 as white solids 
(8.2 g, 87%).
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Conversion of N-Formyl Ketones 146 or 147 to Oxazolinium Salt 159. 
To an oven-dried 25-mL round-bottomed flask equipped with a magnetic stir bar and 
charged with a mixture of ketones 146 and 147 (245 mg, 1.00 mmol, 1.00 equiv) was 
added Ac2O (1.5 mL, 16 mmol, 16 equiv). The mixture was cooled to 0 °C and HClO4 
(70%, 0.10 mL, 1.2 mmol, 1.2 equiv; or 60%, 0.12 mL, 1.2 mmol, 1.2 equiv) was added 
drop-wise over 20 min. The light brown solution was allowed to warm to ambient 
temperature and stirred for 2–3 h. The solution was twice triturated with Et2O and the 
supernatant decanted each time. Residual solvent was removed from the resulting white 
solid under reduced pressure at ambient temperature to afford the crude oxazolinium 
salt 159 as a tan foam (388 mg, quant.), which was immediately used in the subsequent 
conversion to the imidazolium salts.
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1. MesNH2
    PhMe, rt, 12 h
2. Ac2O, cat. HClO4
    PhMe, 80 °C, 2.5 h
Preparation of N-Mesityl substituted imidazolium salt (145) 
To a round-bottomed flask charged with a magnetic stir bar and oxazolinium salt 159 
(700 mg, 1.8 mmol, 1.0 equiv) was added toluene (10 mL) and 2,4,6-trimethyl aniline 
(0.38 mL, 2.7 mmol, 1.5 equiv). The heterogeneous mixture was stirred at ambient 
temperature for 3 h. The solvent was decanted and the precipitate washed with Et2O (2 x 
10 mL). Residual solvent was removed under reduced pressure to afford the aminal 
intermediate as a light white solid and as a mixture of diastereomers (835 mg, quant.). A 
mixture of  the aminal intermediate (98 mg, 0.21 mmol, 1.0 equiv) in toluene (1.0 mL) 
was treated with Ac2O (0.40 µL, 0.42 mmol, 2.0 equiv) and HClO4 (70%, 7.0 µL, 0.082 
mmol, 0.20 equiv) and stirred at 80 °C for 2.5 h. The solution was allowed to cool to 
ambient temperature and concentrated under reduced pressure. The crude solid was 
suspended in Et2O and placed in a sonicating bath. Once the precipitate had become 
white it was collected by suction filtration and washed with EtOAc to yield 145 (73 mg, 
78% over 3 steps). 1H NMR (500 MHz, d6-acetone) # 9.71 (s, 1H), 7.64 (d, 1H, J = 7.6 
Hz), 7.44 (d, 2H, J = 7.4 Hz), 7.40 (t, 1H, J = 7.4 Hz), 7.22 (s, 2H), 6.10 (d, 1H, J = 4.0 
Hz), 5.11 (d, 1H, J = 15.0 Hz), 5.06 (t, 1H, J = 4.5 Hz), 4.98 (d, 1H, J = 15.0 Hz), 3.49 
(dd, 1H, J = 17.0, 4.8 Hz), 3.23 (d, 1H, J = 17.0 Hz), 2.40 (s, 3H), 2.14 (s, 3H), 2.08 (s, 
3H), 2.06 (s, 3H); 13C NMR (125 MHz, d6-acetone) # 141.9, 141.5, 137.8, 136.0, 135.9, 
135.2, 130.3, 130.2, 129.8, 129.6, 127.8, 126.2, 125.8, 125.2, 124.0, 78.0, 61.4, 60.0, 
152
38.0, 20.8, 17.1, 7.6; IR (thin film) ! 3122, 3047, 2925, 2860, 1539, 1461, 1214, 1097 
cm$1; HRMS (ESI) calcd for C23H25N2O+ [M]+ 345.1961, found 345.1931 [M]+; [%]2D
0 = 
$134.0 (c 0.55, CH2Cl2).
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Procedure for Multi-Gram Synthesis of N-Mesityl substituted imidazolium salt 
(145)
To an oven-dried 100-mL Schlenk flask equipped with a magnetic stir bar and charged 
with ketones 146 and 147 (5.0 g, 20 mmol, 1.0 equiv) was added Ac2O (30 mL, 326 
mmol, 16 equiv). The mixture was cooled to 0 °C and HClO4 (60 %, 2.6 mL, 25 mmol, 
1.2 equiv.) was added drop-wise over 20 min. The brown solution was allowed to warm 
to ambient temperature and then stirred for 2 h. The solution was twice triturated with 
Et2O and the supernatant decanted each time. The resulting white solid was dried under 
reduced pressure, dissolved in a minimal amount of CH2Cl2 before 1 volume equivalent 
of toluene was added. Next, 2,4,6-trimethyl aniline (32 mL, 31 mmol, 1.5 equiv) was 
added and the solution stirred overnight. The brown solution was concentrated under 
reduced pressure to an oil. The oil was dissolved in a minimal amount of CH2Cl2 and 
triturated with Et2O in a sonicating bath. The white precipitate was collected by suction 
filtration and washed with excess Et2O to give the aminal intermediate as a white solid 
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and as a mixture of  diastereomers (5.9 g, 63 %). This white solid (5.9 g, 13 mmol, 1.0 
equiv) was transferred to an oven-dried 200 mL round-bottomed flask equipped with a 
magnetic stir bar and dissolved in 85 mL of  1,2-dichloroethane (0.15 M). Next, Ac2O (2.4 
mL, 25 mmol, 2.0 equiv) and HClO4 (60 %, 0.26 mL, 2.5 mmol, 0.20 equiv) were added 
and the solution stirred at 70 °C. The reaction was monitored by 1H NMR analysis of 
aliquots from the reaction. After 4 h, another 0.26 mL of HClO4 was added in order to 
drive the reaction to completion. The reaction was complete as indicated from NMR after 
an additional 2 h of stirring. The solution was allowed to cool to ambient temperature and 
concentrated under reduced pressure. The resulting oil was dissolved in a minimal 
amount of CH2Cl2 and triturated with Et2O in a sonicating bath. The precipitate was 
collected by suction filtration to afford 145 as a white crystalline solid (4.6 g, 81%; 51% 
over three steps).
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Preparation of N-2,6-dimethyl-4-bromophenyl substituted imidazolium salt (161)
To a round-bottomed flask charged with a magnetic stir bar and oxazolinium salt 159 
(388 mg, 1.00 mmol, 1.00 equiv) was added toluene (10 mL) and 4-bromo-2,6-dimethyl 
aniline (300 mg, 1.50 mmol, 1.50 equiv). The heterogeneous mixture was stirred at 
ambient temperature for 13 h. The precipitate was collected by suction filtration and 
washed with Et2O to afford the crude aminal intermediate as a white powder and as a 
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mixture of diastereomers (300 mg, 57%). A 0.25 M solution of  the aminal intermediate 
(200 mg, 0.38 mmol, 1.0 equiv) in 1,2-dichloroethane (1.5 mL) was treated with Ac2O 
(0.070 mL, 0.76 mmol, 2.0 equiv) and HClO4 (70%, 6.0 µL, 0.080 mmol, 0.20 equiv) and 
stirred at 70 °C for 3 h. The solution was allowed to cool to ambient temperature and a 
precipitate collected by suction filtration and washed with 1,2-dichloroethane to afford 
161 as a yellow  solid (170 mg, 89%; 51% over 3 steps). 1H NMR (400 MHz, d6-acetone) 
# 9.78 (s, 1H), 7.65–7.63 (m, 3H), 7.44 (d, 1H, J = 7.4 Hz), 7.40 (t, 1H, J = 7.3 Hz), 7.33 
(t, 1H, J = 7.4 Hz), 6.10 (d, 1H, J = 3.7 Hz), 5.13 (d, 1H, J = 15.0 Hz), 5.06 (t, 1H, J = 4.3 
Hz), 4.98 (d, 1H, J = 15.0 Hz), 3.49 (dd, 1H, J = 16.9, 4.8 Hz), 3.23 (d, 1H, J  = 17.0 Hz), 
2.21 (s, 3H), 2.13 (s, 6H); 13C NMR (100 MHz, d6-acetone) # 141.8, 139.4, 138.1, 132.8, 
132.6, 131.9,130.1, 128.2, 126.5, 125.9, 125.8, 125.4, 124.3, 78.3, 61.8, 60.3, 38.3, 
17.4, 7.9; IR (thin film) ! 3115, 3042, 2913, 2852, 1533, 1460, 1203, 1099, 858, 747 
cm$1; HRMS (ESI) calcd for C23H24BrN2O+ [M]+ 409.0910, found 409.0914 [M]+; [%]2D
0 = 
$109.8 (c 0.25, CH2Cl2). 
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1. PhNH2
    PhMe, rt, 16 h
2. Ac2O, cat. HClO4
    PhMe, 80 °C, 0.75 h
Preparation of N-Phenyl substituted imidazolium salt (162)
To a round-bottomed flask charged with a magnetic stir bar and oxazolinium salt 159 
(388 mg, 1.00 mmol, 1.00 equiv) was added toluene (5.0 mL) and aniline (0.13 mL, 1.5 
mmol, 1.5 equiv). The heterogeneous mixture was stirred at ambient temperature for 16 
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h. The solution was decanted, the remaining oil washed with Et2O (2 x 10 mL), and 
excess solvent removed under reduced pressure to afford the crude aminal intermediate 
as a brown foam and as a mixture of  diastereomers (420 mg, quant crude yield). A 
suspension of the aminal intermediate (420 mg, 1.0 mmol, 1.0 equiv) in toluene (4.0 mL) 
was treated with Ac2O (0.19 mL, 2.0 mmol, 2.0 equiv) and HClO4 (70%, 17 µL, 0.20 
mmol, 0.20 equiv). The mixture was stirred at 80 °C for 45 min. After allowing the 
reaction to cool to ambient temperature the supernatant was decanted, the excess 
solvent removed under reduced pressure, and the resulting residue triturated with Et2O 
in a sonicating bath to afford 135 mg of  162 as a brown solid. The filtrate was then 
purified by flash column chromatography (gradient, CH2Cl2/acetone, 19:1"9:1) to afford 
another 145 mg of  162 as an off-white powder (230 mg, 70% over 3 steps). 1H NMR 
(500 MHz, d6-acetone) # 9.77 (s, 1H), 7.79–7.72 (m, 5H), 7.67 (d, 1H, J = 7.6 Hz), 7.41 
(d, 1H, J = 7.4 Hz), 7.38 (t, 1H, J = 7.4 Hz), 7.30 (t, 1H, J  = 7.4 Hz), 5.99 (d, 1H, J = 4.1 
Hz), 5.08 (d, 1H, J = 15.1 Hz), 4.99 (t, 1H, J = 4.5 Hz), 4.95 (d, 1H, J = 15.0 Hz), 3.47 
(dd, 1H, J = 16.9, 4.8 Hz), 3.21 (d, 1H, J = 16.9 Hz), 2.23 (s, 3H); 13C NMR (125 MHz, 
d6-acetone) # 141.7, 137.8, 135.6, 134.5, 131.7, 131.0, 130.0, 127.9, 127.4, 126.3, 
126.1, 125.0, 124.7, 78.3, 61.5, 60.2, 38.2, 8.6; IR (thin film) ! 3121, 3059, 2928, 1545, 
1460, 1217, 1094, 774 cm$1; HRMS (ESI) calcd for C20H19N2O+ [M]+ 303.1492, found 
303.1502 [M]+; [%]2D
0 = $177.4 (c 0.19, CH2Cl2).
156
O
N
N Me
ClO4
Me
OMe
1. 
    PhMe, rt, 12 h
2. Ac2O, cat. HClO4
    PhMe, 80 °C, 1 h
H2N
Me
OMe
O
N
O Me
OAc
159
ClO4
163
Preparation of N-2-methyl-4-methoxyphenyl substituted imidazolium salt (163)
To a round-bottomed flask charged with a magnetic stir bar and oxazolinium salt 159 
(388 mg, 1.00 mmol, 1.00 equiv) was added toluene (5.0 mL) and 4-methoxy-2-
methylaniline (0.20 mL, 1.5 mmol, 1.5 equiv). The heterogeneous mixture was stirred at 
ambient temperature for 12 h. The supernatant was decanted, the crude oil washed with 
Et2O (2 x 10 mL), and residual solvent removed under reduced pressure to afford the 
crude aminal intermediate as a light purple solid and as mixture of diastereomers (430 
mg, 92% yield). A suspension of the crude aminal intermediate (430 mg, 0.92 mmol, 1.0 
equiv) in toluene (4.0 mL) was treated with Ac2O (0.18 mL, 1.8 mmol, 2.0 equiv) and 
HClO4 (70%, 16 µL, 0.18 mmol, 0.20 equiv). The mixture was stirred at 80 °C for 1 h. 
After allowing the reaction to cool to ambient temperature, the reaction was concentrated 
under reduced pressure to a brown solid. This solid was suspended in Et2O, at which 
time had turned into an oil, in a sonicating bath while methanol was drop-wise added as 
needed until the oil began to precipitate as a light purple powder. This precipitate was 
collected by suction filtration and the purification process repeated on the filtrate to afford 
a second crop of 163 as a light purple solid and as a 1:1 mixture of atropisomers (370 
mg, 66%; 61% over 3 steps). 1H NMR (500 MHz, d6-acetone) # 9.71 (d, 1H, J = 10 Hz), 
7.63 (d, 1H, J = 7.6 Hz), 7.56 (d, 1H, J = 8.4 Hz), 7.44–7.38 (m, 2H), 7.32 (s, 1H), 7.12 
(d, 1H, J = 2.4 Hz), 7.05 (dd, 1H, J = 8.6, 2.4 Hz), 6.04 (s, 1H), 5.09 (d, 1H, J = 14.9 Hz), 
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5.03 (s, 1H), 4.95 (d, 1H, J = 4.6 Hz), 3.91 (s, 3H), 3.48 (d, 1H, J =16.9 Hz), 3.23 (d, 1H, 
J = 17.0 Hz), 2.20 (d, 3H, J = 12.0 Hz), 2.12 (s, 3H); 13C NMR (125 MHz, d6-acetone) # 
162.4, 141.8, 137.9, 136.0, 130.0, 129.9, 128.0, 126.7, 126.4, 125.9, 125.0, 124.8, 
124.4, 117.3, 113.6, 78.3, 61.5, 60.2, 56.1, 38.3, 17.5, 8.2; IR (thin film) ! 3126, 3053, 
2930, 1544, 1502, 1463, 1217, 1094, 734 cm$1; HRMS (ESI) calcd C22H23N2O2+ [M]+ 
347.1754, found 347.1768 [M]+; [%]2D
0 = $147.5 (c 0.28, CH2Cl2).
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Preparation of N-2-hydroxy-6-methylphenyl substituted imidazolium salt (164) 
To a round-bottomed flask charged with a magnetic stir bar and oxazolinium salt 159 
(388 mg, 1.00 mmol, 1.00 equiv) was added toluene (5.0 mL) and 2-hydroxy-6-
methylaniline (185 mg, 1.50 mmol, 1.50 equiv). The heterogeneous mixture was stirred 
at ambient temperature for 14 h. The solution was triturated with Et2O, the supernatant 
was decanted, and residual solvent removed under reduced pressure to afford a mixture 
of the crude aminal intermediate and parent aniline as a brown solid (482 mg, quant 
crude yield). A suspension of  the crude aminal intermediate (450 mg, 1.0 mmol, 1.0 
equiv) in toluene (4.0 mL) was treated with Ac2O (0.12 mL, 1.2  mmol, 1.2 equiv) and 
HClO4 (70%, 17 µL, 0.20 mmol, 0.20 equiv). The mixture was stirred at 80 °C for 1 h. 
After allowing the reaction to cool to ambient temperature, the supernatant was 
decanted, the residual solvent removed under reduced pressure, and the product 
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precipitated from CH2Cl2. The precipitate was collected by suction filtration to afford 164 
as a light grey powder and as a 4:1 mixture of atropisomers (150 mg, 35% over 3 steps). 
1H NMR (500 MHz, d6-acetone) # 9.74* (s, 1H), 9.72 (s, 1H), 9.48 (bs, 1H, OH), 9.43* 
(bs, 1H, OH), 7.64* (d, 1H, J = 7.5 Hz), 7.58 (d, 1H, J = 7.6 Hz), 7.45–7.41 (m, 3H), 
7.41–7.34* (m, 3H), 7.30 (t, 1H, J = 7.4 Hz), 7.09* (d, 1H, J = 8.6 Hz), 7.08 (d, 1H, J = 
8.2 Hz), 7.03 (d, 1H, J = 7.6 Hz), 6.11* (d, 1H, J = 4.1 Hz), 6.08 (d, 1H, J = 4.1 Hz), 5.12 
(d, 1H, J = 15.0 Hz), 5.12–5.09* (m, 2H), 5.06 (t, 1H, J = 4.5 Hz), 4.97* (d, 1H, J = 15.0 
Hz), 4.96 (d, 1H, J = 14.9 Hz), 3.53–3.50* (m, 1H), 3.49 (dd, 1H, J = 16.9, 4.9 Hz), 3.24* 
(d, 1H, J = 16.9 Hz), 3.22 (d, 1H, J = 16.9 Hz), 2.21 (s, 3H), 2.15* (s, 3H), 2.11* (s, 3H), 
2.10 (s, 3H); 13C NMR (125 MHz, d6-acetone) # 153.9, 153.8, 141.8, 138.0, 137.8, 
136.4, 133.0, 132.9, 132.8, 130.1, 130.0, 128.2, 128.0, 126.6, 126.5, 126.4, 124.8, 
124.5, 124.3, 122.9, 120.8, 115.3, 115.2, 78.3, 61.6, 60.2, 38.3, 17.3, 7.9; IR (KBr pellet) 
! 3350, 3132, 3053, 2924, 1592, 1544, 1477, 1298, 1105, 951, 738, 624 cm$1; HRMS 
(ESI) calcd for C21H21N2O2+ [M]+ 333.1598, found 333.1607 [M]+; [%]2D
0 = $129.6 (c 0.22, 
MeOH).
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Preparation of N-2,6-diisopropylphenyl substituted imidazolium salt (165)
To a round-bottomed flask charged with a magnetic stir bar and oxazolinium salt 159 
(388 mg, 1.00 mmol, 1.00 equiv) was added toluene (10 mL) and 2,6-diisopropylaniline 
159
(0.28 mL, 1.5 mmol, 1.5 equiv). The heterogeneous mixture was stirred at ambient 
temperature for 12 h. Et2O was added, the supernatant decanted, and the resultant oil 
concentrated under reduced pressure to afford the crude aminal intermediate as a light 
yellow  foam and as a mixture of  diastereomers (360 mg, 71%). A suspension of  the 
aminal intermediate (360 mg, 0.71 mmol, 1.0 equiv) in toluene (3.0 mL) was treated with 
Ac2O (0.13 mL, 1.4 mmol, 2.0 equiv) and HClO4 (70%, 12 µL, 0.14 mmol, 0.20 equiv) 
and stirred at 80 °C for 15 min. The solution was allowed to cool to ambient temperature, 
concentrated under reduced pressure, and the residue purified by flash column 
chromatography (gradient, CH2Cl2/MeOH, 98:2"95:5) to give 165 as a yellow  foam (235 
mg, 68%; 48% over 3 steps). 1H NMR (500 MHz, d6-acetone) # 9.93 (s, 1H), 7.72–7.69 
(t, 1 H, J = 7.8 Hz), 7.57–7.52 (m, 3H), 7.46 (d, 1H, J = 7.4 Hz), 7.40 (t, 1H, J = 7.4 Hz), 
7.33 (t, 1H, J = 7.4 Hz), 6.10 (d, 1H, J = 4.0 Hz), 5.11 (d, 1H, J = 15.0 Hz), 5.07 (t, 1H, J 
= 4.4 Hz), 4.98 (d, 1H, J = 15.0 Hz), 3.49 (dd, 1H, J = 16.9, 4.8 Hz), 3.23 (d, 1H, J = 16.9 
Hz), 2.80 (d, 1H, J = 16.9 Hz), 2.64 (septet, 1H, J = 6.8 Hz), 2.26 (septet, 1H, J = 6.8 
Hz), 2.10 (s, 3H), 1.26 (dd, 6H, J = 10.0, 6.8 Hz), 1.21 (dd, 6H, J = 6.8, 2.5 Hz); 13C 
NMR (125 MHz, d6-acetone) # 147.1, 146.9, 142.0, 138.2, 135.8, 133.0, 130.2, 129.1, 
128.0, 126.9, 126.6, 126.0, 125.8, 125.8, 124.1, 123.7, 78.3, 61.8, 60.3, 38.4, 25.3, 25.2, 
23.4, 23.2, 8.3; IR (thin film) ! 3116, 3045, 2965, 2929, 2871, 1538, 1462, 1202, 1099, 
733, 624 cm$1; HRMS (ESI) calcd for C26H32N2O+ [M]+ 387.2431, found 387.2446 [M]+; 
[%]2D
0 = $94.5 (c 0.22, CH2Cl2).
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Preparation of N-3,5-bis(trifluoromethyl)phenyl substituted imidazolium salt (166)
To a round-bottomed flask charged with a magnetic stir bar and oxazolinium salt 159 
(388 mg, 1.00 mmol, 1.00 equiv) was added toluene (10 mL) and 3,5-bis(trifluoro-
methyl)aniline (0.23 mL, 1.5 mmol, 1.5 equiv). The heterogeneous mixture was stirred at 
ambient temperature for 16 h. The supernatant was decanted, the crude oil washed with 
Et2O (1 x 10 mL), and residual solvent removed under reduced pressure to afford the 
crude aminal intermediate as a yellow  solid and a mixture of  diastereomers (560 mg, 
quant. crude yield). A suspension of the crude aminal intermediate (560 mg, 1.0 mmol, 
1.0 equiv) in toluene (4.0 mL) was treated with Ac2O (0.19 mL, 2.0 mmol, 2.0 equiv) and 
HClO4 (70%, 17 µL, 0.20 mmol, 0.20 equiv). The mixture was stirred at 80 °C for 15 min. 
After allowing the reaction to cool to ambient temperature, the supernatant was 
decanted, residual solvent removed under reduced pressure, and the resulting residue 
suspended in a mixture of Et2O/EtOAc (2:1, 7 mL) and sonicated until precipitation had 
occurred. The imidazolium salt 166 was collected by suction filtration as a white solid 
(190 mg, 35% over 3 steps). 1H NMR (500 MHz, d6-acetone) # 10.00 (s, 1H), 8.60 (s, 
2H), 8.47 (s, 1H), 7.63 (d, 1H J = 7.7 Hz), 7.43 (d, 1H, J = 7.5 Hz), 7.39 (t, 1H, J = 7.4 
Hz), 7.29 (t, 1H, J = 7.4 Hz), 6.04 (d, 1H, J = 4.1 Hz), 5.13 (d, 1H, J = 15.1 Hz), 5.02 (t, 
1H, J = 4.3 Hz), 4.95 (d, 1H, J = 15.1 Hz), 3.50 (dd, 1H, J = 17.0, 4.8 Hz), 3.23 (d, 1H, J 
= 17.0 Hz), 2.34 (s, 3H); 13C NMR (125 MHz, d6-acetone) # 141.8, 137.6, 136.7, 136.3, 
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134.0, 133.7, 130.2, 129.3, 127.9, 126.7, 126.4, 125.0, 125.0, 78.4, 61.7, 60.2, 38.3, 8.6; 
IR (thin film) ! 3148, 3058, 2937, 1543, 1368, 1280, 1105, 1076, 905, 604 cm$1; HRMS 
(ESI) calcd for C22H17F6N2O+ [M]+ 439.1240, found 439.1246 [M]+; [%]2D
0 = $141.9 (c 0.15, 
CH2Cl2).
O
N
N Me
ClO4
t-Bu t-Bu
2. Ac2O, cat. HClO4
    ClCH2CH2Cl
    70 °C, 0.5 h
1. 
    CH2Cl2/PhMe
    rt, 16 h
O
N
O Me
OAc
159
ClO4
H2N
t-Bu
t-Bu
167
Preparation of N-3,5-di-tert-butylphenyl substituted imidazolium salt (167)
To a solution of oxazolinium salt 159 (388 mg, 1.00 mmol, 1.00 equiv) in CH2Cl2 (3.0 mL) 
was added toluene (10 mL) and 3,5-di-tert-butylaniline (0.23 mL, 1.5 mmol, 1.5 equiv). 
The solution was stirred at ambient temperature for 16 h during which a white solid had 
precipitated. The precipitate was collected by suction filtration and washed with Et2O to 
afford the aminal intermediate as a white powder and as a mixture of diastereomers (420 
mg, 79% yield). A 0.25 M solution of the aminal intermediate (420 mg, 0.79 mmol, 1.0 
equiv) in 1,2-dichloroethane (3.1 mL) was treated with Ac2O (0.15 mL, 1.6 mmol, 2.0 
equiv) and HClO4 (70%, 14 µL, 0.16 mmol, 0.20 equiv) and stirred at 70 °C for 30 min. 
After allowing the solution to cool to ambient temperature, the solvent was removed 
under reduced pressure and the residue purified by flash column chromatography 
(CH2Cl2/MeOH, 30:1) to afford 167 as a light yellow  foam (385 mg, 95%; 75% over 3 
steps). 1H NMR (500 MHz, d6-acetone) # 9.75 (s, 1H), 7.80 (t, 1H, J = 1.7 Hz), 7.65–7.63 
(m, 3H), 7.41 (d, 1H, J = 7.4 Hz), 7.35 (t, 1H, J = 7.3 Hz), 7.29 (t, 1H, J = 7.4 Hz), 5.97 
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(s, 1H, J = 4.2 Hz), 5.06 (d, 1H, J = 15.0 Hz), 4.96 (t, 1H, J = 4.4 Hz), 4.90 (d, 1H, J = 
15.0 Hz), 3.46 (dd, 1H, J = 16.9 Hz, 4.9 Hz), 3.20 (d, 1H,  J = 16.9 Hz), 2.23 (s, 3H), 
1.41 (s, 18H); 13C NMR (125 MHz, d6-acetone) # 154.0, 141.6, 137.8, 135.5, 134.2, 
129.9, 127.8, 126.2, 126.0, 125.3, 124.9, 124.5, 121.6, 78.2, 61.3, 60.1, 38.1, 35.8, 31.4, 
8.7; IR (thin film) ! 3126, 3053, 2952, 2868, 1608, 1597, 1538, 1477, 1365, 1248, 1096, 
733, 624 cm$1; HRMS (ESI) calcd for C28H35N2O+ [M]+ 415.2744, found 415.2742 [M]+; 
[%]2D
0 = $133.7 (c 0.25, CH2Cl2).
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2. Ac2O, cat. HClO4
    ClCH2CH2Cl
    70 °C, 20 h
1. 
    CH2Cl2/PhMe
    rt, 18 h
O
N
O Me
OAc
159
ClO4
ONH2N
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Preparation of N-Morpholino substituted imidazolium salt (168) 
To a solution of oxazolinium salt 159 (388 mg, 1.00 mmol, 1.00 equiv) in CH2Cl2 (5.0 mL) 
was added toluene (5.0 mL) and 4-aminomorpholine (0.15 mL, 1.5 mmol, 1.5 equiv). 
The heterogeneous mixture was stirred at ambient temperature for 18 h. Et2O was 
added to the mixture causing an oil to form. The supernatant was decanted, the oil was 
dissolved in a minimal amount of CH2Cl2 (~5 mL) and triturated with Et2O, the super-
natant decanted, and residual solvent removed under reduced pressure to afford the 
crude aminal intermediate as a light yellow  solid and as a mixture of diastereomers (360 
mg, 84%). A 0.25 M solution of the aminal intermediate (360 mg, 0.84 mmol, 1.0 equiv) 
in 1,2-dichloroethane (3.4 mL) was treated with Ac2O (0.15 mL, 1.6 mmol, 2.0 equiv) and 
HClO4 (70%, 7.0 µL, 0.080 mmol, 0.10 equiv) and stirred at 70 °C for 20 h. After allowing 
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the solution to cool to ambient temperature, the solvent was removed under reduced 
pressure, and the residue purified by flash column chromatography (gradient, CH2Cl2/
MeOH, 95:5"90:10) to afford 168 as a yellow  solid (260 mg, 75 %, 63 % over 3 steps). 
1H NMR (500 MHz, d6-acetone) # 10.09 (s, 1H), 7.58 (d, 1H, J = 7.7 Hz), 7.41–7.35 (m, 
2H), 7.30 (t, 1H, 7.3 Hz), 5.90 (d, 1H, J = 4.1 Hz), 5.00 (d, 1H, J = 15.0 Hz), 4.95 (t, 1H, 
J = 4.4 Hz), 4.82 (d, 1H, J  = 15.1 Hz), 3.92 (t, 4H, J = 4.5 Hz), 3.47 (t, 4H, J  = 4.5 Hz), 
3.43–3.40 (m, 1H), 3.17 (d, 1H, J = 16.9 Hz), 2.35 (s, 3H); 13C NMR (125 MHz, d6-
acetone) # 141.7, 137.7, 132.9, 130.0, 127.9, 126.4, 125.8, 124.8, 122.7, 78.3, 67.3, 
61.4, 60.0, 57.2, 38.2, 7.4; IR (thin film) ! 3115, 2969, 2863, 1460, 1270, 1102, 1080, 
923, 741 cm$1; HRMS (ESI) calcd for C18H22N3O2+ [M]+ 312.1707, found 312.1720 [M]+; 
[%]2D
0 = $174.5 (c 0.20, CH2Cl2).
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2. Ac2O, cat. HClO4
    ClCH2CH2Cl
    70 °C, 10 min
1. MeNH2
    CH2Cl2/PhMe
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Preparation of N-Methyl substituted imidazolium salt (169)
To a solution of oxazolinium salt 159 (388 mg, 1.00 mmol, 1.00 equiv) in CH2Cl2 (5.0 mL) 
was added toluene (5.0 mL) and a solution of N-methyl amine (2.0 M in THF, 0.75 mL, 
1.5 mmol, 1.5 equiv). The heterogeneous mixture was stirred at ambient temperature for 
12 h. The precipitate was collected by suction filtration and washed with Et2O to afford 
the crude aminal intermediate as a white powder and as a mixture of diastereomers (310 
mg, 86 % yield). A 0.25 M solution of the aminal intermediate (300 mg, 0.83 mmol, 1.0 
equiv) in 1,2-dichloroethane (3.3 mL) was treated with Ac2O (0.16 mL, 1.7 mmol, 2.0 
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equiv) and HClO4 (70 %, 7.0 µL, 0.080 mmol, 0.10 equiv) and stirred at 70 °C for 10 min. 
After allowing the solution to cool to ambient temperature, the solvent was removed 
under reduced pressure and the resultant residue dissolved in a minimal amount of 
CH2Cl2 and triturated with toluene. The precipitate was collected by suction filtration to 
afford 169 as a white powder (180 mg, 64%; 53% over 3 steps). 1H NMR (400 MHz, d6-
acetone) # 9.56 (s, 1H), 5.53 (d, 1H, J = 7.6 Hz), 7.41–7.30 (m, 2H), 7.28 (t, 1H, J = 7.3 
Hz), 5.91 (s, 1H), 5.02 (d, 1H, J = 15.2), 4.95 (t, 1H, J = 4.5 Hz), 4.83 (d, 1H, J = 15.0 
Hz), 4.06 (s, 3H), 3.43 (dd, 1H, J = 16.9, 4.9 Hz), 3.18 (d, 1H, J = 17.0 Hz), 2.36 (s, 3H); 
13C NMR (100 MHz, d6-acetone) # 141.6, 138.1, 135.7, 129.9, 127.9, 126.2, 126.0, 
124.7, 124.0, 78.2, 61.1, 60.0, 38.1, 34.2, 7.8; IR (thin film) ! 3137, 3076, 2930, 1636, 
1558, 1446, 1253, 1096, 760, 738, 624 cm$1; HRMS (ESI) calcd for C15H17N2O+ [M]+ 
241.1335; found, 241.1338 [M]+; [%]2D
0 = $163.7 (c 0.33, CH2Cl2).
O
N
N
ClO4
Me
i-Pr
170
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Preparation of N-2-isopropylphenyl substituted imidazolium salt (170) 
To a round-bottomed flask charged with a magnetic stir bar and oxazolinium salt 159 
(388 mg, 1.00 mmol, 1.00 equiv) was added toluene (10 mL) and 2-isopropyl aniline 
(0.21 mL, 1.5 mmol, 1.5 equiv). The heterogeneous mixture was stirred at ambient 
temperature for 12 h during which time a solid precipitated. The precipitate was 
suspended in EtOAc collected by suction filtration and washed with EtOAc to afford the 
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crude aminal intermediate as a white powder and as a mixture of diastereomers (325 
mg, 71%). A mixture of the aminal intermediate (325 mg, 0.70 mmol, 1.0 equiv) in 
toluene (2.8 mL) was treated with Ac2O (0.13 mL, 1.4 mmol, 2.0 equiv) and HClO4 (70%, 
13 µL, 0.14 mmol, 0.20 equiv) and heated at 80 °C for 1 h. The solution was decanted 
and the oil concentrated under reduced pressure to afford a brown foam which was 
dissolved in a minimal amount of EtOAc, placed in a sonicating bath and triturated with 
Et2O. Isolation of the precipitate by suction filtration provided two crops of 170, 100 mg 
and 120 mg respectively, as a white powder (220 mg, 71%; 50% over 3 steps) and as a 
1:1 mixture of  atropisomers. 1H NMR (500 MHz, d6-acetone) # 9.85 (d, 1H, J = 1.6 Hz), 
7.75–7.73 (m, 2H), 7.65–7.51 (m, 3H), 7.47–7.39 (m, 2H), 7.35–7.30 (m, 1H), 6.06 (dd, 
1H, J = 28.6, 4.2 Hz), 5.13–5.08 (m, 1H), 5.05–5.02 (m, 1H), 4.99–4.91 (m, 1H), 3.49–
3.46 (m, 1H), 3.23 (dd, 1H, J = 16.9, 2.7 Hz), 2.77* (septet, 1H, J = 6.9 Hz), 2.59 (septet, 
1H, J = 6.9 Hz), 2.12 (d, 3H, J = 2.6 Hz), 1.30–1.24 (m, 6H); 13C NMR (125 MHz, d6-
acetone) # 146.8, 146.6, 142.0, 141.8, 138.1, 137.8, 136.0, 135.8, 132.9, 132.9, 131.7, 
130.2, 130.1, 129.0, 128.7, 128.5, 128.5, 128.4, 128.3, 128.1, 128.0, 127.0, 126.8, 
126.6, 126.4, 125.0, 124.9, 124.1, 78.3, 61.7, 61.6, 60.3, 60.2, 38.4, 38.3, 28.9, 28.6, 
24.8, 24.8, 23.4, 23.0, 8.4, 8.3; IR (thin film) ! 3120, 3057, 2967, 2930, 2871, 1540, 
1461, 1268, 1224, 1099, 733, 623 cm$1; HRMS (ESI) calcd for C23H25N2O+ [M]+ 
345.1916, found 345.1955 [M]+; [%]2D
0 = $113.3 (c 0.12, CH2Cl2).
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Preparation of N-2-tert-butylphenyl substituted imidazolium salt (171)
To a round-bottomed flask charged with a magnetic stir bar and oxazolinium salt 159 
(388 mg, 1.00 mmol, 1.00 equiv) was added toluene (10 mL) and 2-tert-butylaniline (0.24 
mL, 1.5 mmol, 1.5 equiv). The heterogeneous mixture was stirred at ambient 
temperature for 15 h. The aminal intermediate was collected by suction filtration as a tan 
powder and as a mixture of  diastereomers (410 mg, 86%). A suspension of the aminal 
intermediate (410 mg, 0.86 mmol, 1.0 equiv) in toluene (3.5 mL) was treated with Ac2O 
(0.16 mL, 1.7 mmol, 2.0 equiv) and HClO4 (70%, 16 µL, 0.17 mmol, 0.20 equiv) and 
stirred at 80 °C for 45 min. The solution was decanted and the oil concentrated under 
reduced pressure to a brown foam that was dissolved in a minimal amount of  EtOAc, 
placed in a sonicating bath and triturated with Et2O. Isolation by suction filtration afforded 
171 in 3 crops as a yellow  solid and ~10:1 mixture of  atropisomers (90 mg, 23%; 20% 
over 3 steps). 1H NMR (500 MHz, d6-acetone) # 9.97* (s, 1H), 9.94 (s, 1H), 7.89 (dd, 1H, 
J = 8.2, 1.4 Hz), 7.71–7.68 (m, 1H), 7.68* (d, 1H, J = 1.5 Hz), 7.60–7.57 (m, 1H), 7.54–
7.49 (m, 1H), 7.49–7.47* (m 1H), 7.46–7.41 (m, 4H), 7.40 (d, 1H, J = 7.4 Hz), 7.30–7.16* 
(m, 7H), 6.18* (d, 1H, J = 5.0 Hz), 6.01 (d, 1H, J = 4.2 Hz), 5.13 (d, 1H, J = 15 Hz), 5.10–
5.08* (m, 2H), 5.02 (t, 1H, J = 4.4 Hz), 4.93 (dd, 1H, J = 15.0 Hz, 1.0 Hz), 3.50 (dd, 1H, J 
= 16.9, 5.0 Hz), 3.31* (dd, 1H, J = 16.8, 4.1 Hz), 3.24 (d, 1H, J = 16.9 Hz), 3.15* (d, 1H, 
J = 16.7 Hz), 2.16* (s, 3H), 2.14 (s, 3H), 1.32* (s, 9H), 1.29 (s, 9H); 13C NMR (125 MHz, 
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d6-acetone) # 147.5, 142.0, 138.1, 137.0, 132.6, 131.7, 131.5, 131.3, 130.8, 130.2, 
129.0, 128.8, 128.7, 128.1, 128.0, 127.9, 126.6, 125.0, 124.3, 78.3, 61.6, 60.1, 38.3, 
36.9, 32.1, 8.92; IR (thin film) ! 3123, 3056, 2967, 1540, 1482, 1213, 1099, 733, 624 
cm$1; HRMS (ESI) calcd for C24H27N2O+ [M]+ 359.2118; found, 359.2112 [M]+; [%]2D
0 = 
$202.7 (c 0.073, CH2Cl2).
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Preparation of N-2-bromophenyl substituted imidazolium salt (172)
To a round-bottomed flask charged with a magnetic stir bar and oxazolinium salt 159 
(388 mg, 1.00 mmol, 1.00 equiv) was added toluene (10 mL) and 2-bromoaniline (0.14 
mL, 1.5 mmol, 1.5 equiv). The heterogeneous mixture was stirred at ambient 
temperature for 12 h. The solution was concentrated under reduced pressure to a brown 
foam which was suspended in Et2O (10 mL) and EtOAc (4 mL), placed in a sonicating 
bath and methanol (< 1 mL) added until a solid precipitate formed. The precipitate was 
collected by suction filtration to afford two crops of  the crude aminal intermediate as a 
white solid and as a mixture of  diastereomers (130 mg, 26%). A suspension of the 
aminal intermediate (125 mg, 0.25 mmol, 1.0 equiv) in toluene (1.0 mL) was treated with 
Ac2O (47 µL, 0.50 mmol, 2.0 equiv) and HClO4 (70%, 4.0 µL, 0.050 mmol, 0.20 equiv) 
and stirred at 80 °C for 30 min. The solution was concentrated under reduced pressure 
and the residue purified by flash column chromatography (gradient, CH2Cl2:MeOH, 
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98:2"95:5"92:8"90:10) to afford 172 as a yellow  solid as a 2:1 mixture of 
atropisomers (100 mg, 83 % yield, 22 % over 3 steps). 1H NMR (500 MHz, d6-acetone) # 
9.90* (s, 1H), 9.82 (s, 1H), 8.01 (d, 1H, J = 8.0 Hz), 7.97* (d, 1H, J = 7.3 Hz), 7.79–7.70 
(m, 3H), 7.66* (d, 1H, J = 7.6 Hz), 7.61 (d, 1H, J = 7.6 Hz), 7.44 (d, 1H. J = 7.4 Hz), 7.39 
(t, 1h, J = 7.3 Hz), 7.32 (t, 1H, J = 7.3 Hz), 6.14* (d, 1H, J = 3.6 Hz) 6.02 (d, 1H, J = 3.8 
Hz), 5.13* (d, 1H, J = 15.1 Hz), 5.12 (d, 1H, J = 15.0 Hz), 5.01* (t, 1H, J = 4.4 Hz), 5.01 
(t, 1H, J = 4.4 Hz), 4.92 (d, 1H, J = 15.0 Hz), 3.50* (dd, 1H, J = 16.9, 4.7 Hz), 3.50 (dd, 
1H, J = 16.9, 4.7 Hz), 3.24* (d, 1H, J = 16.9 Hz), 3.22 (d, 1H, J = 16.9 Hz), 2.17* (s, 3H), 
2.14 (s, 3H); 13C NMR (125 MHz, d6-acetone) # 141.8, 138.0, 136.4, 136.1, 134.9, 
134.8, 134.2, 133.5, 131.1, 130.8, 130.5, 130.4, 130.1, 128.1, 128.0, 126.6, 126.5, 
126.3, 125.0, 124.7, 124.3, 121.9, 78.3, 61.7, 60.2, 38.4, 38.2, 8.4, 8.3; IR (thin film) ! 
3124, 3058, 2926, 1544, 1482, 1267, 1219, 1092, 736, 622 cm$1; HRMS (ESI) calcd for 
C20H18BrN2O+ [M]+ 381.0597, found 381.0607 [M]+; [%]2D
0 = $84.9 (c 0.11, CH2Cl2).
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Preparation of N-2-(N-methylbenzamido) substituted imidazolium salt (173)
To a 1.0 M solution oxazolinium salt 159 (388 mg, 1.00 mmol, 1.00 equiv) in CH2Cl2 in a 
round-bottom flask charged with a magnetic stir bar was added a 1 M solution of 2-
amino-N-methylbenzamide3 (1.5 mL, 1.5 mmol, 1.5 equiv) in CH2Cl2 followed by toluene 
(3.0 mL). The cloudy solution was stirred at ambient temperature for 16 h. The solution 
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was triturated with Et2O, the supernatant decanted, and residual solvent removed under 
reduced pressure to afford the crude aminal intermediate as a light tan foam and as a 
mixture of diastereomers (475 mg, 99%). A 0.25 M solution of  the aminal intermediate 
(475 mg, 0.99 mmol, 1.0 equiv) in 1,2-dichloroethane (4.0 mL) was treated with Ac2O 
(0.19 mL, 2.0 mmol, 2.0 equiv) and HClO4 (70 %, 17 µL, 0.20 mmol, 0.20 equiv). The 
solution was stirred at 70 °C for 30 min, concentrated under reduced pressure, and the 
residue purified by flash column chromatography (CH2Cl2/MeOH, 95:5) to afford 173 as 
a white solid (320 mg, 70%; 69% over 3 steps). 1H NMR (500 MHz, d6-acetone) # 9.67 
(s, 1H), 7.9 (br s, 1H, NH), 7.89–7.77 (m, 4H), 7.62 (d, 1H, J = 7.6 Hz), 7.41 (d, 1H, J  = 
7.4 Hz), 7.38 (t, 1H, J = 7.4 Hz), 7.32 (t, 1H, J = 7.4 Hz), 5.97 (s, 1H), 5.04 (d, 1H, J = 
15.0 Hz), 4.99 (br s, 1H), 4.89 (d, 1H, J = 15.0 Hz), 3.47 (dd, 1H, J = 16.9, 4.8 Hz), 3.20 
(d, 1H, J = 16.9 Hz), 2.81 (d, 3H, J  = 4.7 Hz), 2.10 (s, 3H); 13C NMR (125 MHz, d6-
acetone) # 166.4, 141.6, 138.1, 136.6, 135.4, 132.5, 132.4, 131.9, 129.9, 129.8, 129.6, 
127.9, 127.2, 126.2, 124.8, 123.6, 78.3, 61.5, 60.1, 38.3, 26.8, 8.4; IR (thin film) ! 3362, 
3128, 3061, 2931, 1662, 1604, 1545, 1217, 1099, 734, 623 cm$1; HRMS (ESI) calcd for 
C22H22N3O2+ [M]+  360.1707; found, 360.1711 [M]+; [%]2D
0 = $124.9 (c 0.19, CH2Cl2).
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10 mol% cat.
10 mol% DIPEA
0.05 M 10:1 PhMe/THF
20 °C, 23 h
N
O
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Ethyl-2-((3S,4S)-1-(4-methoxyphenylsulfonyl)-2-oxo-4-phenyl-1,2,3,4-tetra- 
hydropyridin-3-yl) acetate (175) 
To an oven-dried 10-mL round-bottomed flask equipped with a magnetic stir bar was 
added trans-N-(4-methoxybenzenesulfonyl)-3-phenylprop-2-ene-1-imine 174 (60 mg, 
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0.20 mmol, 1.0 equiv), the precatalyst (10 mol %), ethyl trans-4-oxo-2-butenoate 111 
(26.5 &L, 0.22 mmol, 1.1 equiv), and 4.0 mL of 10:1 toluene:THF (0.050 M). The flask 
was purged with N2(g), N,N-diisopropylethylamine (DIPEA) was added (3.5 &L, 0.020 
mmol, 0.10 equiv, 10 mol %) and the solution allowed to stir at 20 °C for 23 h. The 
reaction was concentrated under reduced pressure and the resulting mixture purified by 
flash column chromatography (hexanes/EtOAc, 3:1) to afford the title compound (65 mg 
, 76% yield from the triazolium catalyst ent-117•ClO4). 1H NMR (500 MHz, CDCl3) # 8.03 
(d, 2H, J = 8.6 Hz), 7.16–7.12 (m, 2H), 7.05–6.99 (m, 4H), 6.58 (d, 2H, J = 7.4 Hz), 5.59 
(m, 1H), 4.18–4.08 (m, 2H), 3.92 (s, 3H), 3.65 (t, 1H, J = 6.8 Hz), 3.55–3.51 (m, 1H), 
2.57 (dd, 1H, J = 17.3, 6.0 Hz), 1.94 (dd, 1H, J = 17.3, 7.5 Hz), 1.21 (t, 3H, J = 7.0 Hz); 
13C NMR (125 MHz, CDCl3) # 171.7, 168.9, 164.4, 136.8, 131.4, 129.2, 128.9, 127.9, 
127.9, 124.6, 114.3, 113.5, 60.9, 56.0, 44.1, 42.1, 31.5, 14.3; IR (thin film) ! 3086, 
2982, 1720, 1594, 1496, 1454, 1406, 1367, 1264, 1132, 1091 cm$1, m.p. = 111–113 °C; 
HRMS (ESI) calcd for C22H23NO6S [M]+ 429.1246, found 452.1160 [M+Na]+; 99% ee 
from the triazolium precatalyst ent-117•ClO4 as determined by HPLC (AS-H, 9:1 
hexanes/i-PrOH), tr = 34.8 min, tr = 45.0 min; [%]2D
0 = $70.2 (c 1.0, CH2Cl2).
H
O
O CO2Et
20 mol% cat.
20 mol% KHMDS
0.02 M xylenes
25 °C, 24 h O
O
CO2Et
183 184
(R)-(4-Oxo-chroman-3-yl)-acetic acid ethyl ester (184)
An oven-dried 10-mL round-bottomed flask equipped with a stir bar was charged with the 
precatalyst (20 mol %) and xylenes (4.0 mL) and purged with N2(g). A 0.50 M (toluene) 
solution of KHMDS (0.040 mL, 0.024 mmol, 20 mol %) was added and the mixture 
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allowed to stir at ambient temperature for 15 min. Next (E)-ethyl 4-(2-formylphenoxy)but- 
2-enoate 184 (28 mg, 0.12 mmol, 1.0 equiv) in 2.0 mL of  xylenes (0.060 M) was added 
and the solution stirred at 25 °C for 24 h. The solution was immediately poured onto a 
column of  silica gel and eluted (hexanes/i-PrOH, 6:1) to afford the product as a colorless 
oil (26.5 mg, 94% yield from triazolium catalyst ent-117•ClO4). 1H NMR (500 MHz, 
CDCl3) # 7.89 (dd, 1H, J = 7.9, 1.7 Hz), 7.49 (m, 1H), 7.04 (m, 1H), 6.98 (dd, 1H, J = 8.4, 
0.6 Hz), 4.61 (dd, 1H, J = 11.2, 5.2 Hz), 4.30 (t, 1H, J = 11.2 Hz), 4.20 (m, 2H), 3.35 (m, 
1H), 2.95 (dd, 1H, J = 17.0, 4.8 Hz), 2.42 (dd, 1H, J = 17.0, 8.2 Hz), 1.29 (t, 3H, J = 7.1 
Hz); 13C NMR (125 MHz, CDCl3) # 192.8, 171.6, 162.0, 136.2, 127.6, 121.7, 120.7, 
118.0, 70.5, 61.2, 42.8, 30.6, 14.4; IR (thin film) ! 2987, 2929, 2850, 1734, 1690, 1606, 
1301, 1214 cm$1; 98% ee from chiral triazolium catalyst as determined by HPLC (AD-H 
column, 97:3 hexanes:i-PrOH, 0.5 mL/min), tr = 27.7 min, tr = 39.9 min; [%]2D
0 = $17.0 (c 
0.12, CH2Cl2).
O
H
10 mol% cat.
10 mol% KOt-Bu
0.7 M THF
25 °C, 16 h
O
OH
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2-Hydroxy-1,2-diphenylethanone (186)
To an oven-dried 5.0-mL vial equipped with a magnetic stir bar was added the 
precatalyst (10 mol %). The vial was purged with N2(g) and benzaldehyde (50 &L, 0.50 
mmol, 1.0 equiv) and THF (0.35 mL) were added. The reaction mixture was allowed to 
stir at 25 °C for 5 min before a 1.0 M (THF) solution of potassium tert-butoxide (0.050 
mL, 0.050 mmol, 10 mol %) was added drop-wise. The resulting solution was allowed to 
stir at 20 °C for 16 h. The contents of the vial were poured over water (5 mL) and 
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extracted with CH2Cl2 (2 x 5 mL). The combined organic fractions were dried over 
Na2SO4, filtered, and concentrated under reduced pressure. The crude mixture was 
purified by flash column chromatography (hexanes/EtOAc, 5:1) to afford the title 
compound as a white solid (6.0 mg, 11% yield from the imidazolium precatalyst 145; 
44.0 mg, 83% yield from the triazolium precatalyst ent-117•ClO4). 1H NMR (500 MHz, 
CDCl3) # 7.93 (m, 2H), 7.55–7.52 (m, 1H), 7.42–7.39 (m, 2H), 7.36–7.28 (m, 5H), 5.96 
(d, 1H, J = 6.1 Hz), 4.55 (d, 1H, J = 6.1 Hz); 13C NMR (125 MHz, CDCl3) # 199.1, 
139.21, 134.1, 133.7, 129.3, 129.3, 128.9, 128.8, 128.0, 29.9; IR (thin film) ! 3380, 
2924, 2852, 1681, 1449, 1263, 1206, 1092, 1068, 977 cm$1. 
O
H
Br
8 mol% cat.
7 mol% DBU
10:1 THF:t-BuOH
40 °C, 15 h
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Ph
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cis-5-(4-Bromophenyl)-4-phenyl-dihydrofuran-2(3H)-one (188)
Into an oven-dried 5-mL vial equipped with a magnetic stir bar was added the precatalyst 
(8 mol %), 4-bromobenzaldehyde (92 mg, 0.50 mmol, 2.0 equiv), trans-cinnamaldehyde 
(32 &L, 0.25 mmol, 1.0 equiv), and 0.50 mL 10:1 THF: t-BuOH. The vial was purged with 
N2(g) and DBU (2.7 &L, 0.018 mmol, 7 mol %) was added. The solution was allowed to 
stir at 25 °C for 15 h. The solution was concentrated under reduced pressure and the 
mixture purified by flash column chromatography (hexanes/EtOAc, 4:1) to afford the 
lactone diastereomers (55% yield from the imidazolium precatalyst 145; 14% yield from 
the triazolium precatalyst ent-117•ClO4). 1H NMR (500 MHz, CDCl3) # 7.28–7.24 (m, 
shoulder, 2H), 7.15–7.14 (m, 3H), 6.84–6.82 (m, 2H), 6.78 (d, 2H, J = 8.3 Hz), 5.77 (d, 
1H, J = 6.8 Hz), 4.07–4.03 (m, 1H), 3.07 (dd, 1H, J = 17.4, 8.3 Hz), 2.93 (dd, 1H, J = 
173
17.4, 5.8 Hz); 13C NMR (125 MHz, CDCl3) # 176.5, 136.6, 131.3, 128.7, 128.1, 127.9, 
127.6, 122.1, 84.2, 46.9, 35.2; IR (thin film) ! 3064, 3033, 2927, 1784, 1594, 1491, 
1173, 1072, 1010, 980, 732 cm$1; HRMS (EI) calcd for C16H13BrO2 [M]+ 316.0099, found 
316.0111 [M]+; 32% ee from the imidazolium catalyst as determined by SFC (AD-H 
column, 7% i-PrOH in CO2), tr =  14.1 min, tr = 16.7 min; [%]2D
0 = 67.0 (c 0.10, CH2Cl2).
trans-5-(4-Bromophenyl)-4-phenyl-dihydrofuran-2(3H)-one (diast-188)
1H NMR (500 MHz, CDCl3) # 7.48–7.45 (m, 2H), 7.38–7.31 (m, 3H), 7.18–7.16 (m, 2H), 
7.05 (d, 2H, J = 8.4 Hz), 5.37 (d, 1H, J = 8.8 Hz), 3.55–3.49 (m, 1H), 3.06 (dd, 1H, J = 
17.6, 8.4 Hz), 2.90 (dd, 1H, J = 17.6, 11.1 Hz); 13C NMR (125 MHz, CDCl3) # 175.0, 
137.5, 132.0, 129.4, 128.3, 127.6, 127.4, 122.9, 86.9, 51.0, 37.3, 29.9; IR (thin film) ! 
3063, 3032, 2926, 1790, 1491, 1268, 1195, 1143, 1004, 699 cm$1; HRMS (EI) calcd for 
C16H13BrO2 [M]+ 316.0099, found 316.0108 [M]+; 34% ee from the imidazolium 
precatalyst as determined by SFC (AD-H column, 7% i-PrOH in CO2), tr = 11.2 min, tr = 
15.9 min; [%]2D
0 = $28.0 (c 0.10, CH2Cl2).
N
H
Me
S
O O
OMe
15 mol% cat.
10 mol% DBU
0.1 M t-BuOH
60 °C, 15 h
N
O
SO2Ar
p-Tol
+
189 190 191
O
H
1-napth
cis-1-(4-Methoxyphenylsulfonyl)-4-(naphthalen-1-yl)-5-p-tolylpyrrolidin-2-one (191)
To an oven-dried 5-mL vial equipped with a magnetic stir bar was added (E)-3- 
(naphthalen-1-yl)acrylaldehyde 189 (18 mg, 0.10 mmol, 1.0 equiv), (E)-4-methoxy-N-(4- 
methylbenzylidene)benzenesulfonamide 190 (29 mg, 0.10 mmol, 1.0 equiv), and the 
precatalyst (15 mol %) and purged with N2(g). Next t-BuOH (1.0 mL) was added followed 
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by DBU (1.5 mg, 0.010 mmol, 10 mol %) and the vial again purged with N2(g). The vial 
was capped and stirred at 60 °C for 15 h. The reaction mixture was concentrated under 
reduced pressure and taken up in 1.0 mL of  THF and 1.0 mL of  1.0 M aq HCl and stirred 
12 h at ambient temperature to decompose the remaining imine. The solution was 
adjusted to pH 12 using 10% aq NaOH. The solution was extracted with CH2Cl2 (2 x 5 
mL) and the combined organic phases dried over Na2SO4, filtered, and concentrated 
under reduced pressure. The crude residue was purified by PTLC (hexanes/EtOAc, 2:1) 
to yield the title compound as a white solid (11.5 mg, 25% yield from the imidazolium 
precatalyst 145; trace lactam and azabenzoin as an inseparable mixture from the 
triazolium precatalyst ent-117•ClO4). 1H NMR (500 MHz, CDCl3) # 8.24 (d, 1H, J = 8.5 
Hz), 7.84 (d, 1H, J = 8.1 Hz), 7.72 (d, 2H, J = 9.0 Hz), 7.71– 7.66 (m, 1H), 7.60 (d, 1H, J 
= 8.2 Hz), 7.54 (t, 1H, J = 7.5 Hz), 7.04 (t, 1H, J = 7.7 Hz), 6.86 (d, 2H, J  = 9.0 Hz), 
6.63–6.61 (m, 3H), 6.23 (d, 2H, J = 8.0 Hz), 5.94 (d, 1H, J = 7.7 Hz), 4.87–4.81 (m, 1H), 
3.86 (s, 3H), 3.29 (dd, 1H, J = 16.9, 13.7 Hz), 2.70 (dd, 1H, J = 16.9, 7.4 Hz), 2.11 (s, 
3H); 13C NMR (125 MHz, CDCl3) # 172.7, 164.2, 137.6, 133.8, 132.2, 132.0, 131.4, 
131.0, 129.4, 128.7, 128.2, 127.0, 126.4, 126.0, 125.0, 124.4, 122.9, 113.9, 66.2, 55.9, 
41.1, 34.6, 21.1; IR (thin film) ! 3055, 2987, 2306, 1736, 1596, 1422, 1266, 1166, 896, 
740 cm$1; m.p. 200–202 °C; MS (ESI) calcd for C28H25NO4S [M]+ 471.1504, found 
471.1509 [M]+; 20% ee from the imidazolium precatalyst 145 as determined by SFC (AS-
H column, 15% MeOH in CO2) tr  = 14.8 min, tr  = 16.2 min; [%]2D
0 = $90.0 (c 0.067, 
CH2Cl2).
175
General Procedure for NHC-Promoted Cyclization-Lactonization Catalytic 
Reactions
A vial was charged with the NHC precatalyst, the substrate, and purged with N2(g). Next, 
the solvent was added followed by the base under an atmosphere of N2(g). The vial was 
sealed and stirred at the designated temperature until the starting material was con-
sumed as indicated by TLC analysis. Finally, the solvent was removed under reduced 
pressure and the crude reaction mixture purified by silica gel chromatography.
OEt
OEt
O
EtO
O
O
EtO
H
HC(OEt)3
conc. HCl(aq)
EtOH
0 °C!rt, 8 h
(E)-Ethyl 4,4-diethoxybut-2-enoate 
To a 1.0 M solution of  (E)-ethyl 4-oxobut-2-enoate (12.0 mL, 100 mmol, 1.00 equiv) in 
200 proof EtOH cooled to 0 °C was added triethylorthoformate (12.8 mL, 120 mmol, 1.2 
equiv) and conc. aq HCl (0.100 mL, 1.16 mmol, 0.0116 eqiuv). The solution was stirred 
at 0 °C for 4 h, allowed to warm to ambient temperature, and stirred until the disappear-
ence of  the starting material as indicated by TLC analysis (ca 4 h). The solution was 
concentrated under reduced pressure and the crude oil dissolved in EtOAc (150 mL). 
This solution was washed with H2O (150 mL), and the aqueous layer back-extracted with 
EtOAc (150 mL). The combined organic fractions were washed with brine (200 mL), 
dried over Na2SO4, filtered and concentrated under reduced pressure to afford the title 
compound as a clear liquid (19.5 g, 88%). 1H NMR (500 MHz, CDCl3) # 6.80 (dd, 1H, J = 
15.8, 4.2 Hz), 6.13 (dd, 1H, J = 15.8, 1.3 Hz), 5.04 (dd, 1H, J = 4.2, 1.3 Hz), 4.20 (q, 2H, 
J = 7.1 Hz), 3.65 (dq, 2H, J = 7.1, 2.3 Hz), 3.52 (dq, 2H, J = 7.1, 2.4 Hz), 1.29 (t, 3H, J = 
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7.1 Hz), 1.22 (t, 6H, J = 7.1 Hz); 13C NMR (125 MHz, CDCl3) # 166.3, 143.6, 124.2, 99.2, 
61.4, 60.7, 15.3, 14.3; IR (thin film) ! 2981, 2927, 2878, 1722, 1446, 1373, 1304, 1269, 
1181, 1058 cm$1; HRMS (ESI) calcd for C10H18O4 [M]+ 202.1205, found 225.1106 
[M+Na]+.
OEt
OEt
O
HO
198
OEt
OEt
O
EtO
0 °C, 5 h
1 M NaOH(aq)
THF
(E)-4,4-Diethoxybut-2-enoic acid (198)
A 1.0 M aq solution of  NaOH (20 mL, 20 mmol, 1.0 equiv) was added slowly to a chilled 
(0 °C) 1 M solution of (E)-ethyl 4,4-diethoxybut-2-enoate (4.0 g, 20 mmol, 1.0 equiv) in 
THF (20 mL). The solution was allowed to warm to ambient temperature and stirred until 
the consumption of starting material was observed by TLC (ca 5 h). The solution was 
diluted with CH2Cl2 (100 mL) and the pH of the aqueous phase adjusted with 1N aq HCl 
until pH~2 was achieved. The organic layer was separated and the aqueous layer 
extracted with CH2Cl2 (100 mL). The organic layers were combined, dried over Na2SO4, 
filtered and concentrated under reduced pressure to afford the title compound as a 
yellow  liquid (3.5 g, quant.). 1H NMR (500 MHz, CDCl3) # 6.92 (dd, 1H, J = 15.8, 4.0 Hz), 
6.16 (dd, 1H. J = 15.8, 1.4 Hz), 5.09 (dd, 1H, J = 4.0, 1.3 Hz), 3.66 (dq, 2H, J = 7.1, 2.4 
Hz), 3.54 (dq, 2H, J = 7.1, 2.4 Hz), 1.23 (t, 6H, J = 7.1 Hz); 13C NMR (125 MHz, CDCl3) 
# 170.7, 150.5, 125.0, 103.3, 66.2, 15.1; IR (thin film) ! 3104, 2981, 2937, 2898, 1796, 
1761, 1377, 1348, 1136, 1013, 929, 890, 817 cm$1; HRMS (ESI) calcd for C8H14O4 [M]+ 
174.0892, found 173.0803 [M$H]$.
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OEt
OEt
O
HONH3
O
Ph
Cl
+  HBTU, DIPEA
OEt
OEt
O
H
N
O
Ph
197 198
CH2Cl2
rt, 20 h
(E)-4,4-Diethoxy-N-(2-oxo-2-phenylethyl)but-2-enamide 
N,N-Diisopropylethylamine (0.52 mL, 3.0 mmol, 3.0 equiv) was added to a solution of 
198 (0.35 g, 2.0 mmol, 2.0 equiv) and HBTU (0.76 g, 2.0 mmol, 2.0 equiv) in CH2Cl2 (10 
mL). After 10 min of stirring, 2-oxo-2-phenylethanaminium chloride4 197 (0.17 g, 1.0 
mmol, 1.0 equiv) was added in a single portion and the solution stirred at ambient 
temperature for 20 h. The solution was diluted with CH2Cl2 (15 mL) and washed with sat 
aq NaHCO3 (20 mL). The aqueous layer was extracted with CH2Cl2 (20 mL). The com-
bined organic extracts were washed with sat aq NH4Cl (20 mL), dried over Na2SO4, 
filtered and concentrated under reduced pressure. Purification by column 
chromatography afforded the title compound as a white solid (0.195 g, 67%). 1H NMR 
(500 MHz, CDCl3) # 8.00–7.98 (m, 2H), 7.63 (t, 1H, J = 7.4 Hz), 7.51 (t, 1H, J  = 7.8 Hz), 
6.78 (dd, 1H, J = 15.5, 3.8 Hz), 6.70 (bs, 1H), 6.28 (dd, 1H, J = 15.5, 1.4 Hz), 5.10 (dd, 
1H, J = 3.8, 1.4 Hz), 4.84 (d, 2H, J = 4.3 Hz), 3.66 (dq, 2H, J = 7.1, 2.4 Hz), 3.53 (dq, 
2H, J = 7.1, 2.4 Hz), 1.23 (t, 6H, J = 7.1 Hz); 13C NMR (125 MHz, CDCl3) # 194.1, 165.2, 
140.5, 134.4, 129.1, 128.1, 125.9, 99.2, 61.3, 46.7, 15.4; IR (thin film) ! 3311, 2976, 
2873, 1678, 1638, 1377, 1058, 1003, 979 cm$1; HRMS (ESI) calcd for C16H21NO4 [M]+ 
291.1471, found 314.1356 [M+Na]+.
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2N HCl(aq)
H
O
O
H
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O
Ph
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OEt
OEt
O
H
N
O
Ph rt, 5 min
(E)-4-Oxo-N-(2-oxo-2-phenylethyl)but-2-enamide (196)
A solution of  (E)-4,4-diethoxy-N-(2-oxo-2-phenylethyl)but-2-enamide (0.10 g, 0.34 mmol, 
1.0 equiv) in THF (4.0 mL) was treated with 2N aq HCl (1.2 mL, 2.4 mmol, 7.0 equiv) at 
rt and stirred until the consumption of starting material was observed by TLC (ca 5 min). 
The solution was diluted with H2O (15 mL) and EtOAc (15 mL); the organic layer was 
separated, washed with brine (15 mL), dried over Na2SO4, filtered and concentrated 
under reduced pressure affording the title compound as a light tan solid (0.074 g, 
quant.). 1H NMR (500 MHz, CDCl3) # 9.79 (d, 1H, J  = 7.4 Hz), 8.00 (dd, 2H, J = 8.4, 1.2 
Hz), 7.66 (dt, 1H, J = 7.4, 1.2 Hz), 7.53 (t, 2H, J = 7.5 Hz), 7.02 (dd, 1H, J = 15.6, 7.4 
Hz), 6.89 (d, 1H, J = 15.6 Hz), 4.89 (d, 1H, J = 4.3 Hz); 13C NMR (125 MHz, CDCl3) # 
193.5, 192.4, 163.4, 141.4, 138.3, 134.7, 129.2, 129.1, 128.2, 46.8; IR (thin film) ! 
3316, 3060, 2922, 2848, 1695, 1675, 1670, 1540, 1358, 1230, 984 cm$1; HRMS (ESI) 
calcd for C12H11NO3 [M]+ 217.0739, found 240.0622 [M+Na]+.
H
O
O
H
N
O
Ph
196
N
O
O
O
Ph
200
20 mol% IMesCl
20 mol% DBU
 
THF, 40 °C, 12 h
1-(2-Oxo-2-phenylethyl)pyrrolidine-2,5-dione (200)
An oven-dried vial was charged with IMesCl (0.0075 g, 0.022 mmol, 0.20 equiv) and 196 
(0.023 g, 0.11 mmol, 1.0 equiv) and purged with N2(g). To this mixture was added THF 
(1.0 mL) and DBU (3.3 µL, 0.022 mmol, 0.20 equiv). The vial was sealed, and the 
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reaction stirred at 40 °C for 12 h. The solution was concentrated under reduced pressure 
and purified by PTLC (hexanes/acetone, 2:1). 1H NMR (500 MHz, CDCl3) # 7.97 (dd, 2H, 
J = 8.4, 1.2 Hz), 7.63 (dt, 1H, J = 7.4, 1.2 Hz), 7.52–7.49 (m, 2H), 4.95 (s, 2H), 2.87 (s, 
4H); 13C NMR (125 MHz, CDCl3) # 190.3, 176.8, 134.3, 129.0, 128.3, 44.9, 28.5; HRMS 
(ESI) calcd for C12H11NO3 [M]+ 217.0739, found 240.0627 [M+Na]+.
Ph
O
Br
Ph
O
NH2Bn Cl
BnNH2
Et2O
0 °C, 16 h
197
N-Benzyl-2-oxo-2-phenylethanaminium chloride (197)
A 1.0 M solution of 2-bromo-1-phenylethanone (10.0 g, 50.0 mmol, 1.00 equiv) in Et2O 
(50.0 mL) was added to a chilled (0 °C) 2.0 M solution of  benzylamine (10.9 mL, 100 
mmol, 2.00 equiv) in Et2O over a 10 minute period and stirred at 0 °C for 16 h. The 
precipitate was filtered and washed with Et2O. The filtrate was cooled to 0 °C and conc. 
aq HCl (4.0 mL) was slowly added. The resultant orange precipitate was filtered and 
washed with Et2O. The precipitate was sonicated in 60 mL of 1:1 Et2O:EtOH (200 proof) 
until the solid appeared white in color. The precipitate was collected by suction filtration 
and washed with Et2O affording crop 1 (2.80 g, 21.4%) of the title compound as a white 
crystalline solid. The filtrate was then concentrated and the resulting solid sonicated in a 
1:1 Et2O:EtOH (200 proof) solution until the solid appeared white in color. The precipitate 
was collected by suction filtration and washed with Et2O affording crop 2 (3.70 g, 28.2%) 
of the title compound as a white powder. 1H NMR (500 MHz, d6-DMSO) # 9.45 (bs, 2H), 
8.00–7.98 (m, 2H), 7.93–7.91 (m, 1H), 7.77–7.74 (m 1H), 7.63–7.60 (m, 2H), 7.56–7.54 
(m, 2H), 7.48–7.44 (m, 2H), 4.82 (s, 2H), 4.21 (s, 2H); 13C NMR (125 MHz, d6-DMSO) # 
192.2, 134.8, 133.7, 131.8, 130.3, 129.2, 128.8, 128.2, 128.1, 51.9, 50.2; IR (KBr) ! 
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2977, 2912, 2785, 2730, 2608, 2435, 1712, 1579, 1461, 1225, 742 cm$1; HRMS (ESI) 
calcd for C15H16ClNO+ [M]+ 226.1226, found 226.1223 [M]+.
Ph
O
NH2Bn Cl HO
O
OEt
OEt
1. EDCI, NEt3, DMAP
    CH2Cl2, rt, 24 h
2. 2N HCl(aq)
    rt, 1 h
N
O
O
Ph
Bn O
H
201 198 202
(E)-N-Benzyl-4-oxo-N-(2-oxo-2-phenylethyl)but-2-enamide (196)
To a solution of 198 (1.50 g, 8.61 mmol, 2.00 equiv) in CH2Cl2 (50.0 mL) were 
sequentially added 21 (1.12 g, 4.28 mmol, 1.00 equiv), EDCI (1.65 g, 8.60 mmol, 2.00 
equiv), 4-dimethylaminopyridine (0.525 g, 4.30 mmol, 1.00 equiv), and triethylamine 
(3.00 mL, 21.5 mmol, 5.02 equiv) and the resulting brown solution stirred at ambient 
temperature for 24 h. The solution was diluted with CH2Cl2 (100 mL), washed with 1N aq 
HCl (2 x 75 mL) followed by sat aq NaHCO3 (100 mL), dried over Na2SO4, filtered and 
concentrated under reduced pressure affording a brown foam. The foam was dissolved 
in THF (13 mL) and treated with 6N aq HCl (13 mL, 26 mmol, 6.0 equiv) for 1 h. After 
diluting the solution with CH2Cl2 (~70 mL) and H2O (~50 mL) the organic phase was 
separated. The aqueous phase was further extracted with CH2Cl2 (2 x 50 mL). The 
organic phases were combined, dried over Na2SO4, filtered and concentrated under 
reduced pressure to afford the crude aldehyde as a brown solid. Sonication of the crude 
solid in Et2O/EtOAc precipitated the pure aldehyde as a tan solid and as a ~3:1 mixture 
of amide rotamers that was collected by suction filtration and washed with Et2O (0.60 g, 
46% over 2 steps). 1H NMR (500 MHz, CDCl3) # 9.73 (d, 1H, J = 7.5 Hz), 9.64* (d, 1H, J 
= 5.2 Hz), 7.93 (d, 2H, J = 7.5 Hz), 7.85* (d, 2H, J = 7.5 Hz), 7.60–7.22 (m, 9H), 7.65–
7.22* (m, 9H), 7.03 (dd, 1H, J  = 15.5, 7.5 Hz), 7.03* (dd, 1H, J = 15.5, 7.5 Hz), 6.96 (d, 
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1H, J  = 5.5 Hz), 6.96* (d, 1H, J = 5.5 Hz), 4.87 (s, 2H), 4.78 (s, 2H), 4.76* (s, 2H), 4.72* 
(s, 2H); 13C NMR (125 MHz, CDCl3) # 193.4, 192.5, 165.8, 139.9, 139.7,139.4, 138.9, 
135.7, 135.2, 134.7, 134.2, 129.5, 129.4, 129.1, 129.1, 128.9, 128.6, 128.2, 128.1, 
126.9, 52.8, 52.2, 50.6; IR (thin film) ! 3065, 3035, 2932, 1697, 1647, 1451, 1358, 
1230, 1117, 1077, 994 cm$1; HRMS (ESI) calcd for C19H17NO3 [M]+ 307.1208, found 
308.1284 [M+H]+.
Ph
O
Br
Ph
O
N
Br
O
Ph
Bn
PhH, 100 °C, 40 h
BnNH2
209
H
N-Benzyl-2-oxo-N-(2-oxo-2-phenylethyl)-2-phenylethanaminium bromide (209)
Prepared by modification of a published procedure:5 A 2.0 M solution of benzylamine 
(5.5 mL, 50 mmol, 1.0 equiv) in benzene (25 mL) was added to a 1.0 M solution of 2-
bromo-1-phenylethanone (10 g, 50 mmol, 2.0 equiv) in benzene (50 mL). The resultant 
suspension was then diluted by the addition of  an additional 30 mL benzene. The 
suspension was heated under reflux at 100 °C for 2 days. After allowing the reaction to 
cool to ambient temperature, the precipitate was collected by suction filtration and 
washed with benzene (75 mL). The precipitate was suspended in MeOH (75 mL) and 
placed in a sonicating bath for 30 min. The precipitate was collected by suction filtration 
and washed with MeOH (25 mL). Residual solvent was removed under reduced 
pressure affording the title compound as a white powder (8.0 g, 75%). 1H NMR (500 
MHz, d6-DMSO) # 7.88 (d, 4H, J = 7.3 Hz), 7.71 (t, 2H, J = 7.4 Hz), 7.60–7.55 (m, 6H), 
7.34–7.32 (m, 3H), 5.05 (bs, 4H), 4.51 (bs, 2H); 13C NMR (125 MHz, d6-DMSO) # 191.4, 
134.9, 132.0, 129.9, 129.2, 128.8, 128.4, 128.1, 60.2, 60.0; IR (KBr) ! 3011, 2977, 
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2922, 1692, 1604, 1451, 1254, 895 cm$1; HRMS (ESI) calcd for C16H22NO2+ [M]+ 
344.1645, found 344.1647 [M]+.
Ph
O
N
Br
O
Ph
Bn
Ph
O H2
N
Br
O
Ph
cat. Pd/C, H2(g)
MeOH, rt, 8 h
209 210
H
Bis(2-oxo-2-phenylethyl)ammonium bromide (210)
A 200-mL Schlenck flask was charged with 10% Pd/C (0.172 g, 0.162 mmol, 0.010 equiv 
of Pd). The reaction vessel was evacuated and backfilled with H2(g) 10 times. MeOH 
(75.0 mL) was added followed by 209 (6.88 g, 16.2 mmol, 1.0 equiv). H2(g) was bubbled 
through the suspension until all of  209 had dissolved (ca. 8 h). The solution was filtered 
through celite to remove the Pd/C, the Celite cake was washed with MeOH, and the 
filtrate concentrated under reduced pressure. The crude solid was recrystallized from 
MeOH to afford the title compound as a white solid (4.6 g, 85%). 1H NMR (500 MHz, d6-
DMSO) # 9.54 (bs, 2H), 8.00 (d, 4H, J = 7.6 Hz), 7.76 (t, 2H, J = 7.4 Hz), 7.62 (t, 4H, J = 
7.7 Hz), 4.84 (s, 4H); 13C NMR (125 MHz, d6-DMSO) # 192.2, 134.9, 133.6, 129.3, 
128.3, 52.3; IR (KBr) ! 3001, 2912, 2814, 2716, 2588, 1687, 1599, 1554, 1368, 1259, 
969 cm$1; HRMS (ESI) calcd for C15H16NO+ [M]+ 226.1226, found 226.1232 [M]+.
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CH2Cl2, rt, 24 h
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(E)-4,4-Diethoxy-N,N-bis(2-oxo-2-phenylethyl)but-2-enamide (211)
In a single portion, 210 (4.0 g, 12 mmol, 1.0 equiv) was added to a solution of 198 (4.2 g, 
24 mmol, 2.0 equiv) in CH2Cl2 (120 mL). Next, EDCI (4.6 g, 24 mmol, 2.0 equiv), N,N-
dimethylaminopyridine (1.5 g, 12 mmol, 1.0 equiv) and N,N-diisopropylethylamine (10.5 
mL, 60 mmol, 5.0 equiv) were sequentially added. The brown solution was stirred for 24 
h at rt. After concentration of the solution under reduced pressure, the crude material 
was dissolved in EtOAc (250 mL) and sequentially washed with an aq 10% citric acid 
solution (2 x 125 mL), H2O (100 mL), sat aq NaHCO3 (2 x 125 mL), H2O (1 x 100 mL), 
and brine (1 x 100 mL). The EtOAc solution was then dried over Na2SO4, filtered and 
concentrated under reduced pressure. Purification by flash column chromatography 
(hexanes/EtOAc, 2:1) afforded the title compound as a yellow  foam (3.1 g, 63%). 1H 
NMR (500 MHz, CDCl3) # 7.95 (m, 4H), 7.63–7.55 (m, 2H), 7.50–7.43 (m, 4H), 6.74 (dd, 
1H, J = 15.3, 3.8 Hz), 6.38 (d, 1H, 15.3 Hz), 5.01 (s, 4H), 4.99 (d, 1H, J = 3.8 Hz), 3.57–
3.53 (m, 2H), 3.46–3.42 (m, 2H), 1.10 (t, 6H, J = 7.1 Hz); 13C NMR (125 MHz, CDCl3) # 
194.9, 194.0, 167.2, 142.1, 135.1, 134.6, 134.3, 133.9, 129.1, 128.9, 128.2, 128.0, 
122.4, 99.2, 61.2, 54.9, 52.9, 15.2; IR (thin film) ! 3063, 2976, 2927, 1697, 1658, 1449, 
1346, 1229, 1117, 1059, 1004, 756 cm$1; HRMS (ESI) calcd for C24H27NO5 [M]+ 
409.1889, found 432.1788 [M+Na]+.
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211 208
(E)-4-Oxo-N,N-bis(2-oxo-2-phenylethyl)but-2-enamide (208)
A 0.33 M solution of  211 (3.1 g, 7.6 mmol, 1.0 equiv) in THF (23 mL) was treated with 2N 
aq HCl (23 mL, 46 mmol, 6.0 equiv) and stirred vigorously for 1 h at ambient 
temperature. The solution was diluted with EtOAc (125 mL), washed with brine (100 
mL), dried over Na2SO4, filtered, and concentrated under reduced pressure to afford the 
title compound as a yellow  foam (2.5 g, quant). 1H NMR (500 MHz, CDCl3) # 9.66 (d, 1H, 
J = 7.1 Hz), 7.99–7.95 (m, 3H), 7.66–7.60 (m, 2H), 7.54–7.46 (m, 4H), 7.02 (d, 1H, J = 
15.7 Hz), 6.94 (dd, 1H, J = 15.7, 7.1 Hz), 5.05 (s, 4H); 13C NMR (125 MHz, CDCl3) # 
194.1, 193.3, 192.4, 166.0, 139.0, 136.1, 134.8, 134.7, 134.2, 134.1, 129.2, 129.0, 
128.1, 128.1, 55.0, 53.1; IR (thin film) '  3068, 2932, 2834, 2742, 1697, 1654, 1600, 
1449, 1351, 1229, 1112, 917, 756 cm$1; HRMS (ESI) calcd for C20H17NO4  [M]+ 335.1158, 
found 358.1031 [M+Na]+.
O
NHCbz
Me Me
HO
O
Me Me
NHCbz
(MeO)MeN
HN(OMe)Me•HCl
DCC, DMAP,DIPEA
Cbz-AIB 218
CH2Cl2, rt, 5 d
Benzyl-1-(methoxy(methyl)amino)-2-methyl-1-oxopropan-2-ylcarbamate (218)
To stirring solution of  Cbz-AIB6 (23.0 g, 96.9 mmol, 1.00 equiv) in CH2Cl2 (400 mL) was 
sequentially added N,O-dimethyl hydroxylamine hydrochloride (11.3 g, 116 mmol, 1.20 
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equiv), N,N-dimethylaminopyridine (14.2 g, 116 mmol, 1.20 equiv), N,N-
d i i sop ropy le thy l am ine (20 .0 mL , 116 mmo l , 1 . 2 equ i v ) , and N ,N ( -
dicyclohexylcarbodiimide (11.3 g, 116 mmol, 1.20 equiv). The resultant suspension was 
stirred for 5 days. The precipitate was filtered and the filtrate diluted with CH2Cl2 (400 
mL). This solution was sequentially washed with an aq 10% citric acid solution (2 x 400 
mL), sat aq NaHCO3 (2 x 400 mL), and H2O (2 x 100 mL), dried over Na2SO4, filtered 
and concentrated under reduced pressure. Purification by flash column chromatography 
(hexanes/EtOAc, 3:2) afforded the title compound as white solid (18.0 g, 67 %). 1H NMR 
(500 MHz, CDCl3) # 7.35–7.29 (m, 5H), 5.77 (bs, 1H), 5.08 (s, 2H), 3.60 (s, 3H), 3.19 (s, 
3H) 1.60 (s, 6H); 13C NMR (125 MHz, CDCl3) # 174.5, 154.7, 136.8, 128.6, 128.2, 66.4, 
60.8, 57.3, 34.0, 24.2; IR (thin film) ! 3327, 3034, 2985, 2937, 1717, 1649, 1527, 1454, 
1386, 1367, 1258, 1073, 995, 746, 698 cm$1; HRMS (ESI) calcd for C14H20N2O4 [M]+ 
280.1432, found 303.1311 [M+Na]+.
O
Me Me
NHCbz
(MeO)MeN
O
Me Me
NBn(Cbz)
(MeO)MeNNaH, BnBr
218 219
DMF, rt, 24 h
Benzyl benzyl(1-(methoxy(methyl)amino)-2-methyl-1-oxopropan-2-yl)carbamate 
(219)
To a stirring solution of  218 (9.16 g, 32.7 mmol, 1.00 equiv) in DMF (165 mL) cooled to 0 
°C was added NaH (60% mineral oil dispersion, 1.57 g, 39.2 mmol, 1.20 equiv). After 
effervescence had ceased (ca 10–15 min), benzyl bromide (4.30 mL, 36.0 mmol, 1.10 
equiv) was slowly added. The solution was allowed to warm to ambient temperature and 
stirred for 24 h. The solution was poured into a separatory funnel containing a solution of 
1:1 sat aq NH4Cl/brine (500 mL) and extracted with EtOAc (2 x 300 mL). The combined 
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organic fractions were then washed with brine (500 mL), dried over Na2SO4, filtered, and 
concentrated under reduced pressure. Purification by flash column chromatography 
(gradient, hexanes/EtOAc 2:1"4:3"1:1) afforded the title compound as a white solid 
(12.1 g, quant). 1H NMR (500 MHz, CDCl3) # 7.30–7.24 (m, 10H), 5.22 (s, 3H), 4.68 (s, 
2H), 3.38 (bs, 3H), 3.11 (bs, 3H), 1.43 (s, 6H); 13C NMR (125 MHz, CDCl3) # 175.2, 
139.3, 136.5, 128.6, 128.4, 128.2, 127.5, 127.2, 67.5, 62.3, 60.0, 47.7, 33.8, 25.1; IR 
(thin film) ! 3033, 2990, 2939, 1697, 1665, 1401, 1356, 1228, 1095, 998 699 cm$1; 
HRMS (ESI) calcd for C21H26N2O4 [M]+ 370.1893, found 393.1798 [M+Na]+.
O
Me Me
NBn(Cbz)
(MeO)MeN
O
Me Me
NBn(Cbz)
Me
MeMgBr, Et2O
219 220
0 °C!rt, 20 h
Benzyl benzyl(2-methyl-3-oxobutan-2-yl)carbamate (220)
Methyl magnesium bromide (3.0 M in Et2O, 55.0 mL, 165 mmol, 5.00 equiv) was added 
slowly to a chilled solution (0 °C) of  219 (12.1 g, 32.7 mmol, 1.00 equiv) in Et2O (165 
mL). The suspension was allowed to warm to ambient temperature and stirred for 20 h. 
The suspension was cooled again to 0 °C and ice was carefully and slowly added over a 
2 h period until the addition of  more ice no longer caused gas evolution. The solution 
was decanted from the precipitate into a separatory funnel and diluted with EtOAc (300 
mL) and H2O (300 mL). The aqueous phase was removed; the organic phase was 
washed with brine (250 mL), dried over Na2SO4, filtered and concentrated under 
reduced pressure. The crude material was sonicated in Et2O and the title compound 
precipitated as a white solid that was collected by suction filtration (crop 1: 5.5 g, 59%). 
The filtrate was concentrated and sonicated in a 3:2 solution of hexanes/Et2O. Again the 
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title compound precipitated as a white solid and was collected by suction filtration (crop 
2: 2.0 g, 19%). 1H NMR (500 MHz, CDCl3) # 7.30–7.24 (m, 10H), 5.16 (s, 2H), 4.64 (s, 
2H), 2.05 (bs, 3H), 1.26 (s, 6H); 13C NMR (125 MHz, CDCl3) # 207.5, 156.6, 139.4, 
136.2, 128.7, 128.6, 128.3, 127.3, 127.1, 67.9, 66.9, 47.5, 34.0, 23.6, 23.1; IR (thin film) 
! 3063, 2985, 2941, 1722, 1693, 1458, 1405, 1351, 1253, 1220, 1088, 741 cm$1; 
HRMS (ESI) calcd for C20H23NO3 [M]+ 325.1678, found 348.1579 [M+Na]+.
O
Me Me
NH2Bn
Me
221
cat. Pd/C, H2(g)
conc. HCl(aq)
EtOH, rt, 6 h
O
Me Me
NBn(Cbz)
Me
220
N-Benzyl-2-methyl-3-oxobutan-2-aminium chloride (221)
A 2-neck, round-bottomed flask was purged with N2(g) and charged with 10% Pd/C (1.14 
g, 1.08 mmol, 0.0500 equiv of  Pd). The reaction vessel was evacuated and back-filled 
with H2(g) three times before EtOH (200 proof, 100 mL) was added. Next, 220 (7.00 g, 
21.5 mmol, 1.00 equiv) was added followed by conc. aq HCl (3.70 mL, 43.0 mmol, 2.00 
equiv).  The heterogeneous solution was stirred at ambient temperature under an 
atmosphere of H2(g) until the starting material was consumed as indicated by TLC 
analysis. Upon completion of  the reaction, the solids were removed by filtration through 
a pad of Celite and the filter cake washed with MeOH. The filtrate was concentrated 
under reduced pressure to provide a crude white solid. The crude material was 
suspended in CH2Cl2 (200 mL), treated with sat aq NaHCO3 and stirred at ambient 
temperature for 2 h. The biphasic mixture was transferred to a separatory funnel, the 
organic phase removed and the aqueous phase extracted with CH2Cl2 (100 mL). The 
combined organic phases were washed with brine (150 mL), dried over Na2SO4, filtered 
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and concentrated under reduced pressure providing a crude oil. The oil was subjected to 
high vacuum to remove any 3-amino-3-methylbutan-2-one that resulted from over 
hydrogenation. The remaining crude material was dissolved in Et2O (100 mL), cooled to 
0 °C, treated with anhydrous HCl (4.0 M in dioxane, 5.40 mL, 21.6 mmol), and stirred for 
30 min. The resultant precipitate was collected by vacuum filtration to afford the title 
compound as a white solid (4.31 g, 88%). 1H NMR (500 MHz, CDCl3) # 9.89 (bs, 2H), 
7.64 (d, 2H, J = 7.0 Hz), 7.35–7.30 (m, 3H), 3.86 (t, 2H, J = 5.9 Hz), 2.18 (s, 3H), 1.54 
(s, 6H); 13C NMR (125 MHz, CDCl3) # 204.7, 131.4, 130.5, 129.5, 128.9, 67.4, 48.0, 
24.5, 21.6; IR (thin film) ' 3424, 3034, 2917, 2855, 1720, 1547, 1453, 1133, 757, 702 
cm$1; HRMS (ESI) calcd for C12H18NO3 [M]+ 192.1383, found 192.1390 [M]+.
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Me Me
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(E)-N-Benzyl-4,4-diethoxy-N-(2-methyl-3-oxobutan-2-yl)but-2-enamide (222)
Isobutyl chloroformate (0.52 mL, 4.0 mmol, 1.0 equiv) was added drop-wise to a solution 
of 198 (0.70 g, 4.0 mmol, 1.0 equiv) and N-methylmorpholine (2.2 mL, 20 mmol, 5.0 
equiv) in THF (20 mL) at $10 °C. The resultant suspension was stirred for 20 min at $10 
°C before the addition of 221 (1.1 g, 4.8 mmol, 1.2 equiv). The reaction vessel was 
equipped with a water-jacketed condenser and stirred at 50 °C for 20 h. The suspension 
was allowed to cool to ambient temperature, poured onto an aqueous 10% citric solution 
(50 mL) and extracted with EtOAc (75 mL). The organic extract was sequentially washed 
with aq 10% citric acid solution (50 mL), H2O (30 mL), sat aq NaHCO3 (2 x 50 mL), H2O 
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(30 mL), and brine (30 mL). The solution was dried over Na2SO4, filtered and 
concentrated under reduced pressure. Purification by flash column chromatography 
(hexanes/EtOAc, 3:2 doped with 0.5%/vol NEt3) provided the title compound as a white 
solid (1.1 g, 78%). 1H NMR (500 MHz, CDCl3) # 7.40–7.35 (m, 4H), 7.31–7.28 (t, 1H, J = 
6.8 Hz), 6.82 (dd, 1H, J = 15.2, 4.0 Hz), 6.45 (d, 1H, J = 15.2 Hz), 4.96 (d, 1H, J = 4.0 
Hz), 4.67 (s, 2H), 3.59–3.53 (m, 2H), 3.45–3.39 (m, 2H), 2.18 (s, 3H), 1.30 (s, 6H), 1.12 
(t, 6H, J = 7.0 Hz); 13C NMR (125 MHz, CDCl3) # 206.1, 167.2, 142.9, 138.3, 129.1, 
127.7, 126.3, 123.7 99.5, 66.4, 61.5, 47.8, 24.4, 22.9, 15.2; IR (thin film) ! 3034, 2980, 
2931, 2883, 1717, 1663, 1619, 1410, 1351, 1121, 1053, 737 cm$1; HRMS (ESI) calcd for 
C20H29NO4 [M]+ 347.2097, found 348.2163 [M+H]+.
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(E)-N-Benzyl-N-(2-methyl-3-oxobutan-2-yl)-4-oxobut-2-enamide (217)
A chilled (0 °C) solution of  222 (0.25 g, 0.72 mmol, 1.0 equiv) in THF (3.6 mL) was 
treated with 2N aq HCl (2.1 mL, 4.3 mmol, 6.0 equiv). The solution was slowly allowed to 
warm to ambient temperature. Upon completion, as observed by TLC analysis, the 
solution was diluted with EtOAc (25 mL), washed with brine (20 mL), dried over Na2SO4, 
filtered and concentrated under reduced pressure. Purification by flash column 
chromatography (hexanes/EtOAc, 3:2 doped with 0.5%/vol NEt3) provided the title 
compound as a white solid (0.13 g, 64%). 1H NMR (500 MHz, CDCl3) # ; 9.62 (d, 1H, J = 
7.0 Hz), 7.46–7.33 (m, 5H), 7.06–6.97 (m, 2H), 4.74 (s, 2H), 2.23 (s, 3H), 1.37 (s, 6H); 
13C NMR (125 MHz, CDCl3) # 206.0, 192.3, 165.8, 140.1, 137.4, 129.4, 128.2, 126.1, 
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66.8, 48.0, 24.7, 23.0; IR (thin film) ! 3034, 2985, 2931, 2849, 2736, 1712, 1693, 1644, 
1419, 1351, 1254, 1117, 1029, 976 cm$1; HRMS (ESI) calcd for C16H19NO3 [M]+ 
273.1365, found 274.1440 [M+H]+.
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15 mol% IMesCl
10 mol% DBU
10:1 THF:t-BuOH (0.05 M)
40 °C
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(3aR,6aR)-5-Benzyl-6,6,6a-trimethyltetrahydro-2H-furo[2,3-c]pyrrole-2,4(5H)-dione 
(223)
Prepared according to the general procedure for NHC-promoted cyclization-
lactonization. The following procedure is representative: An oven-dried vial was charged 
with IMesCl (13.4 mg, 0.0393 mmol, 0.150 equiv) and 217 (72.0 mg, 0.263 mmol, 1.00 
equiv). The vial was purged with N2(g) and charged with 10:1 THF:t-BuOH (5.2 mL) and 
DBU (0.25 M solution in 10:1 THF: t-BuOH, 0.10 mL, 0.025 mmol, 0.10 equiv). The vial 
was capped and the reaction stirred at 40 °C for 4.5 h. The solvent was removed under 
reduced pressure and the crude solid purified by flash column chromatography 
(gradient, hexanes/EtOAc/i-PrOH, 49:49:2"47.5:47.5:5) affording the title compound as 
a white foam (57 mg, 79%).  1H NMR (500 MHz, CDCl3) # 7.31–7.28 (m, 2H), 7.26–7.21 
(m, 3H), 4.52 (d, 1H, J = 15.5 Hz), 4.41 (d, 1H, J = 15.5 Hz), 3.08 (dd, 1H, J = 18.0, 0.7 
Hz), 3.03 (d, 1H, J = 9.0 Hz), 2.89 (dd, 1H, J = 18.0, 9.0 Hz), 1.45 (s, 3H), 1.26 (s, 3H), 
1.07 (s, 3H); 13C NMR (125 MHz, CDCl3) # 174.0, 171.9, 137.9, 128.9, 127.6, 127.5, 
90.2, 65.9, 46.5, 43.5, 31.7, 24.7, 20.2, 18.9; IR (thin film) ! 2976, 2937, 1780, 1693, 
1410, 1268, 1229, 1200, 1122, 1083, 946 cm$1; HRMS (ESI) calcd for C16H19NO3 [M]+ 
273.1365, found 296.1249 [M+Na]+.
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1. sorbyl chloride
    DIPEA, CH2Cl2
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2. 6N HCl(aq)
    rt, 1 h
3. Dess-Martin, 
    CH2Cl2, rt, 16 h
(R)-Methyl 2-(benzyloxymethyl)-2-((2E,4E)-N-(4-methoxybenzyl)hexa-2,4-
dienamido)-3-oxobutanoate (229)
To a 0.50 M solution of 2278 (0.357 g, 0.80 mmol, 1.0 equiv) in CH2Cl2 (1.6 mL) cooled 
to 0 °C was added N,N-diisopropylethylamine (0.21 mL, 1.2 mmol, 1.5 equiv). Sorbyl 
chloride (0.125 g, 0.96 mmol, 1.2 equiv) was added drop-wise and the solution stirred at 
0 °C for 0.5 h before being allowed to warm to ambient temperature. Stirring was 
continued for an additional 22 h. The solution was diluted with CH2Cl2 (20 mL), washed 
with brine (20 mL), dried over Na2SO4, filtered and concentrated under reduced 
pressure. The crude material was dissolved in THF (4.0 mL) and treated with 6N aq HCl 
(1.0 mL, 6.0 mmol, 7.5 equiv) at ambient temperature for 3 h. The solution was diluted 
with EtOAc (25 mL), washed with brine (20 mL), dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude orange oil was dissolved in CH2Cl2 (8.0 
mL), Dess-Martin periodinane (0.41 g, 0.96 mmol, 1.2 equiv) was added and the 
suspension stirred overnight. The solvent was removed under reduced pressure and the 
crude material taken up in EtOAc (30 mL). The solution was washed with a 1:1 solution 
of sat aq NaHCO3/sat aq Na2S2O3 (20 mL), washed with brine (20 mL), dried over 
Na2SO4, filtered and concentrated under reduced pressure. Purification by flash column 
chromatography (hexanes/EtOAc, 4:1 doped with 0.1%/vol NEt3) provided the title 
compound as a light yellow  foam (0.225 g, 60% over 3 steps). 1H NMR (500 MHz, 
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CDCl3) # 7.33–7.26 (m, 6H), 7.12–7.11 (m, 2H), 6.90 (d, 2H, J = 8.5 Hz), 6.11–6.05 (m, 
2H), 6.02 (d, 1H, J = 14.8 Hz), 4.91 (d, 1H, J = 18.4 Hz), 4.76 (d, 1H, J = 18.4 Hz), 4.30 
(d, 1H, J = 11.9 Hz), 4.26 (d, 1H, J = 11.9 Hz), 3.82 (s, 3H), 3.79–3.74 (m, 2H), 3.77 (s, 
3H), 2.42 (s, 3H), 1.78 (d, 3H, J = 5.0 Hz); 13C NMR (125 MHz, CDCl3) # 198.1, 169.9, 
168.8, 158.8, 145.4, 139.1, 137.0, 130.9, 130.2, 128.5, 128.0, 127.6, 127.3, 117.9, 
114.2, 73.8, 70.7, 55.4, 52.9, 48.9, 28.1, 18.7; IR (thin film) ! 3029, 3000, 2951, 2839, 
1737, 1654, 1617, 1517, 1356, 1249, 1175, 1098, 1029, 1000 cm$1; HRMS (ESI) calcd 
for C27H31NO6 [M]+ 465.2151, found 466.2240 [M+H]+.
Me
N
MeO2C
O
O
Me
OBn
PMB OH
OH
230
AD-mix !, 
(DHQ)2PHAL, OsO4
MeSO2NH2, NaHCO3
3:2 H2O/t-BuOH, rt, 24 h
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(2R)-Methyl-2-(benzyloxymethyl)-2-((E)-4,5-dihydroxy-N-(4-methoxybenzyl)hex-2-
enamido)-3-oxobutanoate (230)
To a round-bottomed flask charged with 229 (0.042 g, 0.090 mmol, 1.0 equiv) was 
sequentially added AD-mix % (0.126 g), (DHQ)2PHAL (0.0077 g, 0.0099 mmol, 0.11 
equiv), NaHCO3 (0.0023 g, 0.27 mmol, 3.0 equiv), MeSO2NH2 (0.0086 g, 0.090 mmol, 
1.0 equiv) and a solution of  H2O/t-BuOH (5:3, 1.5 mL). The mixture was cooled to 0 °C 
and OsO4 (4% wt in H2O, 0.0023 g, 0.0090 mmol, 0.10 equiv) was added. The mixture 
was allowed to warm to ambient temperature and stirred vigourously for 24 h before 
being quenched with sat aq Na2SO3 (0.5 mL). The aqueous mixture was extracted with 
EtOAc (4 x 7 mL), the combined extracts washed with 2N aq KOH (5.0 mL) and brine 
(5.0 mL), dried over Na2SO4, filtered and concentrated under reduced pressure. 
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Purification by flash column chromatography (CHCl3/MeOH, 15:1) yielded the title 
compound as a light tan foam (0.020 g, 44%). 1H NMR (500 MHz, CDCl3) # 7.37–7.26 
(m, 5H), 7.12–7.11 (m, 2H), 6.89 (d, 2H, J = 8.6 Hz), 6.87–6.83 (m, 1H), 6.42 (d, J = 15.0 
Hz), 4.91 (d, 1H, J = 18.4 Hz), 4.79 (d, 1H, J = 18.3 Hz), 4.29 (d, 1H, J = 11.9 Hz), 4.26 
(d, 1H, J = 11.9 Hz), 3.93 (bd, 1H, J = 4.1 Hz), 3.81 (s, 3H), 3.78 (s, 3H), 3.74 (s, 2H), 
3.62 (bs, 1H), 2.56 (d, 1H, J  = 5.0 Hz), 2.41 (s, 3H), 1.70 (bs, 1H), 1.14 (d, 3H, J = 6.3 
Hz); 13C NMR (125 MHz, CDCl3) # 198.1, 169.2, 168.6, 158.9, 146.4, 136.8, 130.5, 
128.5, 128.1, 127.7, 127.3, 121.6, 114.2, 77.5, 76.0, 73.9, 70.5, 70.2, 55.4, 53.0, 49.0, 
28.2, 19.1; IR (thin film) ! 3420, 3029, 2932, 2878, 1737, 1712, 1658, 1615, 1517, 
1409, 1361, 1244, 1092, 824 cm$1; HRMS (ESI) calcd for C27H33NO8 [M]+ 499.2206, 
found 500.2278 [M+H]+.
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(R,E)-Methyl-2-(benzyloxymethyl)-2-(N-(4-methoxybenzyl)-4-oxobut-2-enamido)-3-
oxobutanoate (225)
A solution of  230 (0.043 g, 0.086 mmol, 1.0 equiv) in CH2Cl2 (1.0 mL) was treated with 
sat aq NaHCO3 (0.10 mL) and NaIO4 at ambient temperature for 20 h. The 
heterogeneous mixture was filtered through a plug of Na2SO4 that was further washed 
with CH2Cl2 (15 mL). The filtrate was concentrated under reduced pressure to afford the 
title compound as a white foam (0.039 g, quant). 1H NMR (500 MHz, CDCl3) # 9.56 (d, 
1H, J = 7.1 Hz), 7.38–7.33 (m, 2H), 7.31–7.26 (m, 3H), 7.13–7.11 (m, 2H), 7.01–6.92 (m, 
4H), 4.97 (d, 1H, J = 18.4 Hz), 4.81 (d, 1H, J = 18.6 Hz), 4.32 (d, 1H, J = 11.9 Hz), 4.28 
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(d, 1H, J = 11.7 Hz), 3.83 (s, 3H), 3.81 (s, 3H), 3.79 (s, 2H), 2.45 (s, 3H); 13C NMR (125 
MHz, CDCl3) # 197.8, 192.4, 168.0, 167.5, 159.2, 140.2, 139.6, 136.5, 129.7, 128.6, 
128.2, 127.8, 127.2, 114.5, 77.9, 74.0, 70.3, 55.5, 53.2, 49.2, 28.1; IR (thin film) ! 3006, 
2953, 2922, 2834, 1742, 1694, 1651, 1513, 1412, 1357, 1248, 1110 cm$1; HRMS (ESI) 
calcd for C25H27NO7 [M]+ 453.1788, found 476.1665 [M+Na]+.
N
O
O
O
CO2Me
PMB
OBn
Me
N
O
O
O
CO2Me
PMB
OBn
Me
Me
N
MeO2C
O
O
H
OBn
PMB O
15 mol% IMesCl
10 mol% DBU
10:1 THF/t-BuOH (0.05 M)
40 °C, 3h
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+
231 232
(3aR,6R,6aS)-Methyl 6-(benzyloxymethyl)-5-(4-methoxybenzyl)-6a-methyl-2,4-
dioxohexahydro-2H-furo[2,3-c]pyrrole-6-carboxylate (231 deisred) and (3aS,6R,
6aR)-Methyl 6-(benzyloxymethyl)-5-(4-methoxybenzyl)-6a-methyl-2,4-
dioxohexahydro-2H-furo[2,3-c]pyrrole-6-carboxylate (232 undesired)
Prepared according to the general procedure for the NHC-promoted cyclization-
lactonization. The following procedure is representative: An oven-dried vial containing 
225 (12.4 mg, 0.027 mmol, 1.0 equiv) was charged with IMesCl (1.4 mg, 0.0040 mmol, 
0.15 equiv). The vial was purged with N2(g) and then charged with 10:1 THF:t-BuOH 
(0.55 mL) and DBU (0.50 µL, 0.0036 mmol, 0.10 equiv). The vial was capped and the 
reaction stirred at 40 °C for 6 h. The solvent was removed under reduced pressure and 
the crude solid purified by flash column chromatography (hexanes/acetone, 3:1) to afford 
the mixture of diastereomers as a white film (9.3 mg, 75%). 
231 desired: 1H NMR (500 MHz, CDCl3) # 7.33–7.26 (m, 5H), 7.09 (d, 2H, J = 6.8 Hz), 
6.78 (d, 2H, J = 8.6 Hz), 5.04 (d, 1H, J = 15.2 Hz), 4.28 (d, 1H, J = 15.2 Hz), 3.91 (d, 1H, 
J = 11.5 Hz), 3.83–3.80 (m, 2H), 3.80 (s, 3H), 3.74 (s, 3H), 3.21 (d, 1H, J = 10.4 Hz), 
195
3.04 (d, 1H, J = 9.3 Hz), 2.95 (d, 1H, J = 18.3 Hz), 2.80 (dd, 1H, J = 18.3, 9.6 Hz), 1.60 
(s, 3H); 13C NMR (125 MHz, CDCl3) # 173.7, 173.1, 167.1, 159.2, 136.9, 130.2, 129.6, 
128.6, 128.1, 127.5, 113.8, 88.6, 76.0, 73.0, 67.9, 55.4, 53.0, 47.7, 45.3, 30.9, 19.6; IR 
(thin film) ! 2956, 2922, 2853, 1790, 1761, 1702, 1614, 1512, 1454, 1400, 1249, 1181, 
1131, 737 cm$1; HRMS (ESI) calcd for C25H27NO7 [M]+ 453.1788, found 476.1690 
[M+H]+.
232 undesired: 1H NMR (500 MHz, CDCl3) # 7.36–7.29 (m, 3H), 7.20 (d, 2H, J = 6.8 
Hz), 7.08 (d, 2H, J = 8.6 Hz), 6.78 (d, 2H, J = 8.6 Hz), 4.67 (d, 1H, J = 15.1 Hz), 4.37 (d, 
1H, J = 15.1 Hz), 4.30 (d, 1H, J = 11.6 Hz), 4.25 (d, 1H, J = 11.6 Hz), 3.89 (d, 1H, J = 
10.2 Hz), 3.78 (s, 3H), 3.71 (d, 1H, J = 10.0 Hz), 3.63 (s, 3H), 3.04–2.99 (m, 2H), 2.84 
(dd, 1H, J = 18.4, 10.0 Hz), 1.47 (s, 3H); 13C NMR (125 MHz, CDCl3) # 173.6, 173.4, 
169.4, 160.0, 137.3, 129.4, 129.2, 128.5, 128.0, 127.9, 86.8, 75.5, 73.8, 68.9, 55.4, 53.0, 
47.2, 45.3, 31.1, 21.6; IR (thin film) ! 2951, 2927, 2853, 1790, 1746, 1702, 1610, 1512, 
1439, 1249, 1127, 737 cm$1; HRMS (ESI) calcd for C25H27NO7 [M]+ 453.1788, found 
476.1691 [M+H]+.
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